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α     Womersley number 
b-FGF     Basic fibroblast growth factor 
CFD     Computational fluid dynamics 
ePTFE     Expanded polytetrafluoroethylene 
ID     Inner diameter 
µ     Dynamic viscosity 
OSI     Oscillatory shear index 
PDGF     Platlet derived growth factor 
ρ     Density 
Q     Volumetric flow rate 
RBC       Red blood cell 
Re     Reynold’s number 
Sc     Schmidt number 
τavg(z)    Spatially averaged temporal mean WSS 
τs(z,t)     Spatially averaged WSS 
TGF-β     Tumor growth factor 
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VEGF     Vascular endothelial growth factor 
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Each year, more than one million prosthetic vascular grafts are implanted. Well-
over 50 % of these artificial vessels are of the small caliber variety with an inner diameter 
less than or equal to 10 mm. The challenge rests in implanting these synthetic substitutes 
into a hemodynamic environment with a high downstream resistance and low rates of 
flow.  
Over the course of four interrelated studies, we investigated the healing properties 
of small caliber prosthetic vascular grafts. All of these studies were conducted using 
baboons (papio cynecepahlus). First, we documented the difference in healing response 
between three different types of vascular grafts: (1) autologous artery (2) allogeneic 
vessel (3) prosthetic ePTFE. This comparison furnished an important model of graft 
healing. In addition, our study presented a novel method for measuring intimal thickness 
and used this tool to document morphometric details of the neointima’s leading edge. 
Proliferating endothelial cells were localized to the top 10 % of the neointima, increasing 
in concentration towards the leading edge, while the proliferating smooth muscle cells 
were identified within the lower 10 % of the neointima, increasing in concentration near 
the anastomosis.  
Secondly, we examined the effects of changing a prosthetic graft’s material 
properties and how that change impacts healing of the graft’s surface. These 
ultrastructural changes were introduced by radially stretching a porous 60 µm ePTFE 
vascular graft. Changes to graft ultrastructure were documented with morphometric 
analysis of void fraction, internodal distance, graft thickness, and nodal width. Radially 
 xxiii
stretching the graft material decreased the void fraction, reduced the potential for 
transmural ingrowth, and changed the healing characteristics of the implanted vessels.  
Thirdly, we investigated the effect of a changing hemodynamic environment upon 
the healing of a vascular graft with uniform material properties. The changing 
hemodynamics were generated with a stenotic model rather than with a variation in the 
volumetric flow rate. Under sub-acute conditions, an inverse relationship failed to exist 
between intimal thickening and wall shear stress. The recent deposition of the shear-rate 
responsive endothelium explained this observation. 
 Lastly, the details of this hemodynamic environment were documented with 
computational fluid dynamics (CFD). The computational grids were constructed using 
three sets of geometric information: (1) incorporating the ideal material dimensions of the 
implanted vessel (2) utilizing contour information from pressure-perfused histologic 
cross-sections (3) applying geometric information form detailed MRI imaging. In the 
construction of the computational grids, various smoothing algorithms were applied. 
Pulsatile simulations were conducted using input waveforms from either pulse-transit 
ultrasound or Phase Contrast Magnetic Resonance Imaging. Grid reconstruction using 
MRI imaging information provided the best description of the vessel’s hemodynamic 
environment. With this computational information, correlations were made between the 
intimal thickening of the previously harvested vascular grafts and such hemodynamic 
parameters as spatially averaged wall shear stress, temporally averaged wall shear stress, 







History of Vascular Grafts 
 
 
More than one million vascular grafts are implanted each year, generating well 
over 1 billion dollars in sales [1,2]. Vascular grafts are needed to treat such 
atherosclerotic manifestations as occlusive or aneurysmal disease. Within the United 
States atherosclerotic disease targets one out of every four people, resulting in over 40% 
of all deaths [88]. This staggering percentage emphasizes the need for effective surgical 
repair.  
Vascular graft repair of abdominal and thoracic aneurysms achieves patency rates 
greater than 95% after five years. Several factors contribute towards this success rate: (1) 
the flow environment, (2) the low downstream resistance, and (3) the large diameter of 
the aorta. Long-term patency rates are more challenging for smaller vessels with higher 
downstream resistance and lower rates of flow. For example, in the treatment of ilio-
femoral-popliteal-tibial disease, five-year patency rates are less than 50% [3,89]. 
Unfortunately, with the inclusion of dialysis access grafts, over 70% of vascular grafts 
are these small caliber conduits with an inner diameter equal to or less than 10 mm [1,2].  
 2
Each year vascular surgeons implant well over 500,000 grafts into these peripheral 
circulatory beds [4,5]. In addition, well-over 100,000 patients on hemodialysis contend 
with a monthly reoccurrence of occluded access grafts. Overall, a compelling need arose 
to enhance the performance of surgically implanted peripheral vascular grafts and to 
achieve more favorable clinical outcomes [90]. 
 There exists an array of vascular graft types: autologous, allogeneic, synthetic. 
The surgeon’s first choice is an autologous graft such as the saphenous vein or the 
internal thoracic artery.  Nonetheless, in approximately 30 % of patients, autologous 
vessels will not be used due to pre-existing disease, already utilized, or a size mismatch 
[6,7]. In response, physicians will usually preserve the saphenous vein for more difficult 
reconstructions (e.g., femoral-tibial) and use synthetic grafts for less challenging 
procedures such as femoral-popliteal bypass above the knee [3]. Following World War II, 
various allografts were implanted but encountered poor success due to robust immune 
rejection [8,9]. Allogeneic grafts found some renewed acceptance with the development 
of techniques designed to denature the vessels and remove their antigenicity [2].  
 Early on, researchers identified the need to engineer synthetic vascular grafts. 
Initially, these pioneers sought materials with as smooth a surface as possible. They 
attempted to investigate such materials as metal, glass, or ivory tubes. As expected these 
primitive attempts were quickly met with failure [10]. Things began to change in 1952 
when Voorhees [12] identified a more promising alternative, a woven synthetic graft that 
promoted healing of its lumenal surface. In an experiment Voorhees placed a silk thread 
in the right ventricle of a dog’s heart, only to find it covered several months later with a 
“glistening film of thin-fibrous endothelial-like coating.”  From this finding, Voorhees 
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concluded that the synthetic mesh of “Vinyon N” cloth promoted the formation of a non-
thrombogenic flow surface composed of a tissue coating and fibrin.  In 1954, Voorhees, 
et al., [11, 12] used the new fabric grafts to surgically repair seventeen abdominal aortic 
aneurysms and one popliteal aneurysm. Subsequently, efforts to develop smooth-walled 
grafts were abandoned in favor of textured fabric surfaces that promoted tissue ingrowth 
and healing of the graft surface. This design strategy persists even to today in our 
continuing investigation of new synthetic grafts.  
The success of Voorhees encouraged engineers to develop new synthetic 
materials for vessel replacement, including knitted and woven Dacron and a modified 
version of Teflon (expanded polytetrafluoroethylene, or ePTFE). Interestingly, these two 
materials still comprise the most widely used synthetic vascular prostheses. For small 
caliber vessel reconstruction, ePTFE remains the standard. Over 30 years after the 
introduction of ePTFE, researchers and clinicians have achieved little improvement in 
overall patency rates of these synthetic grafts [3].  Obstacles continuing to limit the 
success of these small caliber ePTFE grafts are most noticeably (1) thrombosis and (2) 
pseudointimal hyperplasia. A number of anti-thrombotic agents and graft coatings are 
under development, although none has received widespread acceptance. Similarly, 
significant questions still persist with the pathogenesis of pseudointimal hyperplasia and 
strategies for inhibiting its growth. Until the intricacies of vascular biology are better 
understood, the development of a successful, small-caliber vascular graft will continue to 













Thrombosis and thromboembolic occlusion pose one of the first challenges to 
synthetic graft patency. A thrombosis represents an abnormal clotting of a blood vessel. 
The origins of a thrombus are either primary, resulting from a genetic predisposition 
involving the coagulation factors, or secondary, resulting from changes in either 
coagulation factors, blood vessels, or blood flow. As Virchow [92] noted well over 150 
years ago, thrombus derives from three possible sources: (1) decreased blood flow or a 
change in the local hemodynamics (2) vessel injury or inflammation (3) alterations in the 
rheologic properties. A thrombus consists of two blood cell types: (1) platelets and (2) 
red blood cells (rbc). These blood cells aggregate with the help of interacting 
glycoproteins, plasma proteins, and fibrin. This process depends upon three platelet 
functions (adhesion, activation, and aggregation) and the plasma coagulation cascade. 
Within arterial systems, a thrombus can consist of either an accumulation of platelets 
with little fibrin (white thrombus) or an aggregation of red blood cells, fibrin, and 
relatively few platelets (red thrombus) [93].  
To some extent, all synthetic vascular grafts are thrombogenic. Synthetic grafts 
less than 2 mm in diameter fail acutely due to thrombotic occlusion [13-15]. Even with a 
diameter of 4 to 6 mm, the grafts demonstrate frequent acute or sub-acute occlusion in 
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spite of anti-platelet or anticoagulant therapies [16-20]. The thrombosis arises from 
alterations in the exposed prosthetic surface, varying hematologic and hemodynamic 
variables, wide-ranging device configurations, and tissue injury at graft-vessel 
anastomoses [21].  
For thrombosis studies, the baboon serves as a very useful animal model with its 
close rheologic similarity to humans [22]. With this animal model in hand, investigators 
questioned which of the two most frequently used synthetic grafts (Dacron or ePTFE) 
was more thrombogenic. In 1989 Schneider [23] concluded through a baboon study of 
111In labeled platelets that knitted Dacron was more thrombogenic than ePTFE. Even 
though researchers identified how the surface chemistry affected thrombosis, no 
relationship was yet established between the two. Investigators have tried many different 
approaches to reduce graft thrombogenicity: (1) seeding the grafts with endothelial cells 
(2) coating the grafts with select polymers (3) administering antithrombotic therapy. 
Despite these efforts clinical graft patency rates have not significantly improved. This 







 In 1906 Carrel and Guthrie [27] first described the intimal hyperplasia adherent to 
a vascular bypass anastomosis as closely resembling the endothelium. Later in 1936, 
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Stchelkounoff [96] reported that the predominant cell type within intimal hyperplasia was 
a vascular smooth muscle cell. Intimal hyperplasia results from damage to the overlying 
endothelium, catalyzing a series of events that transform a subset of smooth muscle cells 
from a contractile state to a synthetic mode. This results in smooth muscle cell 
proliferation and migration into the neointima. Once in the neointima, the smooth muscle 
cells begin a second proliferative process, followed by the final stage when they 
synthesize and deposit a complex extracellular matrix of collagen, elastin, proteoglycans, 
fibronectin, laminin, dermatan sulfate, and heparin sulfate. This process of smooth 
muscle cell proliferation, migration, and synthesis of complex extracellular matrix 
constitutes the basis of intimal hyperplasia. The endothelium, vascular smooth muscle 
cells, and inflammatory cells influence these sequelae through release of several growth 
factors and cytokines (PDGF, FGF, VEGF, TGF-β, TNF, tissue factor, thrombin, 
Angiotensin II, TGF-γ, endothelin, tissue plasminogen activators, metalloproteinases) 
[28-31, 96]. Platlet Derived Growth Factor (PDGF) and bFGF (basic Fibroblast Growth 
Factor) are the two growth factors most intimately involved with smooth muscle cell 
proliferation and migration. BFGF originates from damaged endothelial and vascular 
smooth muscle cells and directly stimulates proliferation of vascular smooth muscle cells. 
PDGF-BB derives from platelet α-granules and stimulates migration but not proliferation 
of smooth muscle cells. Transforming Growth Factor-β, angiotensin II, and bFGF also 
promote vascular smooth muscle cell migration [97]. Intimal hyperplasia can be found at 
many different locations within a vessel: (1) scattered throughout the vessel (2) focal to 
an anastomosis (3) focal to a location within the vessel body. From this intimal 
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hyperplasia either sub-acute or chronic failure of implanted prosthetic vascular grafts 
result.  
It was not until 1971 that researchers and clinicians first identified that intimal 
hyperplasia can contribute to vascular graft failure [95]. Approximately 30% of 
peripheral bypass grafts develop clinically significant stenotic areas within the first year 
following surgery. For prosthetic vascular grafts, anastomotic intimal hyperplasia causes 
the overwhelming percentage of patency failures. Several factors contribute towards this 
troubling sequelae: (1) hemodynamic factors such as separated and disturbed flow (2) 
compliance mismatch between graft and native vessel (3) biomaterial incompatability 
with resultant foreign body response (4) mural injury (5) activation of platelets by barren 






 Before a vascular graft can develop intimal hyperplasia, the luminal surface must 
endothelialize. By virtue of its interface between the blood and the vessel wall, the 
endothelium occupies the important role of regulating vessel wall homeostasis. The 
endothelium regulates vascular tone through release of nitric oxide and prostacyclin, 
potentiates an anticoagulated state through the release of heparin sulfate, and recruits an 
immune response through the release of interleukins that attract inflammatory cells. 
Furthermore, the endothelium controls the structure of the vessel wall by releasing factors 
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such as nitric oxide, prostacyclin, and natriuretic peptides to help regulate smooth muscle 
cell proliferation, migration, and apoptosis. The endothelium regulates the deposition and 
degradation of underlying extracellular matrix through release of enzymes such as 
metalloproteinases. Lastly, endothelial cells function as an important physical barrier 
between growth factors and other circulating hematologic mediators and the underlying 
vascular smooth muscle cells. Overall, this discourse explains why researchers seek 
prosthetic materials that promote the healing of a graft surface with a confluent layer of 
endothelium. Ultimately, this healed surface limits thrombosis and promises to extend 
long-term graft patency [97-101]. 
Over the years, researchers documented three possible sources of graft 
endothelialization. The first and most well chronicled mean occurs by transanastomotic 
pannus ingrowth. This describes a process whereby adjoining host tissue grows across the 
anastomosis onto the lumenal surface of the graft. The second avenue operates through 
fibrous tissue and µ-vessel invasion through the interstices of the synthetic graft’s porous 
wall. Following implantation, perigraft and adhesion tissue deposits on the outside of the 
graft. This tissue then migrates across the wall of the graft, resulting in growth on the 
inner flow surface. Interestingly, not until 1995 did researchers document such 
endothelial ingrowth within a vascular graft implanted into a human [37]. The last 
channel works through deposition of circulating endothelial or multipotential precursor 
cells from the circulating blood onto the luminal flow surface of the graft [32-36]. The 
average normal adult only has 2.6 ± 1.6 circulating endothelial cells per milliliter of 
blood. This sparse number makes endothelializing a graft by this means increasingly 
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difficult [102]. Recently, investigations of endothelial cell seeding have found renewed 
life, but in our discussion, we will focus our attention on the first two mechanisms. 
 Clowes [38] began the first baboon studies to investigate healing of a clinical, 30 
µm ePTFE graft. The baboon serves as an excellent animal model to study 
endothelialization and general cellular healing response of implanted grafts. Through 
placement of carotid and aorto-iliac interposition grafts, researchers established that the 
baboon’s healing response closely mirrored that of humans. In his first studies Clowes 
documented that the endothelium and smooth muscle cells within the ePTFE graft 
derived from the adjacent arteries’ cut ends and grew at a rate of 0.2 mm/day. He showed 
that the endothelial and smooth muscle cells proliferated at two distinct zones: (1) 
neointima’s leading edge (2) suture-line anastomosis. At the leading edge Clowes 
reported that smooth muscle cells and endothelial cells proliferated in association. At the 
anastomosis he concluded that the cell proliferation and the subsequent narrowing 
resulted from chronic endothelial injury at the surgical suture line and continued turnover 
of underlying cells resulting in intimal thickening. The frequent turnover of cells results 
from the dynamic environment of the anastomosis: (1) disturbed, non-laminar blood flow 
(2) compliance mismatch between host and graft vessels. Even with an intact 
endothelium, smooth muscle cells continued to proliferate, and extracellular matrix 
deposition continued [39].  
This work led Clowes to ask whether at late times the endothelial cells and 
smooth muscle cells continued to migrate and to proliferate. Clowes found that at six and 
twelve months the endothelial cell ingrowth was more advanced than at three months; 
however, at twelve months, a significant portion of the flow surface still remained 
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unhealed. In fact, Clowes documented that after twelve months only 60 % of the graft’s 
lumenal surface was endothelialized. Since the surface was not completely healed, 
endothelial and smooth muscle cell proliferation still persisted. These results contrasted 
with previous balloon injury studies of native vessels where endothelial and smooth 
muscle cell proliferation ceased once a confluent endothelium had been established. Once 
again, these results emphasized the importance of a synthetic graft that promoted 
confluent healing of the luminal, flow surface [40].  
In addition, these studies revealed more about anastomotic healing. At the suture 
line the percentage of cells to extracellular matrix reached a limiting ratio of 1:4. For 
long-term implants, this naturally permits for increased intimal thickening and eventual 
occlusion of the graft lumen [40]. Concurrently, other researchers explored options to 
inhibit this trans-anastomotic ingrowth that Clowes described. Hanson [41] created a 
relatively smooth and non-textured graft surface by coating a 30 µm ePTFE vessel with a 
polymer coating of nonporous silicone and vapor-phase deposited fluoropolymer. This 
combination coating produced a smooth blood-contacting surface immune from the usual 
graft porosity and texture of ePTFE. As a result, the coated vessel became immune to 
ingrowth from adjacent native vessels and effectively prevented vascular lesion 
formation. While this prevented extensive ingrowth from neighboring native tissue, it 
also prevented the graft surface from forming a healthy, healed endothelium. Ultimately, 
this approach resulted in adverse surgical outcomes. In response, investigators questioned 
whether the solution was found in a graft that allowed for healing across its wall. 
Well-established that endothelialization occurred by transanastomotic ingrowth, 
scientists explored whether the same process happened transmurally. In 1961 
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Wesolowski and Sawyer [42] concluded that porous synthetic grafts demonstrated 
improved patency rates through their promotion of fibrous ingrowth from perigraft tissue. 
In 1962 Florey [43] observed islands of endothelium along Dacron grafts implanted into 
nonhuman primate subjects. Florey concluded that the endothelium arose from capillary 
invasion of the graft material and subsequent transmural healing. With a porous 60 µm 
ePTFE model, Clowes later confirmed that the confluent endothelium derived from 
transmural capillaries linking the graft lumen to extravascular granulation tissue. Clowes 
showed that these porous ePTFE grafts were completely covered by one to two weeks 
with a confluent layer of endothelial cells. Even after three weeks, the endothelial 
replication rate was still elevated and at a rate that far exceeded that seen in the less 
porous 30 µm ePTFE. This contrasted with the failure of the transanastomotic ingrowth 
to completely endothelialize the surface of the 30 µm ePTFE grafts. Intrigued by this 
result, Clowes investigated an even more porous 90 µm ePTFE graft. Beyond the 
anastomosis, he observed the same results of endothelial coverage and intimal thickening; 
however, at focal sites, he observed endothelial loss resulting from instability of the 
newly deposited intima. Complicating matters further, the 90 µm ePTFE was found to be 
a very thrombogenic surface. On manual exam, its surface has a rough and textured feel. 
From these results, Clowes concluded that a 60 µm internodal distance constituted the 
optimum porosity for a healed ePTFE surface.  
Still, uncertain about the dynamics of the vascular biology, Clowes conducted 
further studies. Upon closer investigation of their luminal surfaces, Clowes used cell 
specific immunostaining to identify how the smooth muscle cell invaded across the wall 
of these porous grafts. Ultimately, this cell ingrowth leads to progressive wall thickening, 
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intimal hyperplasia, and eventual graft failure. Clowes felt that the source of this 
mitogenic activity came from endothelial, smooth muscle, or perigraft inflammatory cells 
rather than such circulating cells as platelets. He later proved through ex vivo experiments 
that these vascular wall cells functioned as the primary source of these growth factors 










Early on, mechanical factors were recognized as important parameters involved in 
long-term graft patency. Researchers identified that one of the factors limiting success of 
prosthetic vascular grafts was their mechanical mismatch with the host vessel. It was long 
known that the patency of grafted arteries and veins surpassed the patency of prosthetic 
vascular grafts. Why was this trend observed? Upon physical exam, the prosthetic grafts 
were found to be much stiffer than the host vessels. Traditionally, investigators described 
this mechanical difference in terms of the ability of the vessel to dilate under pressure or 
the so-called compliance. A stiffer or less compliant vessel impedes the transmission of 
the pulsatile flow wave energy along the course of the arterial tree [148]. This 
interruption establishes pulsatile mechanical stresses at the anastomosis. These stresses 
can result in suture-line disruption, formation of a false aneurysm, and development of 
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subintimal hyperplasia [149]. In all, these events can either result in thrombosis and 








In addition to a compliance mismatch, other mechanical factors were also 
involved. For many years, researchers have known that hemodynamic factors function as 
strong regulators of vessel wall structure. Intraluminal pressure governs wall thickness 
through effects on wall tension [49]. Blood flow influences vessel diameter through 
changes in shear. With chronically reduced blood flow through a vessel, a structural 
modification of the arterial wall occurs, leading to a reduction in the arterial diameter 
[146], while elevations in blood flow culminate in an adaptive expansion of the vessel 
diameter [147]. This dynamic vessel response is mediated by the endothelium. The 
hemodynamic effect is pervasive at all points in time. Even in the earliest years of child 
development, increases in the hemodynamic factors of blood pressure and blood flow 
result in arteries developing greater wall thickness and a larger luminal caliber to help 
maintain wall shear stress within the physiologic range of 10 to 30 dynes/cm2 [50-52]. 
Naturally, researchers began to question whether there was a relation between such 
hemodynamic parameters as wall shear stress and intraluminal healing. Intitially, this 
investigation focused upon examining the pathogenesis of atherosclerotic plaques. 
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In studies of the abdominal aorta, Fry [53] first postulated that elevated levels of 
shear stress were promoting growth of the atheroma. Fry concluded that the high shear 
rates were damaging the endothelium, leading to an increase in lipid permeability, and 
subsequent enlargement of the atherosclerotic plaque. Researchers later found that this 
event only occurred when wall shear stress reached an incredibly high value on the order 
of 400 dynes/cm2. Other investigators offered an array of alternative theories. Fox [140] 
asserted flow separation promoted platelet activation and deposition, Mustard [141] 
contended that “local rapid flow fluctuations” or turbulence promoted atheroma, while 
Mitchell and Schwartz [142] identified a reduction in fatty streaking within localized 
areas of low wall shear rate. Many of these ideas contended that the hemodynamics 
exerted a causative effect upon atherosclerotic plaque formation. Counter to this thinking, 
Caro [54] claimed that the hemodynamics instead exercised a “controlling effect.” In 
essence, high levels of wall shear stress (WSS) inhibit plaque formation, while low levels 
of WSS promote its development.  
Through a series of experiments involving in vitro and in vivo work, investigators 
offered an ever-enlarging voice to Caro’s ideas.  The work of Zarins, Giddens, et al. [55] 
convincingly identified a relation between wall shear stress and plaque deposition in the 
human carotid bifurcation under steady state conditions. They concluded that plaque 
deposition was minimal near the flow divider (inner wall) where shear stress was high, 
while plaque deposition was maximal at the outer wall of the carotid sinus where low 
wall shear stress and separated flow occurred. Ku et al. [56] established the same results 
in a pulsatile model of the carotid bifurcation. Friedman conducted similar studies within 
the bifurcation of the abdominal aorta [143], while Friedman [144] and He [145] 
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examined the complicated coronary vasculature. Even today, researchers still strive to 
better understand this relationship between vascular biology and hemodynamics. 
 
 
Graft Healing and Hemodynamics 
 
 
Native arteries respond to changes in hemodynamics in many ways. As described 
above, that change can occur by remodeling of vascular architecture or through 
vasoconstriction/vasodilation of the native vessel. By introducing a model of a rigid, 
synthetic ePTFE graft, the effect of changes in wall shear stress can be isolated to 
alterations in vascular architecture. Clowes conducted a number of experiments in 
baboon models where he exposed the implanted grafts to varying levels of shear stress. 
With an in vivo model he observed that high wall shear stress resulted in a marked 
decrease in intimal thickening. Through various histologic and immunostaining profiles, 
he demonstrated how high shear levels decrease intimal area, intimal thickness, and 
smooth muscle cell proliferation. He documented these results through three different 
trials in baboon models [59]. In addition, the work demonstrated how an high shear 
environment can induce an upregulation of constitutive nitric oxide synthetase (cNOS) 
within the intima of implanted vascular grafts. This nitric oxide exerts a profound ability 
to inhibit intimal smooth muscle cell proliferation. These observations help to explain the 









In the past, researchers have used a stenotic model to investigate a varying 
hemodynamic environment with changes in wall shear stress. The percent area reduction 
along with the length and shape of the stenosis are all involved in defining this unique 
hemodynamic environment. The stenotic model provides insight into how the 
hemodynamic behavior may influence progression of either atherosclerosis or intimal 
hyperplasia. To a first approximation in a straight vessel segment, WSS varies by the 
reciprocal of the radius raised to the third power; consequently, small changes in the 
radial dimension of the vessel result in large changes in wall shear stress. In the past a 
dog model was used to characterize flow data within different stenoses with varying 
degrees of a constricted band fitted around the thoracic aorta [60]. This was followed by a 
similar study conducted with cynomolgus monkeys fed an atherogenic diet. From this 
work, researchers documented the tendency of flow separation and instability to promote 
atherogenesis, while increased flow was identified as protecting the vessel from atheroma 
[149]. Later on, In vitro work investigated symmetric stenoses with mild, moderate, or 
severe occlusions (50 %, 75 %, 90 % reductions in cross luminal area). Within the 50% 
and 75% symmetric stenosis models, it was found that pulsatile conditions resulted in 
flow disturbances over a range of Reynold’s numbers from 200 – 1000. These 
disturbances assumed the form of starting structures and puff formations, all of which 
impacted measured wall shear stress values [61]. Ultimately, the extent to which these 
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flow disturbances affected the wall shear stress values hinged on the Reynolds number 






 Overall, vascular biology involves the interaction and the kinetics of many 
contributing factors. Our ability to design a patent vascular graft hinges on how 
successful we are in accomplishing two important goals. First and foremost, we need to 
improve our understanding of vascular biology and its many dynamics. Secondly, with 
this knowledge in hand, we need to engineer solutions that both limit and promote 
directed aspects of the vascular biology. In the following discourse, we will address many 









 Researchers continue to seek a small caliber vascular graft immune from failure 
due to thrombosis and pseudointimal hyperplasia. Many different sources of vascular 
grafts have been examined: (1) autologous, (2) allogeneic, and (3) prosthetic. Early on, 
studies identified the following fundamental tenet for a successfully implanted vascular 
graft - regardless of the vessel source, the luminal surface should heal in a way that most 
closely mirrors a native, healthy vessel.  In 1952 Voorhees [11] paved this road with his 
experiments using the “Vinyon N” cloth. Soon after, investigators discovered two 
materials relatively well suited as prosthetic vascular grafts: (1) Dacron and (2) ePTFE 
(expanded polytetrafluoroethylene), a modified version of Teflon. For large caliber 
vessels with an inner diameter greater than 10 mm, these materials demonstrated 5-year 
patency rates of greater than 95 %. The challenge remained in implanting these grafts 
into small caliber vessels (inner diameter less than 10 mm) where low rates of flow and 
high downstream resistance frequently resulted in graft occlusion. Starting with 
Wesolowski’s 1961 work [42], researchers identified the importance of fibrous ingrowth 
onto a graft’s surface and how this leads to improved healing properties. In his studies, 
Wesolowski showed how Dacron grafts implanted into humans evolved a surface 
covered with fibroblasts, fibrin, and other circulatory cells; however these harvested 
 19
vessels failed to show an endothelialized surface. Other researchers such as Berger, 
Goldman, and Stratton [105-107] suggested that porous Dacron grafts implanted into 
humans did not develop an endothelium on their luminal surface.  This later encouraged 
Florey and Clowes [33, 39, 40] to investigate the endothelialization of Dacron and ePTFE 
grafts within such animal models as baboons.  
The baboon functions as a very suitable animal model to study neointima 
formation within an implanted vascular graft. Baboon and human subjects show very 
similar healing patterns in terms of where, when, and to what extent endothelial and 
smooth muscle cells migrate and proliferate. Researchers have long recognized a 
difference in vascular healing response between humans and other animal models such as 
canines, rabbits, and rats. These differences are not as evident in studies with baboons. 
The rheologic and genetic make-up of the baboons resembles that of humans better than 
any other animal model [108,109].  
  With this powerful tool in hand, Florey [33] demonstrated patchy 
endothelialization of a porous Dacron graft within a nonhuman primate. Florey thought 
that the endothelial cells derived from capillaries invading across the graft surface [33]. 
Much later, Sauvage [10] showed conclusive evidence of endothelialization of a Dacron 
vascular graft within an axillofemoral bypass of a 65-year-old man. Within this study, 
Sauvage corroborated Florey’s conclusion that endothelialization was occurring by 
transmural ingrowth across the graft wall. Although Dacron was found to evolve an 
endothelialized surface, the healing pattern was still very incomplete. This deficient 
healing pattern originated from a series of sources: (1) increased thrombogenicity, (2) 
intimal instability during early healing, and (3) toxic product release from the underlying 
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material. As a result, future work focused its attention on the healing properties of the 
other synthetic substitute, ePTFE.  
Clowes, Reidy and others [25, 39, 40, 44 – 46] investigated the healing properties 
of ePTFE. Healing of ePTFE grafts, much like Dacron, occurred by transanastomotic 
ingrowth from adjacent “cut edges” of native tissue onto the luminal surface of the barren 
graft. Clowes [40] documented that this ingrowth occurred at a rate of 0.2 mm/day. In 
their studies they compared the differences in healing between ePTFE and an arterial 
injury model. They created the arterial injury model by using an inflated angioballoon 
catheter to strip away the endothelium of an otherwise healthy artery. In the absence of an 
overlying endothelium, the arterial injury model experienced proliferation of smooth 
muscle cells. Mitogens from circulating blood cells, particularly platelets, lead to this 
smooth muscle cell migration and proliferation. The smooth muscle cells of a healed 
ePTFE vascular graft continued to proliferate even in the presence of a confluently, 
healed endothelial surface. There existed many explanations for this observation. 
Foremost, researchers believed that the surface of the healed ePTFE graft underwent a 
chronic “desquamating, nondenuding injury.” This chronic injury resulted from several 
sources: (1) foreign material immunogenicity, (2) flow induced injury at the suture line, 
and (3) compliance mismatch between the graft and the host vessel. It was observed that 
the ePTFE healed differently depending upon such material properties as internodal 
distance. In fact, Clowes [25] documented that the more porous varieties of ePTFE with 
internodal distances of 60 µm and 90 µm healed by a transmural transport mechanism 
across the wall of the graft. As mentioned earlier, Florey [33] concluded that a similar 
mechanism happened with the porous Dacron grafts.   
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Although several studies investigated the different healing properties of vascular 
grafts, they failed to document the quantitative differences in intimal thickening among 
the three varieties: (1) allogeneic, (2) autologous, and (3) prosthetic. In this study we 
introduced a technique for measuring the intimal thickness as a function of distance along 
the surface of the three healed varities of vascular grafts. We documented the differences 
in healing responses of autologous, allogeneic, and prosthetic grafts. Through this 
investigation we hoped to generate a descriptive model of graft healing and then use that 
model to evaluate new vascular graft alternatives.   
  We were also interested in further characterizing the biology of neointima 
healing within a prosthetic vascular graft. Clowes and others [40, 44, 45] had investigated 
this topic through several earlier papers. They focused their attention on the dynamics of 
the neointima’s leading edge. Clowes [40] demonstrated that the growing edge of the 
neointima contained many proliferating cells. At the anastomotic ends, he documented 
how, even in the presence of a confluent endothelium, the endothelial and smooth muscle 
cells continued to proliferate, leading to anastomotic narrowing. Clowes divided the graft 
into three regions for identifying proliferating cells: (1) anastomosis, (2) midzone, and (3) 
growing edge. Using improved spatial resolution, we wish to identify along the graft’s 
axial direction where the larger percentage of proliferating endothelial and smooth 
muscle cells are found. At a given axial location, we wish to identify whether that larger 
percentage of proliferating cells resides near or distantly removed from the flow surface. 
Moreover, we plan to classify which proliferating cell type predominates at locations 
within the neointima’s thickness.  
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In summary the purpose of this study was to investigate healing patterns of 
different vascular grafts. In so doing, we hoped to improve our understanding of early 
healing events so that greater insight was gained into how to prevent adverse healing 
outcomes. 
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Materials and Methods: 
Animals.  
In this study vascular grafts were implanted into the common carotid artery of 
juvenile male baboons (papio cyncephalus / anubis) of roughly two years of age and 
weighing between 13-24 kg. All animal procedures followed “Principles of Laboratory 
Animal Care”, the “Guide for the Care and Use of Laboratory Animals” (NIH Publication 
No. 8023, revised 1985), and IACUC university guidelines.  
Grafts.  
Three different varieties of vascular grafts were implanted into the baboons. One of the 
grafts was composed of expanded polytetrafluoroethylene with a 4 mm inner diameter, 2 
cm length, and an internodal porosity of  30 µm (Gore-Tex, non-reinforced, thin wall; 
provided by W.L. Gore and Associates, Inc., Flagstaff, Ariz.). For the second type of 
vascular graft, a 2 cm section of a baboon’s common carotid artery was removed, the 
direction of the vessel was reversed, and then the vessel was re-implanted into the 
originating baboon. This variety of vascular graft was termed a (2) reversed autogenous 
artery. For the third variety, a 2 cm section of a baboon’s common carotid artery was 
removed, and the vessel was then re-implanted into the common carotid artery of a 
different baboon. In this procedure attention was adhered to implanting the vessel into the 
same side of the recipient as it was explanted from the donor and into inserting the vessel 
so that the proximal end of the donor vessel corresponded to the proximal end of the 
recipient’s carotid vasculature. This graft variety was termed an (3) allogeneic vessel. 
Graft Placement. 
 One day prior to surgery, 325 mg of aspirin was administered to the baboon. On 
the day of surgery, blood samples were drawn to analyze such hemodynamic parameters 
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as platelet count, hematocrit, and white blood cell count. Under general endotracheal 
anesthesia with 1.5 to 2.5 % isoflurane, an approximately 1 cm section of the animal’s 
common carotid artery was removed. All surgery was performed by the same surgeon 
(Changyi Chen M.D., Ph.D.). After isolation of the common carotid artery, 150 units of 
heparin/kg were infused. All grafts possessed a length of 2 cm, and each variety of 
vascular graft was implanted into the exposed common carotid artery of individual 
baboons. The surgical procedure was performed unilaterally. Our surgical site alternated 
between the right or left side of the animal so that sidedness did not impact our results. 
Each of the varieties of vascular grafts were implanted into a number of baboon subjects: 
(1) 30 µm ePTFE {n = 5}; (2) reversed autogenous artery {n = 9}; and (3) allogeneic 
vessels {n = 4}. Implantation of vascular grafts involved using an end-to-end anastomosis 
with a continuous running suture of 6.0 polypropylene (Davis & Geck, Wayne, N.J.) 
(Figure 2.1). An example of an implanted vessel is demonstrated in Figure 2.2. 
Vessel Harvest.  
All baboon subjects were sacrificed one month following graft placement. 
Bromodeoxyuridine (BRDU; Sigma Chemical Co., St. Louis, Mo), 50 mg/kg dissolved in 
50 ml of normal saline solution, was administered subcutaneously 19, 12, and 7 hours 
before sacrifice. Prior to vessel harvest, blood samples were once again drawn to analyze 
























Figure 2.1: Description of Surgical Implantation. Example of isolateral, implanted 
vascular graft using an end-to-end anastomosis into the common carotid artery of a 
juvenile, male baboon. Each vascular graft possessed a length of 2 cm and an 







Figure 2.2: Example of an Implanted Allogeneic Vessel. Flow occurs from right to left. 








animal, 5000 units of heparin were administered. The animals were sacrificed by 
exsanguination, and the vascular grafts were harvested along with 1 cm sections of 
contiguous native vessel at each anastomosis. The vascular grafts were first flushed with 
lactated Ringer’s solution, then pressure perfused with 10 % buffered formalin (Baxter 
Diagnostics Inc, McGraw Park, Ill) at 100 mmHg mean arterial pressure for thirty 
minutes, followed by submersion in 10 % buffered formalin for a 24 hour period.  
Histology and Morphometry.  
The vessels were prepared into longitudinal sections. The grafts were bisected 
perpendicular to their axial direction. Each respective proximal and distal end was then 
divided into four longitudinal sections, each spanning 90 radial degrees. Next, we 
embedded all the partitioned grafts into paraffin and microtomed the blocks parallel to 
the long axis of the vessel using a 5 µm slice thickness. All grafts underwent staining 
with Hematoxylin and Eosin (H&E). Morphometric measurements were performed to 
evaluate neointima thickness on the luminal surface of the 30 µm ePTFE grafts, reversed 
autogenous arteries, and allogeneic vessels. In the case of the 30 µm ePTFE grafts, the 
neointima was defined as ingrowth overlying the prosthetic graft surface. For the 
reversed autogenous artery and the allogeneic vessels, neointima was defined by cell 
proliferative tissue lying above the internal elastic lamina. All slide specimens were 
analyzed using a microscope with a 1x objective interfaced to a digital camera that 
captured all images into a TIFF format. Using the Image-Pro Plus ® Software (Media 
Cybernetics, Inc.; Silver Spring, Maryland), the average intimal thickness was measured 
in the following way. The program converted the image of the histologic specimen into a 
bitmap representation of pixel intensity. This bitmap representation was exported to 
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MATLAB ® (MathWorks Inc.) where a program called totalconversionfinal.m used 
differences in pixel intensity values to differentiate the two different borders of the 
overlying neointima: (1) the graft material from the overlying neointima and (2) the 
neointima from the empty lumen. The program then calculated the intimal thickness 
between these two borders as a function of axial progression along the length of the graft. 
The resolution of these measurements corresponded to a one-pixel width or 1/500 of a 
millimeter. The average intimal thickness of the vessel’s four 90o arcs was calculated. For 
each vessel, this measurement was then averaged between the proximal and distal ends. 
Finally, for each variety of graft the overall, average intimal thickness and standard 
deviation were calculated.     
Immunocytochemistry and Morphometry.  
The avidin-biotin complex immunoperoxidase procedure (LSAB Kit, DAKO Co., 
Carpenteria, Ca.) was used to differentiate proliferating cells and the different neointimal 
cell-types. This staining procedure was performed upon all the harvested vessels. CD-34 
monoclonal antibody (DAKO Co.) identified T cells within the neointima, while HAM-
56 monoclonal antibody (DAKO Co.) pinpointed infiltrating macrophages within the 
healed grafts. Anti-BRDU monoclonal antibody (DAKO Co.) identified proliferating 
cells that had uptaken the administered BRDU prior to sacrifice, while monoclonal 
antibodies to α-actin (DAKO) and Von Willebrand Factor (vWF; Factor VIII related 
antigen, DAKO) outlined smooth muscle cells and endothelial cells, respectively. 
Proliferating endothelial and smooth muscle cells were located by identifying cells that 
simultaneously stained positive for BRDU and VWF or α-actin. Morphometric 
measurements were performed using stained sections from only the 30 µm ePTFE grafts. 
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Since both the reversed autogenous artery and the allogeneic vessel evolved very little 
neointima, this procedure was not performed for these graft types. For the 30 µm ePTFE, 
the location of the proliferating endothelial and smooth muscle cells was determined 
within the neointima. As with the measurements of intimal thickness, the slide specimens 
were analyzed using a microscope with a 1x objective, interfaced to a digital camera that 
captured all images into a TIFF format. Using the Image-Pro Plus ® Software, a bitmap 
representation of pixel intensity was made of the histologic specimen. This bitmap 
representation was exported to MATLAB ® (MathWorks Inc.) where a program called 
AOI.M used the difference in pixel intensity to determine the borders of the neointima 
and to measure the neointimal area (mm2). The program then calculated four areas of 
interest (AOI) within the neointima: (1) top 10 % near the adluminal, flow surface; (2) 
lower 90 % near the graft surface; (3) lower 10 % near the graft surface; and (4) top 90 % 
near the adluminal, flow surface. The outlines of these four AOIs were imported into the 
Image-Pro Plus ® Software. Within Image-Pro a macro called graft identified the 
immunostained cells based on colorimetric and intensity analysis and then used the 
imported macros to identify the location of the cells within the neointima. Concurrently, 
the Image-Pro macro calculated several other parameters within each AOI: (1) the total 
number of cells; (2) the total number of endothelial cells; and (3) the total number of 
smooth muscle cells. Analyzing the sequential immunostains for BRDU, vWF, and α-
actin, the Image-Pro macro distinguished which of the endothelial cells were proliferating 
and where within the neointima that they were located. Using this table of information, a 
series of immunostaining index markers were calculated for each AOI: (1) BRDU 
immunostaining index reflecting the number of proliferating cells divided by the total 
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number of cells; (2) the proliferating endothelial cell immunostaining index indicating the 
number of proliferating endothelial cells divided by the number of endothelial cells; and 
(3) the proliferating smooth muscle cell immunostaining index signifying the number of 
proliferating smooth muscle cells divided by the total number of smooth muscle cells. 
These indices were calculated from either the proximal or distal anastomotic junction 
along the axial length of the graph up to the leading edge of the neointima. These markers 
were averaged between the proximal and distal locations of each respective vessel.  
Statistics.  
Statistical analysis was performed on a Pentium IV P.C. with the use of either 
MATLAB or Excel 2000 statistical software (Microsoft Co.). Comparisons of intimal 
thickness between the various grafts were made using a Student t test (two-tailed).  The 
documented values are given as the mean ± the standard deviation. The results were 








Patency Rates.  
The different vascular grafts demonstrated a range of patency rates (Table 2.1). 
When grafts occluded, there existed evidence of both red and white thrombi, occluding 
the entire implanted vessel along with adjacent regions of native vessel distal to the 
vascular graft. 
 
Table 2.1: Table of Patency Rates for the Various Implanted Vascular Grafts. 
Vascular Grafts Patency Rates 
Reversed Autogenous Artery 6/9 = 66.7 % 
30 µm ePTFE 4/5 = 80.0 % 
Allogeneic Vessels 4/4 = 100% 
 
Healing in Harvested Grafts.  
In order to understand the different healing responses of implanted vascular 
grafts, a qualitative analysis of a healthy, native vessel was conducted. Figure 2.3a 
displays the outlined regions for the biology of a healthy native vessel. The vessel 
demonstrated a very thin layer of intima (Int), comprised almost entirely of endothelial 
cells. The media (Med) consisted of a composite of smooth muscle cells, fibroblasts, and 
deposited extracellular matrix. The outlying adventitia (Adv) was composed of mainly 
extracellular matrix. For the reversed autogenous artery (Figure 2.3b) the healing pattern 
differed little from the healthy, native vessel. The only noteworthy difference was found 




Figure 2.3: H&E Staining of Healthy Native Vessel and Reversed Autogenous Artery. 
Flow occurs from right to left. (A) Longitudinal cross-section of a healthy, native vessel. 










anastomotic junction. Figure 2.4a displays a quantitative description of average intimal 
thickness, progressing from the anastomotic junction along the axial length of the vessel. 
We observed that this pannus ingrowth at the anastomotic end reached a peak value of 
0.15 mm. Moving away from the anastomotic end, the average intimal thickness 
decreased to a plateau of 0.024 mm. 
In contrast, the H&E staining of the allogeneic vessel demonstrated more 
pronounced intimal thickening not only at the anastomosis but also at the mid-vessel 
point (Figure 2.5a). Its quantitative description of intimal thickening showed a larger 
amount of neointima at the anastomosis (0.20 mm) and an even higher level of intimal 
thickening once removed from the suture line (0.06 mm) (Figure 2.4b). 
 For the 30 µm ePTFE grafts qualitative examination of the H&E slide showed 
even greater levels of intimal thickening both at the anastomosis and distantly removed 
from the suture line (Figure 2.5b). In comparison to the other vascular grafts, quantitative 
examination of the 30 µm ePTFE witnessed the highest anastomotic intimal thickening 





Figure 2.4: Quantitative Description of Intimal Thickening for Reveresed Autogenous 
Arteries and Allogeneic Vessels. Average intimal thickness as a function of axial distance 
removed from the anastomotic end of  (A) reversed autogenous arteries (B) allogeneic 
vessels. 
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Figure 2.5: H&E Staining of Allogeneic Vessel and 30 µm ePTFE Vascular Graft. Flow 
occurs from right to left.  (A) Longitudinal Cross-Section of an Allogeneic Vessel (B) 
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A statistical comparison was made of the three vascular grafts ( (1) reversed 
autogenous artery, (2) allogeneic vessels, (3) 30 µm ePTFE ) and their respective intimal 
thickenings (Figure 2.7). First, a comparison was made of intimal thickness at the 
anastomotic junction. The 30 µm ePTFE vascular grafts demonstrated not only the 
greatest amount of intimal thickening (0.3584 ± 0.003), but they also showed a 
statistically significant difference in intimal thickening when compared to the other two 
classes of vascular grafts (p < 0.05). Although the reversed autogenous artery evolved the 
least amount of intimal thickening (0.11 ± 0.002), it failed to demonstrate a stastically 
significant difference in intimal thickening when compared to the allogeneic vessels (p = 
0.19). Secondly, a comparison was made of intimal thickening at the mid-vessel location 
of the vascular grafts (Figure 2.8). Once again, the 30 µm ePTFE vascular grafts 
demonstrated not only the greatest amount of intimal thickening (0.084 ± 0.002) at the 
mid-vessel point, but they also showed a statistically significant difference in intimal 
thickening when compared to the other two classes of vascular grafts (p < 0.05). At this 
mid-vessel point, the reversed autogenous arteries showcased the least amount of intimal 
thickening (0.024 mm ± 0.003). Furthermore, its intimal thickening was statistically 
different than the other two classes of vascular grafts (p-value < 0.05).  
Media Thickness and Inflammatory Response.  
The allogeneic vessels experienced a statistically significant increase in the 
thickness of the media (0.38 ± 0.022 mm, p-value < 0.05) in comparison to a native, 
healthy vessel (0.32 ± 0.009 mm) or to a reversed autogenous artery (0.28 ± 0.009 mm) 
(Figure 2.9). There existed no statistically significant difference between the reversed 
autogenous arteries and the healthy, native vessels (p-value = 0.11).  
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Figure 2.7: Average Intimal Thickness at the Anastomotic Junction. This figure displays 
the average intimal thickness at the anastomotic junction for the allogeneic vessels, the 
reversed autogenous arteries, and the 30 µm ePTFE vascular grafts. At this location the 
30 µm ePTFE exhibited the largest intimal thickening. There existed no statistically 
significant difference in the intimal thickening between the allogeneic vessels and the 
reversed autogenous arteries. 
























Reversed Autogenous Artery vs Allogeneic      p = 0.19
Reversed Autogenous Artery vs 30 µm ePTFE  p < 0.05




Figure 2.8: The Average Intimal Thickness at Mid-Vessel. This figure displays the 
average intimal thickness at mid-vessel for the allogeneic vessels, the reversed 
autogenous arteries, and the 30 µm ePTFE vascular grafts. At this location, the reverse 
autogenous artery possessed the smallest intimal thickening, and this was statistically 
different from the other two vessel types. The allogeneic vessel demonstrated a smaller 
intimal thickness than the prosthetic 30 µm ePTFE vascular grafts. 

























Reversed Autogenous Artery vs Allogeneic          p < 0.05
Reversed Autogenous Artery vs 30 µm ePTFE      p < 0.05




Figure 2.9: Thickness of Vessel Media. The media of the allogeneic vessel demonstrated 
a thickness that was statistically greater than either the reversed autogenous artery or the 
native vessels. The difference in media thickness between the reversed autogenous artery 
and the native vessels was not statistically significant. 
 






















Allogeneic Vessels vs Native Artery                  p  < 0.05
Allogeneic Vessels vs Reversed Autogenous   p  < 0.05
Native Artery vs Reversed Autogenous             p  = 0.107207
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 CD34 immunostaining was performed to demonstrate the presence or absence of 
lymphocyte infiltration into the healed vascular grafts. CD34 immunostaining of the 
reversed autogenous arteries demonstrated a media relatively devoid of an inflammatory 
response (Figure 2.10a), while CD34 immunostaining of 30 µm ePTFE grafts illustrated 
a distinct response to the prosthetic graft material (Figure 2.10b). In the case of the 
allogeneic vessels (Figure 2.10c), a very well identified inflammatory response was 
elicited within its large media. HAM-56 immunostaining of the allogeneic vessels 
spotlighted macrophage infiltration into the media (Figure 2.11).  
Location of Proliferating Cells. 
 For the 30 µm ePTFE vascular grafts, BRDU, VWF, and α-actin immunostains 
determined the location of proliferating cells by providing information for the 
quantitative immunostaining index. BRDU identified proliferating cells of every origin 
(Figure 2.12). The overwhelming majority of proliferating cells were localized to the 
upper 10 % of the neointimal area, whereas very few proliferating cells were found 
within the lower 90 % of the neointimal area (Figure 2.13). Within the upper 10 % of the 
neointimal area, the number of proliferating cells progressively increased towards the 
leading edge, yet within the lower 90 % of the neointimal area, the number of 
proliferating cells decreased away from the anastomotic junction.  
Using the BRDU results alongside sequential VWF and α-actin immunostaining 
results (Figure 2.14, Figure 2.16), the immunostaining index differentiated where the 
proliferating endothelial and smooth muscle cells (Figure 2.15, Figure 2.17) were 
concentrated. The proliferating endothelial cells resided within the upper 10 % of the  
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Figure 2.10: CD34 Immunostaining of Vascular Grafts. (A) CD34 immunostaining of a 
reversed autogenous artery. Observe the lack of inflammatory cells within the media. (B) 
CD34 immunostaining of a 30 µm ePTFE. Note the presence of inflammatory cells near 
the prosthetic material. (C) CD34 immunostaining of an allogeneic vessel. Notice the 













Figure 2.11: HAM-56 Immunostaining of an allogeneic vessel. Observe the presence of 












Figure 2.12: BRDU Immunostaining of 30 µm ePTFE Vascular Graft. BRDU labeled or 
proliferating cells are stained brown. These proliferating cells (endothelial, smooth 








Figure 2.13: BRDU Labeling Index of 30 µm ePTFE. The majority of proliferating cells 
(enodothelial cells, smooth muscle cells, etc.) are localized to the upper 10 % of the 
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Figure 2.14: VWF Immunostaining of 30 µm ePTFE Vascular Graft. The darkly stained 




























Figure 2.15: Location of Proliferating Endothelial Cells. The proliferating endothelial 
cells are concentrated within the upper 10 % of the neointimal area, increasing in value 
towards the leading edge. 
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Figure 2.16. α-Actin Immunostaining of 30 µm ePTFE. The smooth muscle cells are 
concentrated near the prosthetic graft surface and are stained an intense brown. 
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Figure 2.17: Location of Proliferating Smooth Muscle Cells within Healed ePTFE. The 
proliferating smooth muscle cells are concentrated within the lower 10 % of the 
neointimal area, reaching a maximum at the anastomosis and decreasing away from the 
suture line. 
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neointimal area and increased in number as the leading edge is approached. A negligible 
number of proliferating endothelial cells were found within the lower 90 % of the 
neointimal area. In contrast, the proliferating smooth muscle cells clustered within the 
lower 10 % of the neointima and decreased in number away from the anastomotic 
junction towards the leading edge. Very few proliferating smooth muscle cells resided 
within the top 90 % of the neointima. 
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Discussion:  
In an attempt to better understand some of the encountered problems associated 
with revascularization, researchers investigated the healing response of vascular grafts. 
Still today, incomplete understanding of this healing process persists. For example, there 
exists an unfavorable complication rate of 44 % at 10 years following aortocoronary 
bypass grafting with an autologous artery, while repair of femoropopliteal occlusion 
develops surgically adverse results using both autologous and synthetic grafts [110,111]. 
In the past, investigators dealt with these issues in a very qualitative way. Recently, 
attempts have been made to quantify such parameters as intimal area and intimal 
thickness at specific locations within the vascular graft [44-46]. Unfortunately, these 
studies focused their attention upon the histology and immunochemistry at specific 
locations such as mid-vessel, neglecting the remainder of the graft [25,26,39]. The 
present study represents the first attempt to quantify intimal thickness as a function of 
axial distance from the proximal to the distal anastomosis. Furthermore, our approach to 
measuring intimal thickness provides a mathematically more rigorous method than 
previous attempts. Past studies had quantified intimal thickness by measuring the intimal 
area of a circular cross-section and dividing that value by the circumference of the vessel 
[40,45,46]. This method suffers from at least two shortcomings. First, confusion exists 
whether to use the circumference of the unhealed luminal surface before implantation or 
of the healed luminal surface after implantation.  Regardless, this approach estimates and 
does not measure the value of the intimal thickness. Our approach calculates the distance 
between the luminal flow surface and the original graft surface. This reflects the actual 
thickness of the deposited neointima. Furthermore, our intimal thickness measurements 
claim a resolution of 0.005 mm. This resource assumes greater importance when 
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conducting one-month subacute studies where the intimal thickness may not be that 
pronounced. This tool will be used in our later sub-acute studies of aortic interposition 
grafts. 
  
Model of Graft Healing. 
 
 We investigated the differences in healing patterns among the three different 
choices of vascular grafts: autologous, allogeneic, and prosthetic. Since all three of these 
varieties find clinical use, we attach even greater importance to deciphering their healing 
differences. The reverse autogenous artery mirrors the use of the internal thoracic artery, 
while the allogeneic vessel finds use as a glutaraldehye treated cadaver vessel. The 
reversed autogenous artery or autologous vessel exhibited the least amount of intimal 
thickening in comparison to the other vascular grafts. Less intimal thickening was 
measured not only at the anastomosis but also at the mid-vessel location. The reversed 
autogenous artery showed this healing pattern for several reasons. First, the vessel was 
not introduced into a new flow environment. Unlike such vessels choices as the 
saphenous vein, the reversed autogenous artery represented an arterial conduit 
accustomed to a high flow, high-pressure environment. Secondly, issues of 
immunogenicity did not arise since the vessel came from the same animal. The surgical 
trauma of implanting and re-suturing the vessel constituted the only new parameter. From 
this trauma and the foreign prolene sutures, intimal thickening occurred at the 
anastomotic junctions. With these results in mind, the reversed autogenous artery 
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functioned as our gold standard of comparison when evaluating the healing of the other 
two graft varieties. 
 While the allogeneic vessel produced less intimal thickening than the 30 µm 
ePTFE vascular grafts, it failed to perform as well as the reversed autogenous artery. At 
the mid-vessel location, the reversed autogenous artery possessed statistically less intimal 
thickening than the allogeneic vessels. Although both vessel types derived from baboons, 
the allogeneic vessel introduced more of an immunogenic response due to the donor and 
the recipient vessels coming from different animals. Our immunostaining with CD34 and 
HAM-56 distinctly outlined the infiltration of the allogeneic graft with lymphocytes and 
macrophages. This immune response contributed to the observed increase in media 
thickness. Due to its difference in antigenicity, the allogeneic vessel recruited 
inflammatory cells into the media. These inflammatory cells release such growth factors 
as b-FGF, PDGF-AA, PDGF-BB, TGF-β, and an assortment of cytokines leading to both 
smooth muscle cell migration and proliferation [97]. With these dynamics in mind, we 
were surprised to witness that all of the allogeneic vessels remained patent. This outcome 
was unexpected given previous work documenting alloimmune-mediated vascular 
rejection in an arterial transplantation model [114]. These studies examined the ability of 
allograft endothelium to recruit T lymphocytes and antigen-presenting macrophages by 
releasing vascular adhesion molecules, chemokines, MHC molecules, and other 
proinflammatory vasoactive chemokines. Within this work, they were limited by the use 
of inferior animal models such as rats and mice. This constraint becomes important when 
one considers the interspecies differences in endothelial expression and how that relates 
to clinical human responses. For example, unlike primates, rodents do not constitutively 
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express both class I and II MHC molecules or the co-stimulatory molecule, lymphocyte 
fuction antigen LFA-3 [115]. Why then did all of our allogeneic vessels remain patent? 
The answer may relate to the length of time that the vessels were implanted. At a one 
month time period an immunogenic response had begun, yet it still failed to generate as 
strong of a reaction as seen several months later. This rejection process is more likely to 
occur under chronic and not the sub-acute conditions created by this study. Our observed 
increase in media size and the surrounding infiltration by lymphocytes and macrophages 
may have foretold the eventual cascade of events leading towards possible chronic 
rejection of the vessels. 
 The 30 µm ePTFE vascular grafts exhibited the largest increase in intimal 
thickness. There existed a statistically significant difference not only at the anastomotic 
ends but also at sites distantly removed from the suture line at the mid-vessel point. This 
increase in intimal thickening originated from many sources. First, the prosthetic graft 
generated an immune response based on its material interaction as a foreign body. The 
CD34 immunostaining illustrated this point well. On the underside of the vessel, there 
existed an immune infiltration into the perigraft tissue surrounding the vascular graft. 
Through well-documented studies, the ePTFE has been shown to be thrombogenic [97]. 
As the internodal porosity of the ePTFE enlarges, the thrombogenicity of the prosthetic 
material increases. Although less thrombogenic than 60 µm ePTFE, the 30 µm ePTFE 
still resulted in acute thrombotic occlusion (one out of the five clotted). Even if a 
thrombogenic material does not clot, the activation of platelets and other inflammatory 
mediators promotes the process of intimal hyperplasia. Over time, this results in failure of 
the implanted grafts under chronic conditions.  The compliance mismatch between the 
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cut, native vessel and the ePTFE manifests as a flow disturbance at the suture line. This 
difference in vessel stiffness creates a wall stress disturbance that interferes with arterial 
pulse wave transmission. These stresses can result in suture-line disruption, formation of 
a false aneurysm, and development of subintimal hyperplasia [148, 149]. Researchers 
have clearly shown how these flow disturbances result in increases in anastomotic intimal 
thickening [112].  
 Overall, we documented the differences in healing between the three clinically 
used varieties of vascular grafts. In the future, alternative designs to vascular grafts will 
emerge. Ideally, a graft that mimics the biology of a healthy, native vessel represents the 
most desirable approach. Such a vascular graft heals much like a reversed autogenous 
artery with minimal intimal thickening at the anastomosis and at sites distantly removed 
from the suture line. Such a possible alternative is a prosthetic vascular graft seeded with 
endothelial and smooth muscle cells [113]. The use of porous, prosthetic grafts such as 60 
µm ePTFE represents another potential choice. As Clowes [25] documented, the porous 
ePTFE acquires confluent healing of its luminal surface within two weeks. This rapid 
healing by transmural ingrowth inhibits the ability of transanastomotic or pannus 
ingrowth to cover the unhealed graft surface with a thick layer of neointima. By healing 
rapidly, the porous prosthetic material benefits from the many protective effects of a 
confluent endothelium. Lastly, work is being conducted on developing a prosthetic 
vascular graft with a local drug infusion system that inhibits pannus formation at the 
distal anastomosis [62 – 65]. The drug is stored within a local infusion pump and then 
continuously infused for up to one month into the boundary layer of the flowing blood. 
Through local drug delivery, high concentrations of otherwise very expensive 
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pharmacologic agents can be administered, and in so doing, we can avoid the production 
of either drug tolerance or damaging systemic effects [63]. Hanson and Chen [68, 69, 72] 
have investigated the pharmacologic effect of locally administering such drugs as nitric 
oxide donors, bFGF conjugated to saporin, and heparin. In all cases they observed a 
decrease in intimal area and in the number of proliferating cells [70-72].  
 
Proliferating Cells within the Neointima. 
 
 In this work we characterized the location of proliferating cells within the 
growing neointima. These proliferating cells function in two different capacities; one that 
is beneficial and one that threatens graft patency. First, they help to heal barren, 
prosthetic graft material that is potentially thrombogenic, and if left unhealed, it may lead 
to acute occlusion. Secondly, they produce damaging neointima that threatens to occlude 
the graft. In the past Clowes had identified that the proliferating endothelial cells were 
localized to the leading edge of the neointima [44-45]. Our work further refined this 
study by identifying that the proliferating endothelial cells were localized to the top 10 % 
of the neointima, increasing in concentration from the anastomotic junction until reaching 
their maximum at the leading edge. This result reveals how proliferating endothelial cells 
receive their stimulus to grow from blood borne elements within the lumen. In contrast to 
Clowes’ work, we quantified the number of proliferating endothelial cells as we 
progressed along the axial length of the vessel and differentiated where within that 
growing neointima that the proliferating cells resided. By isolating the proliferating 
 57
endothelial cells to the upper 10 % of the neointima, we provide strong evidence for their 
growth being humoral-mediated.   
 We were also interested in characterizing the location of proliferating smooth 
muscle cells. We observed that the proliferating smooth muscle cells were concentrated 
within the lower 10 % of the neointima, reaching a peak value at the anastomosis and 
then decreasing in value with distance away from the suture line. Unlike the endothelial 
cells, the proliferating smooth muscle cells appear to receive more stimuli for growth 
from the prosthetic graft surface rather than from blood borne elements. This helps to 
explain the vigorous healing response to a foreign material and the subsequent intimal 
thickening. One potential source for this mitogenic activity is the already documented 
inflammatory response in and outside the prosthetic graft material. This conclusion 
contrasts with the governing thought that the mitogenic source of smooth muscle cells 
derives predominantly from platelets and such released growth factors as PDGF-AA and 
PDGF-BB. Our observation that the underlying graft material so significantly affects 
healing emphasizes the importance in careful selection of the prosthetic material. 
Furthermore, this result now helps to better explain why we saw such a wide-range of 
healing responses depending upon whether the graft variety was autologous, allogeneic, 
or prosthetic. Ultimately, this difference in healing response influences our decision for 









Within the United States atherosclerotic disease affects one out of every four 
people, resulting in over 40% of all deaths [88]. Frequently, this occlusive disease 
localizes to the peripheral vasculature, resulting in such problems as claudication of the 
legs. To treat this clinical situation, surgeons construct bypass vascular grafts using such 
prosthetic materials as Dacron and ePTFE. For peripheral vascular disease, ePTFE serves 
as the preferred prosthetic material. To achieve high patency rates, ePTFE vascular grafts 
need to exhibit two properties: a flow surface with reduced thrombogenicity and reduced 
intimal thickening. One way to accomplish this goal is to promote rapid and confluent 
healing of the graft surface. 
For well over thirty years, researchers focused their attention upon the healing 
properties of graft materials. Their studies determined that prosthetic vascular grafts 
healed by the following three mechanisms: (1) transanastomotic ingrowth, (2) seeding 
from circulating blood borne cells, and (3) transmural ingrowth. Through the years, 
transanastomotic ingrowth has been well characterized, while investigators still debate 
the role of “humoral seeding”.  Early on, they identified the potential for vascular grafts 
to heal by the migration of surrounding perigraft tissue across its wall, so-called 
transmural ingrowth.  Beginning with Wesolowski’s 1961 work [42], researchers 
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concluded that porous synthetic grafts achieved better healing properties. The fibrous 
ingrowth of fibroblasts, fibrin, and blood-borne cells improved graft patency rates. 
Clowes [25] later detailed the ability of ePTFE grafts to heal by transmural ingrowth. 
Clowes documented that the more porous varieties of ePTFE, internodal distances of 60 
µm and 90 µm, healed by ingrowth across the graft wall. In fact, these more porous 
varieties of ePTFE showcased a confluent endothelium, a uniformly distributed 
pseudointimal growth, and an improved intimal stability. These results contrasted to what 
was found when porosity was decreased. Even as far as one year after implantation, 
ePTFE with internodal porosities of 10 µm and 30 µm exhibited patchy and incomplete 
healing.  
While these results established the importance of graft porosity, the question 
evolved as to whether changes in the ePTFE ultrastructure affected graft healing. Since 
porosity reflects a structural characteristic of the material, researchers expected to see 
changes with additional material alterations. In 1986 McClurken [48] defined the 
standards for examining the physical properties of ePTFE vascular grafts. He explained 
how the ePTFE grafts must be evaluated for both static (inside diameter, wall thickness, 
internodal distance) and dynamic (hysteresis following mechanical stretch) physical 
properties.  With the development of medical devices, ePTFE ultrastructure assumed 
greater importance in the design and choice of prosthetic vascular grafts. The 
endovascular stent graft represents an example of such a challenging innovation. The 
stent graft consists of a metallic and alloy stent surrounded by 30 µm prosthetic vascular 
graft material. In order to deploy this device, an angio-balloon catheter inflates within its 
lumen, stretching out the metallic infrastructure and subsequently altering the adjoining 
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prosthetic graft material. Williams [48] questioned what happened to the healing 
properties of this material once stretched. In 1995 Palmaz [103] first addressed this 
subject. His work suggested that balloon dilatation of stent grafts failed to alter such 
material properties as internodal distance. Williams’ results [48] extended upon this 
study. By radially stretching sections of 30 µm ePTFE, he corroborated that there were 
no changes in internodal distance, but unlike Palmaz, he observed additional changes 
within other material properties. Such static physical properties as wall thickness, nodal 
thickness, interfiber distance, and fiber width became altered. Williams concluded that 
radially stretching the graft material permanently altered the structure of the ePTFE [48].  
In a later animal study of 30 µm ePTFE implanted into the subcutaneous and 
adipose tissue of Sprague-Dawley rats, Williams [150] observed a greater inflammatory 
response within stretched grafts versus unstretched grafts. This inflammatory response 
became important in its ability to affect cell recruitment and matrix deposition. A chronic 
inflammatory response concentrates macrophages and foreign body giant cells within an 
area of interest. These cells then direct fibroblasts, blood vessels, and other inflammatory 
cells. It would seem then that Williams observed a distinct change in healing outcomes; 
however, his conflicting results regarding adipose and subcutaneous implants made it 
difficult to draw any definitive conclusions regarding how changes in graft ultrastructure 
impact neovascularization or cellular ingrowth. These results emphasized the need to 
study the healing characteristics of mechanically altered graft material within an animal 
model with a pulsatile flow environment.   
In this study we will investigate how radially stretching a porous synthetic graft, 
such as 60 µm ePTFE, will change the healing characteristics of the implanted vessel. We 
 61
will document the ultrastructural changes and how those results relate to the observed 
histopathologic measurements. Furthermore, we will introduce a complicated model of a 
stenotic graft where there will exist both distortion and preservation of the material 
ultrastructure. This model will allow us to investigate how the healing response changes 
as the material properties are progressively altered. In addition, the stenotic throat will 
establish an altered hemodynamic environment with high levels of wall shear stress. 
Based on published literature [54-56], we expect a mechanism to evolve within the 




Material and Methods: 
Animals.  
In this study vascular grafts were implanted into juvenile male baboons (papio 
cyncephalus / anubis) of roughly two years of age and weighing between 13-24 kg. All 
animal procedures followed “Principles of Laboratory Animal Care”, the “Guide for the 
Care and Use of Laboratory Animals” (NIH Publication No. 8023, revised 1985), and 
IACUC university guidelines.  
Grafts.  
Three different vascular grafts constructed of 60 µm expanded 
polytetrafluoroethylene (Gore-Tex, non-reinforced, thin wall; provided by W.L. Gore and 
Associates, Inc., Flagstaff, Ariz.) were used in this study. The first type of vascular graft, 
the so-called unstretched control, possessed a length of approximately 4 cm and an inner 
diameter of 6 mm. The next two varieties of vascular grafts were constructed from the 
same starting material with an inner diameter of 3 mm. The first of these vascular grafts, 
the so-called stretched control, was uniformly stretched in a radial direction from a 3 mm 
inner diameter to a 6 mm inner diameter. The second of these vascular grafts, the so-
called stretched stenosis, consisted of a 75 % reduction in its cross-luminal area. The 
stretched stenosis was constructed by fitting the ePTFE over an aluminum mandrel that 
began with an inner diameter of 6 mm, symmetrically contracted down to 3 mm, and then 
symmetrically expanded back out to 6 mm. The aluminum mandrel was lathed according 
to the following mathematical equation: 
Z = 6.0 mm    for 0 ≤ x < 1.25 and for 2.75 < x ≤ 4.0    
Z = 1-.25(1+cos (π((x-2)/0.75)) for 1.25 ≤ x ≤ 2.75                                        (Equation 1) 
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The aluminum mandrel was separable in the middle, allowing for easy separation and 
removal of the graft prior to surgery. A schematic of the stretched stenosis illustrates this 












Figure 3.1: The Stretched Stenosis. The stenotic graft was constructed from 60 µm 
ePTFE with an initial inner diameter of 3mm. By fitting the graft material over the 





 One day prior to surgery, 325 mg of aspirin was administered to the baboon. 
Blood samples were drawn to analyze such hemodynamic parameters as platelet count, 
hematocrit, and white blood cell count. Under general endotracheal anesthesia with 1.5 to 
2.5 % isoflurane, a mid-line incision was made, followed by exposure of the 
retroperitoneum. Following isolation of the distal abdominal aorta, 150 units of 








a perivascular flow probe (Transonic Inc.) around the exposed aorta, just distal to the 
bifurcation of the renal arteries. The transonic flowmeter was connected to a PC 
computer using an Analog/Digital card. On the PC, Labview recorded the volumetric 
flow rate for thirty cardiac cycles (Figure 3.2). Twenty ePTFE grafts were implanted into 
the distal abdominal aortas of individual baboons. Implantation of vascular grafts 
involved using an end-to-end anastomosis with a continuous running suture of 6.0 
polypropylene (Davis & Geck, Wayne, N.J.) (Figure 3.3).  An example of an implanted 
vessel is demonstrated in Figure 3.4. Changyi Chen M.D., Ph.D performed all of the 
surgeries. 
Vessel Harvest. 
  All baboons were sacrificed one month following graft placement. 
Bromodeoxyuridine (BRDU; Sigma Chemical Co., St. Louis, Mo), 50 mg/kg dissolved in 
50 ml of normal saline solution, was administered subcutaneously 19, 12, and 7 hours 
before sacrifice. Prior to vessel harvest, blood samples were once again drawn to analyze 
hemodynamic parameters. Twenty minutes before sacrificing the animal, 5000 units of 
heparin were administered. The distal abdominal aorta was once again exposed. Using 
the perivascular flow probe, we acquired the volumetric flow rate just distal to the renal 
arteries for thirty cardiac cycles. The animals were sacrificed by exsanguination. The 
implanted grafts were fixed in vivo by implanting a 14-gauge angiocatheter into the 
abdominal aorta and infusing the fixative from a 60 cc syringe. Before infusing the 
fixative, the grafts were first flushed with 0.1 M phosphate buffered saline (PBS) at pH 
7.4 and 37° Celsius. Next, Evan’s Blue Dye (50mg/kg) was administered, followed by 




Figure 3.2: Data Acquisition for the Volumetric Flow Rate. The perivascular flow probe 
connected to the pulse-transit ultrasound flowmeter that interfaced with an analog to 











































Figure 3.3: Illustration of Implanted Vascular Graft. The vascular graft was implanted 





















inserted into the right common iliac to control the rate at which perfusate drained, while 
another 14-gauge angiocatheter was fed into the left common iliac up to the level of the 
aorta’s bifurcation to measure mean arterial pressure (MAP) using a sphygmomanometer. 
The vessels were perfused at a MAP of 100 mmHg for at least thirty minutes with either 
10 % buffered formalin (Baxter Diagnostics Inc, McGraw Park, Ill), accomodating a 
protocol for immunohistochemistry, or 2.5 % glutaraldehye (Sigma Inc), accommodating 
a protocol for scanning electron microscopy (SEM). Figure 3.5 illustrates the set-up for 
the in vivo pressure perfusion of the grafts. Following fixation, the grafts were harvested 
along with 1 cm sections of contiguous native vessel at each anastomosis and then 
submersed in fixative for a 24-hour period. 
Histology and Morphometry. 
All harvested grafts were divided into 5 mm long segments with circular cross 
sections, embedded into paraffin, and microtomed perpendicular to the long axis of the 
vessel using a 5 µm slice thickness. At the proximal anastomosis, the center of the graft, 
and the distal anastomosis, microscope sections were cut every millimeter from the 
embedded blocks, while elsewhere in the vessel, only one representative set of sections 
was taken from each embedded block. As a result, greater resolution was obtained at the 
anastomotic ends and at the center of the vessels. All grafts underwent staining with 
Hematoxylin and Eosin (H&E). Morphometric measurements were performed to evaluate 
neointimal thickness and area. Neointima was defined as ingrowth overlying the 
prosthetic graft surface. All slide specimens were analyzed using a microscope with a 1x 
objective interfaced to a digital camera that captured all images into a TIFF format. Using 


































Figure 3.5: In Vivo Pressure Perfusion of Implanted Vascular Graft. The perfusate 
consisted of either 10 % buffered formalin allowing for immunohistochemistry or 2.5 % 
glutaraldehyde allowing for Scanning Electron Microscopy. The angiocatheter in the 
right common iliac was fed up to the aorta’s bifurcation. This allowed the 











average intimal thickness was measured in the following way. A macro within Image-Pro 
called graft1 identified the two borders of the neointima defined by the surface of the 
ePTFE graft and the adluminal surface of the neointima. The software then calculated the 
distance between these two borders, progressing with a one-pixel resolution (0.005 mm) 
around the circumference of the vessel. For each cross-section an average intimal 
thickness was calculated. A macro called area measured the intimal area between these 
two borders. Since the length of harvested vascular grafts varied by 12 %, the axial 
locations were normalized to a scale from 0 to 1. This adjustment allowed for comparison 
of intimal thickness and area measurements at the same relative location within vascular 
grafts of different lengths. For each particular graft type the intimal thickness and area 
measurements were processed using an autoregressive moving average (ARMA). The 
ARMA technique generates a representative measurement of intimal thickness by 
incorporating measurements that precede, follow, and occur at a location of interest. At 
0.1 normalized distances along the vascular graft, standard deviations were calculated. 
For each vascular graft type, a comparison of intimal thickness at the proximal and distal 
anastomoses was performed. Furthermore, a comparison of intimal thickness 
measurements at the mid-vessel point of the different graft varieties was conducted.  
 Immunocytochemistry and Morphometry. 
 The avidin-biotin complex immunoperoxidase procedure (LSAB Kit, DAKO 
Co., Carpenteria, Ca.) was used to differentiate proliferating cells and the different 
neointimal cell-types. This staining procedure was performed upon all the harvested 
vessels. Anti-BRDU monoclonal antibody (DAKO Co.) identified proliferating cells that 
had uptaken the administered BRDU prior to sacrifice, while monoclonal antibodies to α-
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actin (DAKO) and Von Willebrand Factor (vWF; Factor VIII related antigen, DAKO) 
outlined smooth muscle cells and endothelial cells, respectively.  
Scanning Electron Microscopy. 
 Two different sets of scans were performed using a Topcon-ISI DS-130 operated 
with a LaB6 electron source at 9 kV. First, an analysis of the graft ultrastructure was 
performed upon vascular grafts that were not implanted. For three of the respective 
control and stenotic models, a longitudinal strip with a width of 5 mm was analyzed. 
Secondly, healing patterns were observed by analyzing implanted vascular grafts. From 
the harvested vascular grafts, two longitudinal sections with a width of 5 mm were taken 
from each of the respective control and stenotic models. The SEM protocol required 
fixation of the sample in 2.5 % electron microscopy grade glutaraldehyde diluted in 
cacodylate. The samples were then dehydrated with graded alcohol, critical point dried, 
and then sputter coated with gold palladium with a deposited thickness of 20 ∆. Both the 
anastomotic ends and the middle of the vascular grafts were interrogated and digital 
images captured.  
Graft Ultrastructure. 
 With the SEM images described above, the vascular grafts’ material properties 
were measured. For each of the vascular graft types, internodal distance (distance 
between nodes of ePTFE) and nodal width (width of a node of ePTFE) were measured 
(Figure 3.6). Using the H&E stained circular cross-sections, the ultrastructural properties 
of graft thickness and void volume were measured (Figure 3.7). Using Image-Pro, the 
graft thickness was measured by calculating the distance between the outer and inner 
borders of the prosthetic graft at each radial location around the vessel’s circumference,  
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Figure 3.6: Scanning Electron Microscopy of Unstretched 60 µm ePTFE. (A) designates 
















Figure 3.7: H&E Staining of a Circular Cross-Section of a Harvested 60 µm ePTFE 





and then the average was calculated. Void Fraction reflected the percentage of empty 
space within the prosthetic graft that permitted for transmural ingrowth across its wall. A 
macro within Image-Pro called Void evaluated void fraction by calculating the area of 
empty space unoccupied by ePTFE material and dividing it by the total area of the graft 
material. For each control graft, the average of these parameters was taken between the 
anastomotic and mid-vessel location. For the stretched stenosis, these parameters were 
individually evaluated at the mid-vessel and anastomotic location. Since the material 
properties of the graft changed from the anastomosis to the stenotic throat, their 
measurements were not averaged as with the control grafts. 
Fluid Mechanics. 
Computational fluid mechanics characterized the flow field within the vascular 
grafts. Chapter V describes in detail how this was accomplished. Briefly, computational 
grids were constructed of the control and stenotic grafts. The grids were constructed 
using contours outlined from the harvested, circular cross-sections of the vascular grafts. 
A best-fit line calculated from an MRI analysis of an implanted vascular graft determined 
the orientation of these contours in space. The Gambit software (Fluent Inc) helped 
construct the computational grids. An ensemble average of the measured volumetric flow 
rates at harvest was calculated to obtain a representative description of blood flow for 
both the control and stenotic grafts. This ensemble averaged volumetric flow rate was 
then applied to a Womersley solution [151] to derive velocity values for the flowing 
blood at the vessel inlet. This velocity profile then functioned as the boundary condition 
at the inlet of the vascular graft. Using Fidap (Fluent Inc), pulsatile simulations were run 
for three cardiac cycles. From these simulations, wall shear stress within the vascular 
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graft was calculated.  Wall shear stress is defined as the dynamic viscosity of the fluid 
times the gradient of the velocity, evaluated at the wall. The dynamic viscosity of blood 
was assumed to be 0.04 Poise. The hemodynamic data were compressed into a 
description of wall shear stress as a function of distance along the axial direction of the 
vascular graft. This was accomplished by averaging the WSS measurements around the 
circumference of the vessel. This term is referred to as spatially averaged WSS or τs(z,t) 
(Equation 3.2).  
Equation 3.2 
 
At each axial location along the graft, the pulse spatially averaged WSS (Pulse WSS) was 
calculated. Over a cardiac cycle, the Pulse WSS measures the difference between the 
maximum spatially averaged WSS and the minimum spatially averaged WSS. Lastly, the 
temporal mean of the spatially averaged WSS was calculated. This manipulation 
produced the spatially averaged, temporal mean wall shear stress {τavg(z)} (Equation 
3.3). 
                                                                                                                         Equation 3.3     
 
Statistics.  
Statistical analysis was performed on a Pentium IV P.C. with the use of either 












thickness between the various grafts were made using a Student t test (two-tailed).  The 
documented values are given as the mean ± the standard deviation. The results were 
considered significant if the p value was less than 0.05. 
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Results: 
Graft Ultrastructure.  
 In this study stretching the vascular graft altered the material properties of the 
ePTFE. A qualitative comparison of the SEM and H&E pictures best illustrated this 
point. The SEM picture of the unstretched ePTFE (Figure 3.8a) showed empty space or 
void fraction within the graft material, while the SEM picture of the stretched ePTFE 
(Figure 3.8b) highlighted the dense and compact nature of the graft material with its 
noted absence of void fraction. The H&E stained cross-sections (Figure 3.7) further 
demonstrated how stretching the vascular graft made the material more compact and 
reduced its thickness. The morphometric measurements of the graft material attempted to 
quantify these mechanically induced changes in the graft ultrastructure.   First, the void 
fraction of the material was analyzed (Figure 3.9). The void fraction of the unstretched 60 
µm ePTFE (74.1 ± 1.8 %) notably exceeded the void fraction of the stretched 60 µm 
ePTFE (45.8 ± 1.7 %) and of the 30 µm ePTFE (39.3 ± 6 %). Furthermore, the difference 
in void fraction between the unstretched 60 µm ePTFE and the other two graft varieties 
was statistically significant. Secondly, the thickness of the graft material was investigated 
(Figure 3.10). The thickness of the stretched 60 µm ePTFE (0.25 ± 0.05 mm) was notably 
smaller than the graft thickness of the unstretched 60 µm ePTFE (0.46 ± 0.02 mm) and of 
the 30 µm ePTFE (0.41 ± 0.02 mm). Also, there existed a statistically significant 
difference between the graft thickness of the stretched 60 µm ePTFE and the other two 
graft varieties. Thirdly, the internodal distance of the ePTFE varieties was measured 
(Figure 3.11). The internodal distance of the stretched 60 µm ePTFE (33.8 ± 2.1 µm) was 














Figure 3.8: SEM Pictures of Unstretched and Stretched ePTFE. (A) Unstretched ePTFE 
demonstrating the empty space within the graft material. (B) Stretched ePTFE illustrating 









Figure 3.9: Void Fraction of Stretched 60 µm ePTFE, Unstretched 60 µm ePTFE, and 30 
µm ePTFE. The void fraction of the unstretched 60 µm ePTFE significantly exceeded the 
void fraction of the stretched 60 µm ePTFE and the 30 µm ePTFE, while there was no 























Unstretched vs Stretched : p value         << 0.05
Unstretched vs 30 micrometer : p value << 0.05
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Figure 3.10: The Thickness of the Different ePTFE Vascular Grafts. The stretched 60 
µm ePTFE possessed a notably smaller thickness than the other two varieties of vascular 
grafts. The difference in graft thickness between the stretched and unstretched 60 µm 
ePTFE was statistically significant.  






















Unstretched vs Stretched : P-Value < 0.05














Figure 3.11: The Internodal Distance of the Different Varieties of ePTFE. The internodal 
distance of the stretched 60 µm ePTFE vascular graft exceeds that of the other two graft 
types. The difference in internodal distance between the stretched 60 µm ePTFE and the 

































Stretched vs Unstretched : P-Value < 0.05



















2.4 µm) or the 30 µm ePTFE (18.1 ± 3.5 µm). Once again, this difference was found to 
be statistically significant. Lastly, the nodal width was measured (Figure 3.12). There 
existed no statistically significant difference between the nodal width of the stretched 60 
µm ePTFE (5.58 ± 0.6 µm) and the unstretched 60 µm ePTFE (5.5 ± 0.7 µm). 
Graft Healing.  
On gross examination, the implanted vascular grafts appeared to have undergone 
healing of their flow surface (Figure 3.13). The H&E stained sections better explained the 
extent of the luminal healing. First, we examined the stained circular cross-sections of the 
unstretched controls (Figure 3.14). At the anastomotic ends there existed very distinct 
pannus ingrowth. At the mid-vessel point the surface had healed by transmural ingrowth 
from the surrounding perigraft tissue across the wall of the vascular graft. The Evan’s 
blue dye qualitatively indicated that the graft surface possessed a confluent layer of 
endothelium (Figure 3.15). Before administering the Evan’s blue dye, an angioballoon 
catheter was fed up to the level of the graft’s proximal anastomosis and then inflated. The 
catheter was gradually withdrawn, stripping the endothelium off the native vessel. This 
region of native vessel, devoid of endothelium, uptook the Evan’s blue dye, while the 
healed graft surface excluded it. At the mid-vessel section, the VWF immunostain 
(Figure 3.16) further outlined how the graft surface healed with a confluent endothelium. 
The intimal thickening of the unstretched control grafts was quantified (Figure 3.17). At 
the anastomotic ends the intimal thickness reached an average of 0.43 mm. There existed 
no significant difference in intimal thickening between the proximal and distal 
anastomosis (Figure 3.18). The intimal thickness decreased towards the mid-point, 
reaching a minimum value of 0.08 ± 0.02 mm.   
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Figure 3.12: The Nodal Width of the Stretched and Unstretched 60 µm ePTFE.  There 
existed no statistically significant difference in the nodal width between the stretched and 































Figure 3.13: Photograph of a Harvested, Stretched Stenotic Graft. Flow occurs from 
right to left. On initial observation the graft surface has undergone some healing. The 













Figure 3.14: H&E Staining of Circular Cross-Sections from the Unstretched Control. (A) 









Figure 3.15: Evan’s Blue Dye Stain of Harvested, Unstretched Control Graft. The 
Evan’s Blue Dye (50 mg/ml) was administered through an angioballoon catheter into the 
vessel’s lumen. The inflated angioballoon catheter stripped away the endothelium of the 
native vessel, resulting in uptake of blue dye. Note the absence of dye uptake upon the 
surface of the healed graft. This experiment qualitatively shows that the graft surface was 
healed. 
 
Figure 3.16: VWF Immunostain of Unstretched Control. The positive staining on the 




Figure 3.17: A Quantitative Description of Intimal Thickness along the Axial Length of 
an Unstretched Control Graft. The pannus ingrowth resulted in the pronounced 
thickening at the anastomotic junction. Once removed from the suture line, the intimal 
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Figure 3.18: Comparison of Proximal and Distal Anastomosis for Unstretched Control 
Graft. There existed no statistically significant difference between the proximal and distal 
ends. 
Comparison of Proximal and Distal Anastomosis 


























Secondly, we investigated the stained circular cross-sections of the stretched controls 
(Figure 3.19). In comparison to the unstretched controls, the graft material appeared 
compressed and very compact. Pannus ingrowth was observed at the anastomotic ends 
while very little, if any ingrowth, was observed at the mid-vessel location. The intimal 
thickening of the stretched control grafts was quantified as a function of distance along 
the axial length of the vascular graft (Figure 3.20). At the anastomotic ends the intimal 
thickness reached an average value of 0.25 mm, while at the mid-vessel point the intimal 
thickness was 0.09 ± 0.06 mm. At the proximal and distal anastomosis, there existed no 
difference in intimal thickening (Figure 3.21). Lastly, we examined the stained circular 
cross-sections of the stretched stenosis (Figure 3.22). As with the controls, pannus 
ingrowth was observed at the anastomoses, but there existed no difference in intimal 
thickening between the proximal and distal ends (Figure 3.23). Unexpectedly, an increase 
in intimal thickening was recorded at the mid-vessel point. Quantitative exam revealed 
that at the stenotic throat the intimal thickness increased to 0.34 ± 0.06 mm (Figure 3.20). 
To ensure that the intimal thickness measurements were reflecting the healing pattern 
accurately, the deposited intimal area was measured as a function of axial distance 
(Figure 3.24). The figure displays the results for the stretched control and stretched 
stenotic grafts. The intimal area results mirrored the earlier discussion for intimal 
thickness. 
Graft Healing at Mid-Vessel.   
The intimal thickness measurements at the mid-vessel location were compared 
between the different vascular graft types. First, we examined the unstretched and 










Figure 3.19: H&E Staining of Circular Cross-Sections from the Stretched Control. (A) 
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Figure 3.20: A Quantitative Description of Intimal Thickness along the Axial Length of 
the Stretched Control and the Stretched Stenosis. The raw intimal thickness data was 
processed using an ARMA, producing the above waveforms. The increase in intimal 
thickening at the stenotic throat was very unexpected. Several contributing factors helped 




Figure 3.21: Comparison of Intimal Thickening at the Proximal and Distal Anastomoses 
of the Stretched Control Grafts. There existed no statistically significant difference in 




















































Figure 3.22: H&E Staining of Circular Cross-Sections from the Stretched Stenosis. (A) 
















Figure 3.23: Comparison of Intimal Thickening at the Proximal and Distal Anastomoses 
of the Stretched Stenotic Grafts. There existed no statistically significant difference in 
intimal thickening between the proximal and distal ends of the vascular graft. 
Comparison of Proximal versus Distal 



































































Figure 3.24: Intimal Area of Stretched Control and Stretched Stenotic Grafts. This 





Figure 3.25: Comparison of Intimal Thickening at Mid-Vessel Between Stretched and 
Unstretched Control. No statistically significant difference was observed between the 
intimal thickenings of the two different types of control grafts. 






















statistically significant difference between the unstretched control (0.08 ± 0.02 mm) and 
the stretched control (0.09 ± 0.06 mm). When comparing the controls to the stretched 
stenosis, different results evolved. There emerged a statistically significant difference 
between the unstretched control (0.08 ± 0.02 mm) and the stretched stenosis (0.34 ± 0.06 
mm) (Figure 3.26), as well as between the stretched control and the stretched stenosis 
(Figure 3.27).   
BRDU at Mid-Vessel. 
 BRDU immunostains were performed on cross-sections at the stenotic throat and up to 
0.5 cm upstream and downstream of this location (Figure 3.28). Qualitatively, the number 
of proliferating cells was concentrated at the stenotic throat and decreased with 
translation from this region.  
Hemodynamics.  
Based on the CFD simulations, WSS values under harvest conditions were obtained for 
the control and stretched stenosis grafts. For the control grafts the τavg(z) averaged 4 
dynes/cm2. For the stretched stenotic grafts, the proximal and distal graft segments with a 
6 mm internal diameter had a τavg(z) of 3 dynes/cm2 , while the  stenotic throat had a 
τavg(z) of 18 dynes/cm2. Within the stenotic throat, the Max WSS equaled 82 dynes/cm2, 






Figure 3.26: Comparison of Intimal Thickness at Mid-Vessel Between Unstretched 
Control Graft and Stretched Stenotic Graft. There existed a statistically significant 
difference between the intimal thickening of the unstretched control graft and the 
stretched stenotic graft.  
Comparison at Mid-Vessel between the 



































Figure 3.27: Comparison of Intimal Thickening at Mid-Vessel Between Stretched 
Control Graft and Stretched Stenotic Graft. There existed a statistically significant 
difference between the intimal thickening of the Stretched Control Graft and the 
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Figure 3.28: BRDU Immunostaining of the Stretched Stenosis. The proliferating cells 
are located near the adluminal flow. Based on their location nearthe flow surface, they are 
predominantly endothelial cells. 
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Discussion:  
Our study documented how changes in the material ultrastructure affected healing of a 
prosthetic vascular graft. We investigated this topic using two different models. Before 
discussing how the grafts healed, we will begin by documenting how the vessel 
ultrastructure was altered. 
 
Graft Ultrastructure.  
The radial stretching of the 60 µm ePTFE induced a definitive change in the initial 
material properties. First and foremost, the stretching reduced the void fraction of the 
graft material. Without empty space within the graft material, there existed no avenue for 
tissue to migrate from outside the vessel into its inner lumen. The void fraction reflects 
the ability of the graft to heal by transmural ingrowth. Without transmural ingrowth, the 
ePTFE grafts fail to evolve a confluently healed surface. Nonporous grafts such as 30 µm 
ePTFE do not heal by transmural ingrowth. Even one year following implantation, 30 µm 
ePTFE still demonstrates patchy and incomplete healing [39]. In a study of porous grafts, 
the void fraction distinguishes itself as the most informative parameter regarding how 
quickly and how completely the graft will heal. While Palmaz [103] and Williams [48] 
evaluated many structural properties within their studies, they did not investigate this 
very important parameter since their studies only focused upon 30 µm ePTFE. While 
they investigated the effect of material deformation on graft healing, they began with a 
material that did not permit for transmural ingrowth even in its native, unstretched state 
[47,103]. 30 µm ePTFE heals primarily by transanastomotic ingrowth. Any stretching 
and mechanical deformation will exert little change upon this mechanism of healing. This 
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helps to explain why both Palmaz and Williams reported inconclusive findings in their 
animal studies with healed, stretched grafts. 
In contrast to their studies, our work began with the porous 60 µm ePTFE that 
healed completely within two weeks. Unlike 30 µm ePTFE, the 60 µm ePTFE graft heals 
both by transanastomotic ingrowth and by transmural ingrowth [25]. The radial stretching 
of the 60 µm ePTFE mechanically deformed the material so that the void fraction was 
reduced by nearly 38 %. Even before quantitatively measuring the void fraction, the SEM 
images illustrated how stretching made the grafts very compact and dense (Figure 3.8b). 
The SEM images displayed the luminal graft surface parallel to the vessel’s axial 
direction. From this angle, we observe a very distorted graft material that appears devoid 
of any empty space. This picture contrasts with Figure 3.8a that shows a relaxed, 
unstretched 60 µm ePTFE that is receptive to tissue ingrowth. The H&E stained cross 
sections illustrated this point from an alternative perspective. These stained cross sections 
highlighted the empty space perpendicular to the vessel’s axial length. The unstretched 
control graft showed empty space that was inviting to tissue ingrowth and was 
unoccupied by surrounding graft material. By stretching the porous 60 µm ePTFE, the 
void fraction was reduced to a level commensurate with the 30 µm ePTFE. The process 
of stretching removed a distinguishing property of the porous material. The void fraction 
between stretched, 60 µm ePTFE and unstretched 30 µm ePTFE only differed by 10 %, 
and this difference was not found to be statistically significant. Based on this result, we 
expected the stretched 60 µm ePTFE and the unstretched 30 µm ePTFE to heal in a very 
similar fashion. In the end, our results with the 60 µm ePTFE mirrored previously 
published observation with 30 µm ePTFE [25,39,40].  
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The radial stretching reduced the thickness of the vascular graft material. The 
thickness of the stretched graft material decreased by 45 % and was statistically different 
than the unstretched graft material. There existed no statistically significant difference in 
graft thickness between unstretched, 60 µm ePTFE and unstretched, 30 µm ePTFE. By 
stretching the graft material, the distance between the outside of the vessel and its luminal 
lining was reduced. In essence, tissue now had to travel less distance to heal the 
intraluminal surface. A very interesting question emerged from this observation. By 
stretching the graft material, we reduced the void fraction that facilitates transmural 
ingrowth, but we also reduced the distance that tissue now needed to migrate to heal the 
intraluminal surface. As far as graft healing was concerned, stretching the ePTFE 
material reduced void fraction in an unfavorable way, while it decreased graft thickness 
in a beneficial way. In the end did we alter the ability of these stretched porous ePTFE 
vascular grafts to heal? The results from the harvested grafts answered this question.  
The other two parameters of internodal distance and nodal width were also 
measured. Unlike Williams [48], we observed that stretching lengthened the internodal 
distance by 36 %. Doubt surrounds whether this lengthening of the internodal distance 
impacts graft healing to any degree. If nothing else, any effect that it exerts has already 
been incorporated into our evaluation of graft thickness and void fraction. A similar line 
of thought applies to our evaluation of nodal width and the lack of any appreciable 





Healing of the Stretched and Unstretched Control Grafts. 
First, we examined the healing patterns of the two different varieties of control grafts. 
The unstretched control graft demonstrated confluent healing of its intraluminal surface. 
This was verified through several different methods. The H&E stained sections displayed 
complete healing at every examined cross-section. Furthermore, tissue migration across 
the graft wall was revealed from ingrowth laden within its interstices. The Evan’s Blue 
Dye was noticeably excluded from the vessel’s intraluminal lining. This exclusion only 
occurs in the presence of a confluent layer of endothelium that shields the vessel from 
dye uptake. On exam with SEM, we observed a healed surface with healthy and “cobble-
stone” endothelium. Lastly, immunostaining with VWF illustrated a healed endothelial 
layer. This picture was consistently observed in any examined section. In comparison, the 
stretched control graft failed to evolve a completely healed graft surface. This was 
evident just on observation of the H&E staining. On some of the circular cross-sections, 
there appeared very little if any tissue migration across the graft wall; consequently, some 
of these cross-sections showed no healing at all. The Evan’s blue dye was uptaken by the 
graft, resulting in a distinct blue staining. This dye uptake hinted at the absence of an 
endothelium. The SEM demonstrated very incomplete healing with sections of graft 
covered only by an occasional platelet or other blood-borne cell. Most importantly, the 
VWF immunostain was conspicuously absent on many of the examined cross-sections.  
 Clearly, the unstretched control was more healed than the stretched control. As 
expected, there existed no difference in intimal thickening at the anastomotic ends of the 
two grafts types. At this location both varieties healed by the same mechanism of pannus 
ingrowth. Next, we examined the mid-vessel regions that are immune from healing by 
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transanastomotic ingrowth. Surprisingly, there existed no statistically significant 
difference in the quantitative measurements between the two graft varieties. At the mid-
graft both types of grafts evolved the same amount of average intimal thickening. With 
the preservation of graft ultrastructure in the unstretched control, we expected to observe 
greater average intimal thickening. This peculiar healing process occurred for several 
reasons. First, the unstretched control grafts heal very quickly with an established layer of 
protective endothelium. This protective endothelial layer shields the underlying tissue 
from potentially mitogenic and chemogenic mediators within the flowing blood. In 
addition, the endothelium releases such vasodilatory products as nitric oxide and vascular 
endothelial growth factor (VEGF) that inhibit smooth muscle cell proliferation. By 
healing very rapidly, the unstretched control graft stymied several of the processes that 
lead to pronounced intimal thickening. On the other hand, the stretched control failed to 
evolve this confluent and protective endothelium. As a result, some of the examined 
cross-sections developed very significant intimal thickening with large amounts of 
extracellular matrix, while other cross-sections evolved little to no intimal thickening at 
all. Even with its incomplete healing, the stretched control grafts developed on average 
the same amount of intimal thickening as the unstretched control grafts. The marked 
thickening at some locations compensated for its absence in other regions. This trend was 
best reflected by a comparison of standard deviations between the stretched (0.06 mm) 
and unstretched (0.02 mm) control grafts. The standard deviation of the stretched control 
grafts was three times as large as that for the unstretched control grafts. In conclusion, the 
amount of intimal thickening fails to function as the most reflective parameter of graft 
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healing. Instead, the ability of the graft to heal quickly and to evolve a confluent 
endothelium has assumed that ever-important role. 
 
Healing of the Stenotic Grafts.  
The stretched stenotic graft introduces a very interesting model, for within its borders 
there exists both preservation and distortion of the graft ultrastructure. At each of the 
anastomotic ends the graft material has been stretched from an inner diameter of 3 mm to 
an inner diameter of 6 mm. As we progress toward the stenotic throat, the graft material 
has also been stretched, albeit not to the same extent since its size progressively 
approaches the starting diameter of 3 mm.  At the stenotic throat the material properties 
are identical to those of unaltered 60 µm ePTFE. Since both the starting 60 µm ePTFE 
and the stenotic throat have an inner diameter of 3mm, no stretching occurs at this 
location. As a result, surrounding tissue can migrate across the wall of the stenotic throat, 
depositing on the luminal surface. The animal experiments revealed significant intimal 
thickening at the stenotic throat. In fact, the average intimal thickness at the stenotic 
throat was statistically different than either control. On average the intimal thickness at 
the stenotic throat exceeded that of the control grafts’ mid-vessel value by nearly 300 %. 
This observation was all the more surprising because it happened in the stenotic throat 
where there exists an elevation of wall shear stress values (WSS).  As many investigators 
have documented through animal experiments, elevations in WSS furnish a mechanism to 
inhibit intimal thickening. Through several studies examining the carotid arteries, 
coronary arteries, and abdominal aorta, these in vivo experiments presented results where 
high levels of WSS led to decreased intimal thickening. Conversely, they have shown 
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that low and oscillatory levels of WSS promote pronounce and progressive thickening 
[54-56,60].  
 The explanation for the stenotic throat’s intimal thickening probably involves 
several interacting factors. First, the preservation of the original graft ultrastructure 
encourages transmural ingrowth. Transmural ingrowth fails to occur either upstream or 
downstream of the stenotic throat where the inner diameter is stretched from its starting 3 
mm internal diameter. At these locations the material has been too mechanically altered. 
As a result, the stenotic throat then functions as an origin for healing to spread upstream 
and downstream of this infiltrated location. If the stenotic throat operates in this capacity, 
there must exist a population of proliferating cells prepared to migrate. Through BRDU 
immunostaining, we identified a large number of proliferating endothelial cells and some 
proliferating smooth muscle cells. In many respects, the healed surface of the stenotic 
throat resembled the leading edge of the neointima. Just as the leading edge attempts to 
cover unhealed graft surfaces away from the anastomotic junctions, this neointima 
attempts to migrate towards adjacent areas of unhealed graft that have been stretched and 
mechanically altered, making them impermeable to transanastomotic ingrowth. Still, a 
certain caveat must be heeded with this analogy. While the throat’s neointima 
demonstrates some resemblance to a leading edge, we cannot definitively conclude that it 
functions in that capacity. In order to empirically draw that conclusion, the vessels need 
to be processed into longitudinal sections rather than the present circular cross-sections. 
While circular cross-sections visualize proliferating cells, they fail to illustrate the shape 
or progression of the leading edge. Future studies will be needed to elucidate this 
mechanism. 
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 At the stenotic throat there exists an elevation of WSS; however the WSS values 
still reside within high physiologic limits. Over the 0.5 cm length of the stenotic throat, 
the τavg(z) hovered near a mean value of 18 dynes/cm2. Although this value exceeded 
the 2 - 3 dynes/ cm2 seen either upstream or downstream, its magnitude failed to achieve 
a sufficient range to exert its inhibitory effect upon intimal thickening [117-121]. In their 
work researchers often correlated the WSS measurements to the measured intimal 
thickness, hoping to reveal a causative relationship between these biologic measurements 
and the mechanical forces. In this study altering the material ultrastructure obviated any 
future ability to isolate the effect of changing hemodynamics upon such biologic 
variables as intimal thickness; consequently, no correlative studies were conducted. 
Another possible explanation for the increased intimal thickening may derive from 
humoral-mediated factors. At the stenotic throat an elevation of blood velocity occurs. 
This faster velocity can result in damaging of such blood-borne elements as platelets. 
While the τavg(z) did not exceed 30 dynes/cm2, other parameters such as the Pulse WSS 
and Max WSS did. The Pulse WSS exceeded 47 dynes/cm2, while the Max WSS was 
greater than 87 dynes/cm2. These values represented transiently high levels of WSS. 
While they were not sustained for a long enough period to inhibit intimal thickening, 
their magnitude was sufficient enough to damage the blood-borne platelets. Once 
damaged, platelets release such potent mediators as PDGF-AA, PDGF-BB, thromboxane 
A2, b-FGF, and many other cytokines. These mediators and growth factors can lead to 
smooth muscle cell migration, proliferation, and deposition of extracellular matrix, all 
contributing factors to increased intimal thickening. In the end, a combination of all these 
contributing influences may have led to the observed intimal thickening.  Since these 
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models incorporated several parameters, it becomes difficult to distill which was the most 
important or exerted the most pervasive effect. In the future we would like to conduct a 
study of graft ultrastructure where we alter the void fraction but where we do not change 
the thickness of the graft material. This modification simplifies an analysis of graft 
ultrastructure and its subsequent effects on healing. Furthermore, we would like to isolate 
the effect of a changing hemodynamic environment on graft healing but without any 









Since its inception, expanded polytetrafluoroethylene (ePTFE) has functioned as the 
preferred prosthetic vascular graft for repair of occlusive, peripheral vascular disease. 
Clinically, physicians use a rigid ePTFE with an internodal porosity of 30 µm and with 
reinforced rings that ensure material integrity. In the absence of an available autologous 
vessel like the saphenous vein, ePTFE is frequently used in femoropopliteal 
reconstruction. Clinicians prefer ePTFE because of its smooth and relatively 
nonthrombogenic surface, its ease of use, and its lack of pre-clotting. Interestingly, when 
used for surgical repair of femoropopliteal arteries, the patency rates of Dacron and 
ePTFE are indistinguishable, and quite often, a physician’s choice of ePTFE is governed 
by an allegorical feel rather than a well-established scientific basis. An even more 
surprising fact is that both of these synthetic substitutes were developed in the 1950s, and 
even in the technologically advanced world of today, they still function as the only 
available choices for a prosthetic vessel [115,116]. A possible alternative to both of these 
clinically used synthetic substitutes can be found with a more porous, prosthetic material 
such as 60 µm ePTFE. Unlike the less porous 30 µm ePTFE, 60 µm ePTFE allows for 
tissue migration across its wall and subsequent transmural ingrowth onto its luminal 
lining. As a result, researchers have documented how these more porous grafts heal with 
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a well-identified confluent endothelium within two weeks following implantation; 
however, further investigation of these prosthetic grafts is required before they can be 
used clinically. 
 Prosthetic vascular grafts occlude because of two reasons: (1) thrombosis and (2) 
pseudointimal hyperplasia. Hemodynamic factors modulate both of these causative 
factors. For quite some time, published literature has investigated the ability of 
hemodynamics to affect vessel wall structure and healing. We have long known how 
intraluminal pressure or wall tension regulates the vessel wall thickness. Furthermore, we 
have recognized how changing blood flow influences the vessel’s vasodilatory reaction 
and vascular remodeling. Much work has documented the ability of such hemodynamic 
parameters as wall shear stress to affect atherosclerotic plaque formation. Early 
researchers such as Fry [53] proposed that high wall shear stress leads to increased plaque 
formation. Fry reasoned that the high wall shear stress damaged the endothelium and 
promoted subsequent thickening of the vessel wall. In a canine model, Fry identified that 
the endothelium possessed a critical shear threshold of 380 dynes/cm2 at which point the 
integrity of the endothelium became compromised. In contrast, studies conducted by 
Taylor and Zarins [117-119] in primates demonstrated that high wall shear stress resulted 
in little to no disruption of the endothelial integrity. With this context in mind, 
researchers soon began to investigate the role of low and oscillatory wall shear stress in 
the pathogenesis of atherosclerotic disease. 
 Caro et al. [54] were the first to suggest that the location of arterial plaques 
coincides with regions of low wall shear rate. Unlike Fry, Caro interpreted such 
hemodynamic parameters like high wall shear stress as exercising a “controlling or 
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inhibiting” influence on plaque formation rather than a causative role [54,120].  
Investigators confirmed this theory through a series of experiments. In an investigation of 
the human carotid bifurcation, Zarins et al. [56] showed that under steady state conditions 
an inverse relationship existed between wall shear stress and intimal thickening. Ku et al. 
[55] later extended this study by identifying the same relationship under pulsatile 
conditions. Friedman [143] found similar results in his investigation of the abdominal 
aorta, while He [145] studied the same relationship within the coronary arteries. 
Overwhelmingly, we see a uniform message relating hemodynamics and atherosclerotic 
plaque formation. Now, we ask how does a changing hemodynamic environment affect 
healing and intimal thickness within an implanted prosthetic, vascular graft.  
 The prosthetic vascular graft presents an interesting model to investigate the 
effect of changing wall shear stress upon neointimal thickening. The synthetic substitute 
is a rigid material, immune from vasconstriction or vasodilation; consequently, variations 
in the neointimal expansion can be directly related to the changing hemodynamic 
environment. Early on, Bassiouny et al. [121] investigated the contribution of local 
hemodynamics upon intimal thickening at the distal junction of an end-to-side 
anastomosis. Flow visualization studies revealed a stagnation point on the anastomosis’ 
arterial floor coincident with low and oscillating shear along with increased intimal 
thickening. Furthermore, Bassiouny reconfirmed an earlier suspicion that the compliance 
mismatches between native vessel and prosthetic graft resulted in disturbed and separated 
flow that lead to increased intimal thickening at the suture-line anastomosis. Loth [122] 
later confirmed these conclusions using laser Doppler anemometry to measure wall shear 
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stress values within a transparent model of a canine end-to-side anastomosis involving a 
30 µm ePTFE vascular graft.  
Clowes [57] used the porous 60 µm ePTFE to examine the effect of wall shear 
stress upon intimal area. Since these porous grafts heal rapidly, the effects of changing 
hemodynamics upon wall thickening can be more easily discerned. With an in vivo 
model, he attempted to extend the thinking that wall shear stress can “inhibit and control” 
more than just atherosclerotic plaque formation. Through various histologic and 
immunostaining profiles, he demonstrated that within a porous, prosthetic vascular graft 
high wall shear stress levels decrease intimal area and smooth muscle cell proliferation. 
He documented these results through three different trials in baboon models. First, he 
implanted 60 µm ePTFE grafts into a high wall shear stress environment of the 
abdominal aorta, and then he concurrently implanted two ePTFE grafts into the lower 
wall shear stress environment of an aorta-iliac bypass [57]. Second, he implanted 60 µm 
ePTFE vascular grafts into aorta-iliac bypasses and induced a high shear stress 
environment by distally creating an AV fistula between the femoral artery and the 
superficial femoral vein. He then removed the fistula to normalize the shear stress levels 
and to observe any subsequent changes on the intimal area. Lastly, he performed a variant 
of the above procedure by first implanting the grafts into a low shear stress environment 
and then by imposing higher shear level with an AV fistula. [57-59]. While drawing some 
interesting conclusions, there were limitations to Clowes’ work. First, within all the 
experiments, the hemodynamic environment was altered by changing the volumetric flow 
rate through the vessels. Temporarily, this alters the wall shear stress incident upon the 
vessel wall, but the circulation compensates and reduces the level of blood flow through 
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the vessels. Furthermore, Clowes chronicled the hemodynamic effect by using a very 
simplified assumption of Poiseuille steady state flow. As researchers have explained, this 
greatly simplifies an otherwise complicated and dynamic system. 
In this work we propose to investigate the effect of a changing hemodynamic 
environment on the intimal thickening of an implanted porous, 60 µm ePTFE vascular 
graft. We will alter the hemodynamic environment not through a change in the 
volumetric flow rate but through a stenotic geometry. We will measure the hemodynamic 
environment through a combination of magnetic resonance imaging (MRI) and 
computational fluid dynamics (CFD). We will then attempt to correlate this 
hemodynamic information to our detailed measurements of intimal thickness along the 
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Material and Methods: 
Animals.  
In this study vascular grafts were implanted into juvenile male baboons (papio 
cyncephalus / anubis) of roughly two years of age and weighing between 13-24 kg. All 
animal procedures followed “Principles of Laboratory Animal Care”, the “Guide for the 
Care and Use of Laboratory Animals” (NIH Publication No. 8023, revised 1985), and 
IACUC university guidelines.  
Grafts. 
 Two different vascular grafts constructed of 60 µm expanded 
polytetrafluoroethylene (Impra ©, non-reinforced, thin wall) were used in this study. The 
first type of vascular graft, the so-called unstretched control, possessed a length of 
approximately 4 cm and an inner diameter of 6 mm. The Impra Corporation constructed 
the second type of vascular graft, the so-called unstretched stenosis. In the center of the 
graft the cross-luminal area reduced by 75 %. The vascular graft consisted of a central 
stenotic section with a 3 mm internal diameter and a length of 1.5 cm melded to two 
separate segments with an inner diameter of 6 mm and a length of 2 cm. The artistic 
configuration of Figure 4.1 best describes this design.  
Surgery. 
  One day prior to surgery, 325 mg of aspirin was administered to the baboon. 
Blood samples were drawn to analyze such hemodynamic parameters as platelet count, 














Figure 4.1: The Unstretched Stenosis. This artistic configuration describes the design of 
the vascular graft constructed with 60 µm ePTFE. A central stenotic portion with an inner 
diameter of 3 mm and a length of 1.5 cm was melded to two separate 2 cm lengths of 





2.5 % isoflurane, a mid-line incision was made, followed by exposure of the 
retroperitoneum. Following isolation of the distal abdominal aorta, 150 units of 
heparin/kg were infused. The volumetric flow rate of the baboon was measured by fitting 
a perivascular flow probe (Transonic Inc.) around the exposed aorta, just distal to the 














Transonic© pulse-transit ultrasound flow meter that was connected to a PC computer 
using an Analog/Digital card. On the PC, Labview® recorded the volumetric flow rate 
for at least thirty cardiac cycles (Figure 4.2). Fifteen ePTFE grafts were implanted into 
the distal abdominal aortas of individual baboons. Implantation of vascular grafts 
involved using an end-to-end anastomosis with a continuous running suture of 6.0 
polypropylene (Davis & Geck, Wayne, N.J.) (Figure 4.3). An example of an implanted 
vessel is demonstrated in Figure 4.4. Changyi Chen M.D., Ph.D performed all of the 
surgeries. 
MRI Imaging. 
 Two weeks following surgery, the implanted vascular grafts were imaged using a 
1.5 Tesla mobile MRI (Phillips Inc.). The animal was sedated with a combination of 70 
mg of telazol and 0.1 mg/kg of ketamine. With the help of 15 cc of a Gadolinium contrast 
marker, the vasculature was visualized. Coronal sections were recorded to evaluate the 
overall position of the graft within the arterial tree (Figure 4.5). Axial cross-sections were 
acquired using a slice thickness from 1 to 2 millimeters. The recorded axial cross-sections 
started 0.5 cm upstream of the graft’s proximal anastomosis and extended downstream to 
the bifurcation of the iliac arteries. Phase Contrast Magnetic Resonance Imaging 
measured the velocity of flowing blood at three separate locations: (1) proximal 
anastomosis, (2) mid-vessel, and (3) distal anastomosis. Cardiac gating facilitated 
acquisition of the blood velocity. The cardiac gating involved placing an 
electrocardiogram (ECG) upon the sedated animal and marking the p-wave as the start of 
the cardiac cycle. This procedure provided the MRI processing software with very 
valuable information in regards to the beginning and end of the cardiac cycle. 
 117
 
Figure 4.2: Data Acquisition for Volumetric Flow Rate. The perivascular flow probe 
connected to the pulse-transit ultrasound flow meter that interfaced with an analog to 















































Figure 4.3: Illustration of an Implanted Vascular Graft. The graft was implanted into the 
abdominal aortic tree, just distal to the bifurcation of the renal arteries, using an end-to-





















Figure 4.4: A Gross Illustration of an Implanted Unstretched Stenosis. This picture 
shows an implanted vascular graft shortly after suturing. Observe the central stenotic 
















Figure 4.5: MRI Coronal Cross-Section of an Implanted Stenotic Graft. The stenotic 
throat is easily observed at the center of the vascular graft.  
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Vessel Harvest. 
All baboons were sacrificed one month following graft placement. Bromodeoxyuridine 
(BRDU; Sigma Chemical Co., St. Louis, Mo), 50 mg/kg dissolved in 50 ml of normal 
saline solution, was administered subcutaneously 19, 12, and 7 hours  
before sacrifice. Prior to vessel harvest, blood samples were once again drawn to analyze 
hemodynamic parameters. Twenty minutes before sacrificing the animal, 5000 units of 
heparin were administered. The distal abdominal aorta was once again exposed. Using 
the perivascular flow probe, the volumetric flow rate was acquired just distal to the renal 
arteries for thirty cardiac cycles. The animals were sacrificed by exsanguination. The 
implanted grafts were fixed in vivo by implanting a 14-gauge angiocatheter into the 
abdominal aorta and infusing the fixative from a 60 cc syringe. Before infusing the 
fixative, the grafts were first flushed with 0.1 M phosphate buffered saline (PBS) at pH 
7.4 and 37° Celsius. Next, Evan’s blue dye (50mg/kg) was administered, followed by 
another flushing of the distal aortic tree with 0.1 M PBS. A 14-gauge angiocatheter was 
inserted into the right common iliac to control how quickly the perfusate drained, while 
another 14-gauge angiocatheter was fed into the left common iliac up to the level of the 
aorta’s bifurcation to measure mean arterial pressure (MAP) using a sphygmomanometer. 
The vessels were perfused at a MAP of 100 mmHg for at least thirty minutes with either 
10 % buffered formalin (Baxter Diagnostics Inc, McGraw Park, Ill), accommodating 
protocols for immunohistochemistry, or 2.5 % glutaraldehye (Sigma Inc), accomodating 
protocols for scanning electron microscopy (SEM). Figure 4.6 illustrates the set-up for 

































Figure 4.6: In Vivo Pressure Perfusion of Implanted Vascular Graft. The perfusate 
consisted of either 10 % buffered formalin allowing for immunohistochemistry or 2.5 % 















along with 1 cm sections of contiguous native vessel at each anastomosis and then 
submersed in fixative for a 24-hour period. 
Histology and Morphometry. 
All harvested grafts were divided into 5 mm long segments with circular cross sections, 
embedded into paraffin, and microtomed perpendicular to the long axis of the vessel 
using a 5 µm slice thickness. 
At the proximal anastomosis, the center of the graft, and the distal anastomosis, 
microscope sections were cut every millimeter from the embedded blocks, while 
elsewhere in the vessel, only one representative set of sections was taken from each 
embedded block. As a result, greater resolution was attained at the anastomotic ends and 
at the center of the vessels. All grafts underwent staining with Hematoxylin and Eosin 
(H&E). Morphometric measurements were performed to evaluate neointimal thickness 
and area. Neointima was defined as ingrowth overlying the prosthetic graft surface. All 
slide specimens were analyzed using a microscope with a 1x objective, interfaced to a 
digital camera that captured all images into a TIFF format. Using the Image-Pro Plus ® 
Software (Media Cybernetics, Inc.; Silver Spring, Maryland), the average intimal 
thickness was measured in the following way. A macro within Image-Pro called graft1 
identified the two borders of the neointima as defined by the surface of the ePTFE graft 
and the adluminal surface of the neointima. The software then calculated the distance 
between these two borders, progressing with a one-pixel resolution (0.005 mm) around 
the circumference of the vessel. For each cross-section an average intimal thickness was 
calculated. A macro called area measured the intimal area between these two borders. 
Since the length of harvested vascular grafts varied by 12 %, the axial locations were 
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normalized to a scale from 0 to 1. This adjustment allowed for comparison of intimal 
thickness and area measurements at the same relative location within vascular grafts of 
different lengths. For each particular graft type the intimal thickness and area 
measurements were processed using an autoregressive moving average (ARMA) method. 
The ARMA technique generates a representative measurement of intimal thickness by 
incorporating measurements that precede, follow, and occur at a location of interest. At 
0.1 normalized distances along the vascular graft, standard deviations were calculated. 
For each vascular graft type, a comparison of intimal thickness at the proximal and distal 
anastomoses was performed. Furthermore, a comparison of intimal thickness 
measurements at the mid-vessel point of the different graft varieties was performed.  
 Immunocytochemistry and Morphometry. 
 The avidin-biotin complex immunoperoxidase procedure (LSAB Kit, DAKO Co., 
Carpenteria, Ca.) was used to differentiate proliferating cells and the different neointimal 
cell-types. This staining procedure was performed upon all the harvested vessels. Anti-
BRDU monoclonal antibody (DAKO Co.) identified proliferating cells that had uptaken 
the administered BRDU prior to sacrifice, while monoclonal antibodies to α-actin 
(DAKO) and Von Willebrand Factor (vWF; Factor VIII related antigen, DAKO) outlined 
smooth muscle cells and endothelial cells, respectively.  
Scanning Electron Microscopy. 
 Two different sets of scans were performed using a Topcon-ISI DS-130 operated with a 
LaB6 electron source at 9 kV. First, an analysis of the ultrastructure was performed on 
unimplanted vascular grafts. For three of the respective control and stenotic models, 
longitudinal strips with a width of 5 mm and a length of 0.5 cm were sectioned from three 
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different locations within the vessel:  (1) proximal, (2) mid-vessel (3) distal. Secondly, 
healing patterns were observed by analyzing implanted vascular grafts. From the 
harvested vascular grafts, two longitudinal sections with a width of 5 mm were taken 
from each of the respective control and stenotic models. The SEM protocol required 
fixation of the sample in 2.5 % electron microscopy grade glutaraldehyde, diluted in 
cacodylate. The samples were then dehydrated with graded alcohol, critical point dried, 
and then sputter coated with gold palladium with a deposited thickness of 20 Å. Both of 
the anastomotic ends and the mid-vessel regions were interrogated, and digital images 
captured.  
Graft Ultrastructure. 
With the SEM images described above, the vascular grafts’ material properties were 
measured. For each of the vascular graft types, internodal distance (distance between 
nodes of ePTFE) and nodal width (width of a node of ePTFE) were measured (Figure 
4.7). The ultrastructural properties of graft thickness and void volume were measured 
using the H&E stained circular cross-sections (Figure 4.8). Using Image-Pro, the graft 
thickness was measured by calculating the distance between the outer and inner borders 
of the prosthetic graft at each radial location around the vessel’s circumference, followed 
by calculating their average. Void Fraction reflected the percentage of empty space 
within the prosthetic graft that permitted for transmural ingrowth across its wall. A macro 
within Image-Pro called Void evaluated void fraction by calculating the area of empty 
space unoccupied by ePTFE material and dividing it by the total area of the graft 
material. For the control graft, the average of these parameters was taken between the 




Figure 4.7: Scanning Electron Microscopy of Unstretched 60 µm ePTFE. (A) designates 
















Figure 4.8: H&E Staining of a Circular Cross-Section of a Harvested 60 µm ePTFE 





individually evaluated at the mid-vessel and anastomotic location. Since the material 
properties of the graft changed from the anastomosis to the stenotic throat, their 
measurements were not averaged as with the control graft. 
Fluid Mechanics. 
Computational fluid mechanics characterized the flow field within the vascular grafts. 
Chapter V describes in detail how this was accomplished. Briefly, using the MRI axial 
images, a computational grid was constructed of the control and stenotic grafts. The grid 
was composed of luminal contours outlined from the MRI axial images.  The Gambit 
software (Fluent Inc.) took the information extracted from these contours  
and helped construct the computational grids. With all pulsatile simulations, boundary 
conditions at the inlet were needed. A representative description of blood flow at implant 
and at harvest for both the control and stenotic grafts was calculated by ensemble 
averaging the volumetric flow rates. These waveforms were then applied to a Womersley 
solution [151] to derive velocity values for the flowing blood at the vessel inlet. Using 
Fidap (Fluent Inc), pulsatile simulations were run for three cardiac cycles. From these 
simulations, wall shear stress within the vascular graft was calculated.  Wall shear stress 
is defined as the dynamic viscosity of the fluid times the gradient of the velocity, 
evaluated at the wall. The dynamic viscosity of blood was assumed to be 0.04 poise. The 
hemodynamic data were compressed into a description of wall shear stress as a function 
of distance along the axial direction of the vascular graft. This was accomplished by 
averaging the WSS measurements around the circumference of the vessel. This term is 




At each axial location along the graft, the pulse spatially averaged WSS (Pulse WSS) was 
calculated. Over a cardiac cycle, the Pulse WSS measures the difference between the 
maximum spatially averaged WSS and the minimum spatially averaged WSS. Lastly, the 
temporal mean of the spatially averaged WSS was calculated. This manipulation 
produced the spatially averaged, temporal mean wall shear stress {τavg(z)} (Equation 
4.2).  
                                                                                                                         Equation 4.2     
 
 
These different descriptions of WSS were then correlated with the measured histologic 
data. The three dimensional oscillatory shear index was calculated (Equation 4.3). 
 




























Statistical analysis was performed on a Pentium IV P.C. with the use of either MATLAB 
or Excel 2000 statistical software (Microsoft Co.). Comparisons of intimal thickness 
between the various grafts were made using a Student t test (two-tailed).  The 
documented values are given as the mean ± the standard deviation. The results were 







Graft Ultrastructure.  
The material properties of the unstretched stenosis were investigated (Figure 4.9). 
Corroboration was needed that the ultrastructure of the stenotic throat was identical to 
those parameters within the straight, 6mm internal diameter (id) sections of the vessel. 
First, the void fraction was examined (Figure 4.10). The 3 mm id stenotic throat had a 
void fraction of 78.3 ± 4.8 %, while the 6 mm id regions had a void fraction of 73.0 ± 4.8 
%. There existed no statistically significant difference in the void fraction between these 
two investigated areas. Secondly, the graft thickness was investigated (Figure 4.11). The 
3 mm id stenotic throat had a graft thickness of 0.44 ± 0.03 mm, while the 6 mm id 
regions had a graft thickness of 0.34 ± 0.06 mm. There existed no statistically significant 
difference in the graft thickness between these two examined regions. Lastly, the 
internodal distance was measured. The 3 mm id stenotic throat had an internodal distance 
of 20.4 ± 8 µm, while the 6 mm id regions had an internodal distance of 19.8 ± 8 µm. 
There existed no statistically significant difference in the internodal distance between the 
two investigated areas. 
Graft Healing. 
On gross-inspection of the harvested stenotic graft, the intraluminal surface appeared 
healed (Figure 4.13). Within the lumen, a “glistening” and healed surface was observed. 
Over the next several experiments confirmation was gathered that the graft surface had 
confluently healed. The infused Evan’s Blue Dye was selectively excluded from the 
surface of the unstretched, 60 µm ePTFE control graft (Figure 4.14). The absence of 
Evan’s blue staining hints at the presence of a deposited endothelial surface within the
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Figure 4.9: Scanning Electron Microscopy of 60 µm ePTFE Sampled from the Proximal 
and Throat Regions of the Unstretched Stenosis. The ultrastructure of the two graft 
regions is nearly identical, indicative of very similar material properties.   
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Figure 4.10: Void Fraction for the Proximal and Throat Regions of the Stenotic Graft. 
There existed no statistically significant difference in the void fraction between the two 


















3 mmP-Value = 0.81
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Figure 4.11: The Graft Thickness for the Proximal and Throat Regions of the Stenotic 
Graft. There existed no statistically significant difference between the two examined 

















3 mmP-Value = 0.32
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Figure 4.12: The Internodal Distance for the Proximal and Throat Regions of the 
Stenotic Graft. There existed no statistically significant difference between the two 
































Figure 4.13: Gross Examination of Unstretched Stenosis. A “glistening”, healed surface 
was observed within the lumen of the harvested vessel. Blood flows from right to left. 
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Figure 4.14: Evan’s Blue Dye Injection of Healed, 60 µm ePTFE Control Graft. The 
Evan’s Blue Dye (50 mg/ml) was administered through an angiocatheter into the vessel’s 
lumen. Note the absence of dye uptake upon the surface of the healed graft. Dye was 
uptaken by the native tissue stripped of its endothelium by the inflated angioballoon 
catheter. This experiment qualitatively shows how the graft surface was healed. 
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prosthetic graft. A complete endothelial layer blocks the uptake of the infused dye, unlike 
the upstream vessel where the endothelium was stripped away using an angioballoon 
catheter. Endothelium was also observed on examination with SEM (Figure 4.15). Within 
the stenotic throat an endothelial surface was observed. Due to the high velocity at this 
location, the endothelial cells are not “cobble-stone” shaped, but instead, they are 
elongated and oriented in the blood flow direction. Finally, the presence of a complete 
endothelium was confirmed by VWF immunostaining. For the control vessel, positive 
immunostaining was observed around the circumference of every examined cross-section 
(Figure 4.16). For the unstretched stenosis, positive immunostaining was observed 
everywhere within the graft except for the 0.25 cm transition regions where the graft 
material was melded. Within the stenotic throat, staining of the confluent endothelium 
was observed (Figure 4.17).  
                     The H&E stained cross-sections illustrated the amount of intimal thickening 
deposited upon the graft surfaces. First, the healed control grafts were examined (Figure 
4.18). The proximal and distal anastomosis demonstrated the expected pannus ingrowth. 
The midpoint of the control graft showed a healed surface with some intimal thickening. 
Next, the healed, unstretched stenosis was investigated (Figure 4.19). As with the 
controls, intimal thickening was documented at the suture line. At the stenotic throat, the 
graft surface was healed with a well-identified neointima. The intimal thickening of the 
control and stenotic grafts was quantified (Figure 4.20). On examination, the intimal 
thickening at the anstomotic ends of both the control and stenotic grafts did not differ 
between their respective proximal and distal ends (Figures 4.21 and 4.22). At the Mid-
vessel point, the average intimal thickening of the stenotic throat (0.132 ± 0.03 mm). 
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Figure 4.15: Scanning Electron Microscopy of Healed Surface at the Stenotic Throat. 
Elongated and flow-oriented endothelial cells are observed. 
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Figure 4.16: VWF Immunostaining of Straight and Unstretched Control. Positive 




Figure 4.17: VWF Immunostaining of Unstretched Stenosis. (A) Cross-section of the 
stenotic throat demonstrating the healed endothelium. (B) Magnified view highlighting 







Figure 4.18: H&E Staining of Circular Cross-Sections from the Unstretched Control. (A) 









Figure 4.19: H&E Staining of Circular Cross-Sections from the Unstretched Stenosis. 










Figure 4.20: Quantitative Description of Intimal Thickening for the Unstretched Control 
and Stenotic Grafts. Pannus ingrowth was observed at the anastomotic ends of the control 
and stenotic grafts. At the vessel mid-point the stentotic throat demonstrated a modest 
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Figure 4.21: Comparison of Intimal Thickening at the Proximal and Distal Anastomosis 
of the Unstretched Control Grafts. There existed no statistically significant difference 
between the two ends. 




























Figure 4.22: Comparison of Intimal Thickening at the Proximal and Distal Anastomosis 
of the Unstretched Stenosis. There existed no statistically significant differences between 
the two respective ends. 
Comparison of Intimal Thickening at the Proximal and Distal 























exceeded the average intimal thickening of the control’s mid-vessel region (0.08 ± 0.02 
mm) (Figure 4.23). Upon statistical comparison, a p-value of 0.10 was calculated. The 
intimal area of the control and stenotic grafts was also compared (Figure 4.24). This 
illustration told a very similar story to what was seen with our comparison of intimal 
thickening. With increased intimal thickening and area at the stenotic throat we suspected 
that a large number of proliferating cells were concentrated in this region. The BRDU 
immunostaining revealed very few proliferating cells (Figure 4.25). 
Hemodynamics.  
 The CFD simulations calculated WSS measurements in both the unstretched 
control and the unstretched stenosis. The results for the control grafts gave low WSS 
values of 2 to 4 dynes/cm2. These results differed markedly from the unstretched stenosis. 
For the stenotic grafts, two different boundary conditions were applied to the 
computational grid. The first boundary condition derived from the ensemble averaged 
volumetric waveform at harvest. The spatially averaged temporal mean WSS (τavg) was 
calculated along the length of the vascular graft (Figure 4.26). At the stenotic throat, the 
τavg intitally increased to over 42 dynes/ cm2. Further within the stenotic throat, the τavg 
values returned to a baseline level near 27 dynes/cm2. Within the stenotic throat, the 
Pulse WSS went as high as 100 dynes/cm2 with a baseline level near 60 dynes/cm2 
(Figure 4.27). Furthermore, excluding any averaging algorithms, the maximum WSS 
within the stenotic throat reached a ceiling of 130 dynes/cm2 during systole and 93 
dynes/cm2 during diastole.  The second boundary condition originated from the PCMRI 




Figure 4.23: Comparison of Intimal Thickening at the Mid-Point of the Unstretched 
Control and the Unstretched Stenosis. Although the stenotic throat had a higher average 
intimal thickness than the mid-point of the control, the p-value was not less than 0.05. 
 

































































Figure 4.24: The Intimal Area of the Unstretched Control and Unstretched Stenosis. The 
red line describes the unstretched stenosis, while the blue line details the unstretched 
control. As with the intimal thickness description, the intimal area within the stenotic 




Figure 4.25: BRDU Immunostaining at the Throat of the Unstretched Stenosis. There 
existed an absence of proliferating cells at the throat of the Unstretched Stenosis. Only 
one or two positively, stained cells are identified within the neointima. 
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Unstretched Study : Harvest 
















Figure 4.26: τavg(z) with an Applied Boundary Condition from the Ensemble Averaged 
Volumetric Flow Rate at Harvest.  
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Figure 4.27: Pulse Wall Shear Stress with an Applied Boundary Condition from the 
Ensemble Averaged Volumetric Flow Rate at Harvest.  
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the length of the vascular graft (Figure 4.28). At the stenotic throat, the WSS initially 
increased to a little less than 40 dynes/ cm2. Further within this expanse, the WSS values 
returned to a baseline level near 24 dynes/cm2. Within the stenotic throat, the Pulse WSS 
went as high as 80 dynes/cm2 with a baseline level of 45 dynes/cm2 (Figure 4.29). 
Furthermore, excluding any averaging algorithms, the maximum WSS within the stenotic 
throat reached a ceiling of 122 dynes/cm2 during systole and 83 dynes/cm2 during 
diastole.  
For the unstretched stenosis, correlation coefficients were calculated between the 
intimal thickness data and the hemodynamic data. For the harvest volumetric flow rate 
boundary condition, the correlation coefficient between the reciprocal of τavg and intimal 
thickness was r = -0.77 with a p-value less than 0.05. In addition, the correlation 
coefficient between the reciprocal of the Pulse WSS and the intimal thickness was r = -
0.79 with a p-value less than 0.05. Lastly, the correlation coefficient between the 
reciprocal of the Max WSS and the intimal thickness was r = -.80 with a p-value less than 
0.05. For the PCMRI boundary condition, the correlation coefficient between the 
reciprocal of τavg and intimal thickness was r = -0.78 with a p-value less than 0.05. In 
addition, the correlation coefficient between the reciprocal of the Pulse WSS and the 
intimal thickness was r = -0.80 with a p-value less than 0.05. Lastly, the correlation 
coefficient between the reciprocal of the Max WSS and the intimal thickness was r = -
0.80 with a p-value less than 0.05. For the two simulations, the oscillatory shear index 
detailed transient flow separation distal to the stenotic throat (Figure 4.30 and 4.31). 
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Unstretched Study : PCMRI
















Figure 4.28: τavg(z) with an Applied Boundary Condition from the Phase Contrast 






Figure 4.29: Pulse Wall Shear Stress with an Applied Boundary Condition from the 





Figure 4.30: Oscillatory Shear Index With An Applied Boundary Condition from the 
Ensemble Averaged Volumetric Flow Rate At Harvest.  
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Figure 4.31: Oscillatory Shear Index With An Applied Boundary Condition from the 
Phase Contrast Magnetic Resonance Imaging. 
 158
Discussion:  
This study focused upon the effect of a changing hemodynamic environment upon 
intimal thickening within a porous ePTFE vascular graft. Before discussing any 
conclusions, we first needed to establish that the material properties of the graft were 




 Our material analysis revealed that the ultrastructure of the 3 mm stenotic throat and the 
6 mm straight expanses were relatively consistent. More specifically, there existed no 
statistically significant difference in their respective void fraction and graft thickness. The 
transition regions between the 3 mm stenotic throat and the 6 mm straight expanses 
signified the only locations where any material variations arose. Upon examination of the 
H&E cross-sections, these transition regions showed an overlap of the two adjoining graft 
materials. Due to this material inconsistency, the intimal thickness within these rather 
short 0.25 cm sections were ignored. Our detailed method of measuring intimal thickness 
easily accommodated this method. 
 
The Stenotic Model.  
Overall, the unstretched stenosis furnished a valuable model to investigate the effect of 
changing hemodynamics on intimal healing. This model altered the wall shear stress 
levels through a change in the flow geometry. This differed from Clowes’ method [58] of 
adjusting the volumetric flow rate through an adjustment of the downstream resistance. 
Clowes [57,58] modulated the downstream resistance by inserting and removing an AV 
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fistula between the femoral artery and the superficial femoral vein. Temporarily, this 
arrangement furnished elevated wall shear stress levels within the prosthetic graft. The 
animal compensated for this elevated blood flow by adjusting its vascular resistance 
downstream of the graft. Over the course of months, this adjustment led to significant 
variation in the measured volumetric flow rate. In Clowes study he even documented that 
during the first week that the volumetric flow rate reduced by over 60 %. As expected, 
this variation in volumetric flow rate resulted in changes of the wall shear stress levels. 
These results contrasted markedly with our stenotic model. The unstretched stenosis 
maintains the same hemodynamic environment for an extended period of time. The 
stenotic model was constructed of prosthetic ePTFE that rigidly kept its original shape. 
Unlike an autologous vessel, the synthetic substitute is immune from any vasoconstrictive 
or vasodilatory response. Previously, researchers had investigated stenotic models by 
imposing a coarctation upon the abdominal aorta of animal models. This model consisted 
of fitting a constrictive band around the artery [123]. Over time, this model changed. The 
native vessel adjusted its diameter in an attempt to reduce the wall shear stress levels.  
Previous attempts to characterize the hemodynamic environment were limited by 
this adaptive change in the volumetric flow rate. Our protocol assured some level of 
consistent hemodynamic measurements by evaluating the dynamics of the flowing blood 
at two different time points. The volumetric flow rate was measured at sacrifice, while 
the PCMRI velocity profile was gathered two weeks following surgery. The simulations 
at these two time points produced very similar estimates of vessel wall shear stress. 
Between the two time points, the τavg differed by only 12 %, while the Pulse WSS varied 
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by only 20 %. This fluctuation was significantly less than what other researchers had 
reported. 
 
Graft Healing.  
Within our unstretched stenosis, confluent healing of the graft surface was verified using 
several different tools. Researchers documented that the surface of the 60 µm ePTFE 
heals within two weeks [25]. With a confluently, healed surface, the porous graft 
provides a good model for discerning the effect of hemodynamics upon graft healing. At 
the anastomotic junctions, pannus ingrowth occurred within all the harvested vessels. 
This transanastomotic ingrowth occured at a maximum rate of 0.2 mm/day [39]. For a 
graft implanted for thirty days, this pannus ingrowth progressed up to 6 mm into each 
respective graft end. The rate and extent of the transanastmotic ingrowth was governed 
by factors other than just the hemodynamic environment. At the anastomosis, a 
compliance mismatch between the synthetic substitute and the native vessel resulted in 
intimal thickening. This mismatch caused disturbed flow patterns and pulsatile 
mechanical stresses that affected pannus ingrowth. Moreover, the perianastomotic ends 
healed by a steadily progressing leading edge. At the leading edge, the neointima 
advanced with the help of proliferating endothelial and smooth muscle cells. As detailed 
in an earlier study, the dynamics of these proliferating cells were regulated by a 
combination of humoral factors and interaction with the immunogenic graft surface. 
Transmural ingrowth was not impacted by these same parameters; and therefore, it 
provided a better medium to investigate the effect of changing hemodynamics on graft 
healing. With these factors in mind, we choose to ignore those regions that were healed 
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by transanastomotic ingrowth and to focus our attention upon how hemodynamics impact 
transmural ingrowth.  
 The mid-point of the unstretched control and the unstretched stenosis furnished 
the best insight into the hemodynamic’s effect. At this location the stenotic throat (0.13 
mm) demonstrated greater intimal thickening than the corresponding mid-point within the 
unstretched control (0.08 mm). This difference in average thickening was not statistically 
significant. Using a two-sided student t-test, a p-value of 0.10 was generated. While this 
value does not demonstrate a statistically significant difference, the result does suggest 
that other factors are influencing healing within the stenotic throat that are absent within 
the unstretched control graft. This thinking was strengthened by our correlative results 
between intimal thickening and the computational estimates of wall shear stress. An 
inverse relationship was defined between intimal thickening and the reciprocals of three 
wall shear stress estimates: (1) τavg(z) (2) Pulse WSS (3) Max WSS. These results were 
consistent between the simulations using the two different boundary conditions of 
PCMRI and harvest volumetric flow rate. For all of the comparisons, the correlation 
coefficients were statistically significant. This inverse relationship suggests that an 
elevation in wall shear stress assists the thickening of the healed prosthetic vascular graft. 
The question then arises as to why this result emerges? 
Over the past forty years researchers have published results [54-56] contending 
that elevations in WSS “inhibit and control” intimal thickening. This inverse relationship 
has been well documented through in vivo and in vitro studies; however, our examined 
results assert quite the opposite relationship [54-56]. Several distinguishing features help 
to explain this phenomenon. First, this study investigates the healing of prosthetic 
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vascular grafts and not the pathogenesis of atherosclerotic plaque. Much of the published 
literature deals with wall shear stress and its relationship to atheroma. While very similar, 
the pathology of atherosclerotic plaques differs from that of neointima deposition. An 
atherosclerotic plaque never constitutes a desirable outcome. Billions of dollars are 
expended each year attempting to prevent this damaging result, and even more money 
and time are spent in treating its sequelae. On the other hand, prosthetic vascular grafts 
respond best when a healed flow surface evolves. The most successful vascular grafts 
mirror the native state of an autologous vessel with its confluent layer of thin 
endothelium. When a prosthetic vascular graft heals quickly, the possibility of an acute, 
thrombotic episode reduces significantly. The healed surface possesses a healthy 
endothelium that provides many protective benefits. First and foremost, it functions as a 
border between the underlying synthetic material and the flowing blood. This prevents 
platelets from becoming activated by the rough prosthetic surface. Secondly, the 
endothelium protects the underlying smooth muscle from such reactive factors within the 
blood as PDGF-AA, PDGF-BB, b-FGF, TGF-β, IL-3, IL-5, IL-6, and many others 
intermediates. The endothelium functions not only as a physical barrier, but it also 
inhibits underlying smooth muscle proliferation through the release of prostacyclin, nitric 
oxide, and heparin sulfate.  
Neointima growth becomes undesirable when it progresses to a point that 
occludes the graft. How the graft heals during the initial stages frequently dictates how it 
performs under chronic conditions and whether it remains patent. This study provides 
valuable insight into how the vascular graft heals during the first month and how the 
hemodynamic environment alters that behavior. Our observations suggest that different 
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dynamics are at work under these sub-acute conditions. All other published studies 
limited their investigation to chronic conditions [39,40,44,57,58]. The studies of 
atherosclerotic plaque involved measuring the intimal thickness of harvested cadaver 
vessels that were from patients ranging between eighteen and forty-five years of age or 
canines fed a cholesterol rich diet [55,56,147,119,121]. In Clowes’ study involving the 
AV fistula [39,40], the grafts were implanted for at least four months, while in 
Bassiouny’s study [121], ePTFE grafts were harvested at two months. During such a 
nascent study held under subacute conditions, hemodynamics fail to function as the 
critical mediator of intimal growth. In order for elevated levels of WSS to inhibit intimal 
thickening, a vascular graft needs a prolonged and chronic exposure spanning several 
months. 
In this study, the vessel experienced high levels of WSS. To some degree, the 
pulse WSS and τavg measurements were misleading. Within the stenotic throat, the 
instantaneous WSS values exceeded 130 dynes/cm2 during systole and 93 dynes/cm2 
during diastole. These were several reasons for these selectively high WSS values. First, 
the pulsatile flow temporarily leads to high levels at peak systole. Second, the vascular 
graft assumed a curved shape at the stenotic throat. The curvature was produced by the 
animal’s lumbar lordosis. This curvature produced higher velocities on the posterior 
surface of the graft. Variations in graft shape can produce these large fluctuations in wall 
shear stress. Third, with elevations in velocity the WSS increased in value too. This effect 
was very apparent within the stenotic throat. 
 Our post-processing of computing the temporal and spatial averages obscured 
these instantaneous levels. These instantaneous measurements highlight the benefits of 
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performing pulsatile simulations using computational fluid dynamics. Steady state 
measurements fail to reveal these important dynamics. While useful for a quick 
assessment, Poiseuille flow overlooks many of the details inherent to a pulsatile flow 
environment. This trend is further suppressed if the vessel is treated as an axi-symmetric 
pipe devoid of any three-dimesional artifacts like vessel curvature. 
 Reconstruction of the computational grid provided a very good representation of 
the vessel in vivo. The MRI axial cross sections preserved very good information 
concerning the vessel’s three-dimensional shape. The MRI images did suffer from some 
problems associated with image artifacts, contrast, and resolution. These obstacles were 
easily overcome through image processing. With its noninvasive means of analyzing 
vessel geometry, MRI imaging provided the best investigative modality. With our 
computational grid and the appropriate boundary conditions, we possessed all the 
necessary tools to thoroughly interrogate the vessel’s hemodynamics.  
CFD has long been recognized as a reliable means for furnishing this exquisite 
flow information. In comparison to experimental approaches such as laser Doppler 
anemometry, CFD accommodates intricate three-dimesional shapes and different input 
flow waveforms. CFD generates a wealth of hemodynamic information. Unfortunately, 
its potential use extends only as far as the resolution of the biologic data. In this study, 
there existed no preservation of how the circular cross sections were oriented in three-
dimensional space. As a result, no potential existed for specifying intimal thickness 
values around the vessel’s circumference such as its anterior, posterior or lateral walls. 
The intimal thickness could only be described as a function of distance along the axial 
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length of the graft. In the future, the use of such tools as molecular beacons and 
immunofluorescent dyes may preserve this information.  
In our results we identified very disturbed and separated flow distal to the stenotic 
throat. The transient flow separation was evaluated by measuring the three-dimensional 
oscillatory shear index. Post-stenotically, the oscillatory shear index reflected pronounced 
transient flow separation, particularly at end-systole and the beginning of diastole. The 
flow separation possesses the potential to thicken the graft surface downstream of the 
stenotic throat. In our results, there was no observed difference in intimal thickening 
between the regions proximal or distal to the stenotic throat. Even in this disturbed flow 
environment, the graft had not been exposed to altered hemodynamics for a long enough 
period of time. A certain caveat must be heeded in this conclusion. At these regions 
upstream and downstream of the stenotic throat, the transition areas of altered graft 
ultrastructure resided. Still, when these 0.25 cm regions were excluded from the analysis, 
the same conclusions held true. Furthermore, the area of post-stenotic transient flow 
separation extended as far as the distal anastomosis; therefore, there were ample regions 
with consistent ultrastructure to perform the analysis.  
In the end this study investigated the healing response of prosthetic vascular grafts 
under sub-acute conditions. The changing hemodynamic environment failed to exert a 
pervasive effect upon intimal thickening. The elevated WSS neither promoted nor 
inhibited intimal thickening. Ultimately, the graft was not exposed to the WSS conditions 
for a period of time long enough to change its pattern of healing. In the future, a 
comparative study must be conducted where the stenotic model is implanted under more 









There has been a growing body of knowledge related to hemodynamics in 
vascular grafts. Intially, studies involved using qualitative tools such as flow visualization 
techniques to describe the hemodynamic environment. Soon after, they progressed to 
more quantitative methods such as Laser Doppler Anemometry (LDA). Researchers 
applied these techniques in their investigation of how the prosthetic vascular grafts 
healed. Bassiouny et al. [121] conducted a study where polymer casts were made from 30 
µm ePTFE vascular grafts implanted within the aorto-iliac circulation of mongrel dogs 
using an end-to-side anastomosis.  From these polymer casts, transparent silicone models 
were constructed that allowed for flow visualization studies using helium-neon laser 
illuminated particles. Through this study, these investigators qualitatively examined the 
dynamics within the distal end-to-side anastomotic geometry. Loth et al. [125, 126] later 
attempted to quantify this hemodynamic environment by investigating flow in a 
polysiloxane cast first under steady flow conditions and subsequently under pulatile flow. 
LDA provided detailed information concerning the near-wall velocity gradients and the 
wall shear stress distribution. Loth et al. identified a region of low wall shear stress near a 
stagnation point on the floor of the distal anastomotic junction. This area of low wall 
shear stress extended to the sidewalls and the suture lines [125,126].  
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Another way of studying detailed hemodynamics is through numerical 
simulations of pulsatile flow. Perktold et al. [127] documented the dynamics of an arterial 
T- bifurcation model by solving the Navier-Stokes equations within a finite element field. 
Taylor and Zarins [128] later attempted a three-dimensional pulsatile simulation of the 
abdominal aorta. The computational grid was based on an idealized abdominal aorta 
derived from averaged measurements. They attempted to correlate this hemodynamic 
data to sudanophilic lesions reported by Cornhill [129]. Lei et al. [130-132] later 
performed computational studies of pulsatile flow through an end-to-side vascular graft 
model. In these and later studies, Lei et al. investigated the behavior of temporal and 
spatial wall shear stress gradients. Some researchers believed that these hemodynamic 
parameters helped predict distortion of the healed graft surface along with future 
locations of intimal hyperplasia. Lei et al. later compared the computational results to 
Loth’s [125,126] LDA measurements of the wall shear stress environment. Lei et al. 
concluded that the computational approach functioned an effective tool for a quantitative 
assessment of graft hemodynamics.   
While these studies provided useful information, there still exist many additional 
details to investigate. From the published litrerature, most of the measurements of 
biologic data were frequently qualitative, lacking rigorous measurements of intimal 
thickness. Other studies derived their hemodynamic models from idealized arterial 
geometries. With sensitive variables such as wall shear stress, slight variations in velocity 
values produce large variations in the velocity gradient. An attractive alternative involves 
computationally modeling the blood flow using geometric grids constructed from three-
dimensional in vivo medical images. Moore et al. [133-136] used time-of-flight MRI 
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imaging sequences to model the hemodynamics of the carotid arterial bifurcation. 
Phantom models of the carotid bifurcation were imaged with MRI and then processed 
with various smoothing algorithms. These investigators concluded that the smoothing 
algorithms eliminated many of the problems associated with the MRI images (resolution 
detail, flow artifacts, non-unifrom lumen signals, partial volume effects) without 
compromising the anatomic detail. As opposed to past attempts using direct surface 
triangulation, Moore outlined the cross-sectioned arterial profiles from axial images. 
When attempting to reconstruct models of in vivo carotid bifurcations, smoothing of the 
cross-sections and created surfaces was absolutely critical. With a representative in vivo 
model in hand, calculated wall shear stress measurements varied little from the accepted 
“gold standards.” This established MR arterial reconstruction as an acceptable means for 
investigating in vivo hemodynamics.  Later, Moore compared the differences in arterial 
geometry preservation between in vivo medical imaging and post-mortem tissue 
preparation.  She investigated the post-mortem tissue techniques of in situ casting and ex 
situ pressure fixation. Computational simulations were then conducted using these 
different information sets. She concluded that in vivo MRI provided the best overall 
model for replicating vessel geometry. 
In this study we explore different approaches to modeling the hemodynamic 
environment of 60 µm ePTFE vascular grafts implanted within the abdominal aortic tree 
of juvenile, male baboons. The vascular graft incorporates a stenotic shape with a 75 % 
reduction in luminal area. The vessel geometry is reconstructed into a series of 
computational grids using three different sources: (1) the geometric parameters of the 
graft prior to implantation, (2) in vivo pressure-perfused histologic cross-sections, and (3) 
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MRI imaging of the implanted grafts. Pulsatile simulations will be run using boundary 
conditions from two different sources: (1) the measured ensemble averaged volumetric 
flow rate and (2) phase contrast magnetic resonance imaging of the inlet velocity. The 
computational results from all the generated grids will be presented and their estimates of 
wall shear stress compared. In the end, we hope to discern which of these computational 
grids best represents the graft geometry; but moreover, which one provides the best 
description of the in vivo vascular graft flow environment. Towards this end, we will 
compare the CFD simulation results with PCMRI velocity measurements made at 
selected downstream locations. Furthermore, we will evaluate the accuracy of the 
volumetric flow rate as an inlet condition by comparing its results to simulations using 
PCMRI.  
 170
Material and Methods: 
Animals.  
In this study vascular grafts were implanted into juvenile male baboons (papio 
cyncephalus / anubis) of roughly two years of age and weighing between 13-24 kg. All 
animal procedures followed “Principles of Laboratory Animal Care”, the “Guide for the 
Care and Use of Laboratory Animals” (NIH Publication No. 8023, revised 1985), and 
IACUC university guidelines.  
Grafts.  
Four different vascular grafts constructed of 60 µm expanded polytetrafluoroethylene 
(Gore-Tex, non-reinforced, thin wall; provided by W.L. Gore and Associates, Inc., 
Flagstaff, Ariz.) were used in this study. The first type of vascular graft, the so-called 
unstretched control, possessed a length of approximately 4 cm and an inner diameter of 6 
mm. The next two varieties of vascular grafts were constructed from the same starting 
material with an inner diameter of 3 mm. The first of these vascular grafts, the so-called 
stretched control, was uniformly stretched in a radial direction from a 3 mm inner 
diameter to a 6 mm inner diameter. The second of these vascular grafts, the so-called 
stretched stenosis, consisted of a 75 % reduction in its cross-luminal area. The stretched 
stenosis was constructed by fitting the ePTFE over an aluminum mandrel that began with 
an inner diameter of 6 mm, symmetrically contracted down to 3 mm, and then 
symmetrically expanded back out to 6 mm. The aluminum mandrel was lathed according 
to the following mathematical equation: 
Z = 6.0 mm    for 0 ≤ x < 1.25 and for 2.75 < x ≤ 4.0    
Z = 1-.25(1+cos (π((x-2)/0.75)) for 1.25 ≤ x ≤ 2.75                                     (Equation 5.1) 
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The aluminum mandrel was separable in the middle, allowing for easy separation and 
removal of the graft prior to surgery. A schematic of the stretched stenosis illustrates this 












Figure 5.1: The Stretched Stenosis. The stenotic graft was constructed from 60 µm 
ePTFE with an initial inner diameter of 3mm. By fitting the graft material over the 




The Impra Corporation constructed the fourth type of vascular graft, the so-called 
unstretched stenosis. In the center of the graft the cross-luminal area was reduced by 75 
%. The vascular graft consisted of a central stenotic section with a 3 mm internal 
diameter and a length of 1.5 cm melded to two separate segments with an inner diameter 
of 6 mm and a length of 2 cm. All material used in this construction was unstretched 60 














Figure 5.2: The Unstretched Stenosis. This artistic configuration describes the design of 
the vascular graft constructed with 60 µm ePTFE. A central stenotic portion with an inner 
diameter of 3 mm and a length of 1.5 cm was melded to two separate 2 cm lengths of 




 One day prior to surgery, 325 mg of aspirin was administered to the baboon. Blood 
samples were drawn to analyze such hemodynamic parameters as platelet count, 
hematocrit, and white blood cell count. Under general endotracheal anesthesia with 1.5 to 
2.5 % isoflurane, a mid-line incision was made, followed by exposure of the 
retroperitoneum. Following isolation of the distal abdominal aorta, 150 units of 
heparin/kg were infused. The volumetric flow rate of the baboon was measured by fitting 














bifurcation of the renal arteries. The transonic flowmeter was connected to a PC 
computer using an Analog/Digital card. On the PC, Labview® recorded the volumetric 
flow rate for thirty cardiac cycles. The volumetric flow rate was again measured at 
sacrifice. Twenty ePTFE grafts were implanted into the distal abdominal aortas of 
individual baboons. Implantation of vascular grafts involved using an end-to-end 
anastomosis with a continuous running suture of 6.0 polypropylene (Davis & Geck, 
Wayne, N.J.).  An example of an implanted vessel is demonstrated. Changyi Chen M.D., 
Ph.D performed all of the surgeries. 
MRI Imaging.  
Two weeks following the surgery, two of the animals were imaged using a 1.5 Tesla 
Phillips Mobile scanner with a time of flight imaging sequence. The imaging parameters 
were TR = 20 ms, TE = 6 ms, FOV = 190 mm, 256 x 256 acquisition, 2 mm slice 
thickness, flip angle = 40 degrees. After placing three EKG leads upon the animal, 
cardiac gating was used during image acquisition. Two animals were imaged, one with an 
unstretched control and the other with an unstretched stenosis. The animals were sedated 
with a combination of ketamine (0.1mg/kg) and telazol (5 mg/kg). The sedative effect 
lasted about forty-five minutes. Once within the scanner, the animal’s abdomen was 
placed within a head coil. In order to visualize the vessels, a radio-opaque contrast 
marker of 15 cc of gadolinium was infused. At first, coronal sections were taken to 
visualize the vessels within the animal (Figure 5.3). Next, the vessels were interrogated 
using a sequence of axial slices acquired 2 cm upstream of the proximal anastomosis and 
extending up to 2 cm downstream of the distal anastomosis. This process captured the 




Figure 5.3: Coronal Cross-Section of an Implanted Unstretched Stenosis within a 
Baboon. The image shows the proximal and distal anastomosis. The stenotic throat of the 
graft was well visualized.  
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unsigned 16-bit format with the aid of a MATLAB generated program (Marijn Brummer, 
Ph.D., Emory University Department of Radiology). Next, phase contrast magnetic 
resonance imaging (PCMRI) velocity data were collected at three different locations 
within the analyzed grafts: (1) proximal anastomosis, (2) mid-vessel, and (3) distal 
anastomosis. Additionally, using a black-blood imaging sequence, the captured pixel 
intensity reflected blood velocity within the vascular graft. 
MRI Contours. 
With the MRI axial images, the outlines of the graft luminal surfaces were 
captured (Figure 5.4 and 5.5). First, the location of the vessel wall was defined (program 
mricontmain.m). The captured images were converted to pixel intensity values from 0 to 
1 (program pixtocm.m). A scale was input that helped to define the inside of the vessel 
as a white entity. If the pixel value was above the scale, its value was redefined as 
equaling 1, while if the pixel value was below the scale, its value was redefined as 
equaling 0. The edges of the vessel posed a significant challenge. A binary dilation and 
erosion procedure helped to differentiate the inside from the outside of the graft (program 
edgedetect.m). Based on the value of the input parameter, this signal processing helped 
either to expand or to contract the vessel edge until the wall was defined. A contour line 
was then fit to the analyzed vessel borders. This line was then smoothed using an 
algorithm that calculated an average value based on values that preceded and followed 
the location of interest (program smoothfil.m). From the contour’s location within the 
MRI image, the pixel values were then converted to a scale of centimeters. 
 The contour specified the location of the vessel wall within a Cartesian coordinate 
frame. This information was then further smoothed based on an algorithm  
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Figure 5.4: Axial Cross-Section of an Implanted Prosthetic Vascular Graft. The red 
arrow highlights the vascular graft. Next to the graft is the Inferior Vena Cava.  
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Figure 5.5: Axial Cross-Section of an Implanted Prosthetic Vascular Graft at the Level 
of the Stenotic Throat. The red arrow highlights the stenotic throat. 
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introduced by Moore [137].  First, along the length of the vessel each captured contour 
was smoothed using a fifth order smoothing spline. Secondly, a cubic spline was used to 
smooth the resulting vector that connected the centroids of all the slice contours. Lastly, 
the square root of each contour’s cross-sectional area was smoothed using a cubic spline 
(program loop2.m). The last two steps adjusted the coordinates of the slice contour 
according to equation 5.2. 
 
                                                                                                                                                                        
),(/*)],(),[(),( ,, smoothedcensmoothedcensmoothedcencennewnew yxareaareayxyxyx +−=  
           (Equation 5.2) 
Histologic Contours. 
 The contours of the harvested vessels were captured from vascular grafts fixed by in vivo 
pressure perfusion. All baboons were sacrificed one month following graft placement. 
The distal abdominal aorta was exposed, and the animals were sacrificed by 
exsanguination. The implanted grafts were fixed in vivo by implanting a 14-gauge 
angiocatheter into the abdominal aorta and infusing the fixative from a 60 cc syringe. 
Before infusing the fixative, the grafts were first flushed with 0.1 M phosphate buffered 
saline (PBS) at pH 7.4 and 37° Celsius. A 14-gauge angiocatheter was inserted into the 
right common iliac to control the rate at which perfusate drained, while another 14-gauge 
angiocatheter was fed into the left common iliac up to the level of the aorta’s bifurcation 
to measure mean arterial pressure (MAP) using a sphygmomanometer. The vessels were 
perfused at a MAP of 100 mmHg for at least thirty minutes with 10 % buffered formalin 




Figure 5.6: In Vivo Pressure Perfusion of Implanted Vascular Graft. The perfusate 
consisted of either 10 % buffered formalin for immunohistochemistry or 2.5 % 
glutaraldehyde for Scanning Electron Microscopy. The angiocatheter in the right 
common iliac was fed up to the aorta’s bifurcation. This allowed the sphygmomanometer 










set-up for the in vivo pressure perfusion of the grafts. Following fixation, the grafts were 
harvested along with 1 cm sections of contiguous native vessel at each anastomosis and 
then submersed in fixative for a 24-hour period. All harvested grafts were divided into 5 
mm circular cross sections, embedded into paraffin, and microtomed perpendicular to the 
long axis of the vessel using a 5 µm slice thickness. The entire axial length of the vessel 
was interrogated. At the proximal anastomosis, the center of the graft, and the distal 
anastomosis, microscope sections were cut every millimeter from the embedded blocks, 
while elsewhere in the vessel, only one representative set of sections was taken from each 
embedded block. As a result, greater resolution was obtained at the anastomotic ends and 
at the center of the vessels.  
All grafts underwent staining with Hematoxylin and Eosin (H&E) (Figure 5.7). 
All slide specimens were analyzed using a microscope with a 1x objective interfaced to a 
digital camera that captured all images into a TIFF format. Using the Image-Pro Plus ® 
Software (Media Cybernetics, Inc.; Silver Spring, Maryland), the vessel contour was 
outlined. The vessel contours were obtained for all four different vascular graft varieties. 
These contours were then processed using the Moore [137] smoothing algorithm as 
discussed in the MRI grid construction section; however, one important adjustment was 
introduced. The histologic cross-sections lacked information that connected them to the 
graft’s position within three-dimensional space. This problem was addressed in two 
different ways. In the first approach, all the contours were aligned along the same z-axis 
(program loophistreorgflat.m).  An alternative approach was explored in which the 
three-dimensionsal information from the MRI scans was combined with the histologic 
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contours in the following way. From our processing of the MRI contours, a smoothed 
vector passing through each image centroid was generated. This information was then 
used to reorient the histologic contours within three-dimensional space (program 
loophistreorg.m).  
Ideal Contours. 
 Contours were outlined based on the pre-implantation geometry of the vascular grafts. 
For the stretched and unstretched controls, this process was based on their straight 
shapes. For the stentoic grafts, the mathematical definitions of their shapes helped to 
define their cross-sectional contours. 
Grid Construction. 
 With the contour information from these three different approaches, three-dimensional 
computational grids were next created. This step was completed within the preprocessor 
software GAMBIT (Fluent Inc., Lebanon, NH).  A wire frame of the vascular graft was 
constructed from these contours using a combination of connecting spline functions. 
From this wire frame or computational volume, a mesh was generated using a cooper 
scheme with a grid spacing of 0.025. A total of thirteen different grids were constructed 
from the MRI, histologic, and ideal contours with approximately 90000 nodes (Tables 
5.1, 5.2, 5.3, 5.4, 5.5). For the purposes of demonstrating grid independence, three 
additional grids were constructed of the ideal control graft. These grids contained 90 %, 
80 %, or 70 % of the number of nodes within the original ideal control graft. In the case 
of the MRI stenosis and the histologic unstretched stenosis, two extended grids were 
constructed by extending their outlet lengths by 3 diameter distances (1.8 cm).   
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Table 5.1: Table of Ideal Computational Grids for Grid Independence and Applied Inlet 
Boundary Conditions. Executed simulations show Reynolds number based on the 
boundary condition’s mean flow rate.  
 
 Implant Harvest PCMRI Nodes 
Ideal Control 
0.9  















Table 5.2: Table of Ideal Computational Grids and Applied Inlet Boundary Conditions. 
Executed simulations show Reynolds number based on the boundary condition’s mean 
flow rate.  
 
 Implant Harvest PCMRI Nodes 
Ideal Control Re (mean Q) 
=134 
Re (mean Q) 
=141 





Re (mean Q) 
=132 
Re (mean Q) 
=113 




Re (mean Q) 
=132 
Re (mean Q) 
=113 
















Table 5.3: Table of MRI Computational Grids and Applied Inlet Boundary Conditions. 
Executed simulations show Reynolds number based on the boundary condition’s mean 
flow rate.  
 




Re (mean Q) 
=125 
Re (mean Q) 
=134 






Re (mean Q) 
=125 
Re (mean Q) 
=108 






 Re (mean Q) 
=108 








Table 5.4: Table of Histologic Stretched Computational Grids and Applied Inlet 
Boundary Conditions. Executed simulations show Reynolds number based on the 
boundary condition’s mean flow rate.  
 
 




Re (mean Q) 
=118 
Re (mean Q) 
=127 




Re (mean Q) 
=118 
Re (mean Q) 
=127 




Re (mean Q) 
=118 
Re (mean Q) 
=103 




Re (mean Q) 
=118 
Re (mean Q) 
=103 





Table 5.5: Table of Histologic Unstretched Computational Grids and Applied Inlet 
Boundary Conditions. Executed simulations show Reynolds number based on the 
boundary condition’s mean flow rate. 
 




Re (mean Q) 
=132 
Re (mean Q) 
=141 






Re (mean Q) 
=132 
Re (mean Q) 
=141 




Re (mean Q) 
=132 
Re (mean Q) 
=113 







 Re (mean Q) 
=113 










  90000 
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Inlet Boundary Condition. 
In order to conduct pulsatile simulations with these computational grids, boundary 
conditions at the inlet were required. The boundary conditions came from two different 
sources: (1) the measured volumetric flow rate and (2) PCMRI velocity measurements. 
 The volumetric flow rate was obtained from the abdominal aorta just distal to the 
bifurcation of the renal arteries at the time of surgery and at sacrifice. The waveforms 
acquired at surgery and at sacrifice were ensemble averaged for the two control and two 
stenotic grafts to obtain representative descriptions (program ensembleinit1.m). These 
ensemble averaged waveforms were then input into a Womersley solution (Equation 5.3 
and 5.4) with an α = 4.8 to derive velocity values at the inlet (program nodefinalyep.m).  
 
          Equation 5.3 
Equation 5.4 
 
In order to define the velocity values, a description of the nodes at the inlet was required. 
At the walls the velocity was set equal to 0. A linear interpolation scheme was then used 



















































             The PCMRI collected information concerning the blood velocity moving across 
an interrogated region of interest as a function of time (Figure 5.8). The intensity of the 
pixel values within the vessel’s lumen reflected the velocity of the blood. In order to 
convert the intensity values, the maximum velocity over the cardiac cycle was needed. 
The maximum velocity was determined from an in house program (Marijn Brummer, 
Ph.D., Emory University Department of Radiology). With this value in hand, the 
intensity values were then converted to units of cm/sec.  In order to define the velocity 
values, a description of the nodes at the inlet was required. At the walls the velocity was 
set equal to 0. A linear interpolation scheme was then used to define velocity values at 
each node as a function of time. 
FIDAP Simulations.  
With the computational grids and the boundary conditions, CFD simulations were run 
using FIDAP (Fluent Inc., Lebanon, NH). All simulations were executed with certain 
established parameters: (1) no slip boundary conditions at the wall; (2) zero traction 
boundary condition at the outlet; (3) three-dimensional non-moving geometry; (4) 
laminar flow conditions; (5) non-linear Navier-Stokes equations; (6) isothermal 
conditions; (7) fluid dynamic viscosity was assumed to be 0.04 Poise; and (8) fluid 
density of 1.081 g/cm3. The convergence criteria specified a tolerance value of 0.0001 for 
the pressure and all three-velocity components. First, simulations were run under steady-
state conditions. A blunt inlet profile was assumed, and its average velocity was specified 
as the axial boundary condition. The average velocity for the measured ensemble 
averaged flow rates were as follows: (1) control at implantation = 8.25 cm/sec; (2) 






Figure 5.8: PCMRI Images as a Function of Time. The intensity of the black pixels 
within the vessel lumen reflects the velocity of the blood. We observe that the velocity 





T=0.2 sec T=0.4 sec
T=0.6 sec T=0.8 sec
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stenosis at harvest = 7.10 cm/sec. A segregated interative solver was used. Secondly, 
simulations were run under pulsatile conditions. As described earlier, the boundary 
conditions were specified by both the ensemble averaged flow rates and the PCMRI. For 
all the computational grids, pulsatile simulations were run using the ensemble averaged 
volumetric flow rates at implantation and at sacrifice, while the PCMRI was only used 
for the computational grids describing the unstretched control and the unstretched 
stenosis (Tables 5.1, 5.2, 5.3, 5.4, 5.5).  In order to eliminate any start-up effects, the 
pulsatile simulations ran for three cardiac cycles. Once again, a segregate interative 
solver was used. The simulations were executed with a Backward Euler algorithm 
involving a variable time step with a window of 0.3 normalized units. Initial conditions 
were imported from the previously run steady state simulations. 
 Once the simulations converged, the datafiles for each simulation were 
concatenated into one file (program concatenate1.m). The velocity vectors and pressure 
at each node were exported to text files for post-processing. The WSS values were 
generated within FIDAP by decomposing the total fluid stress into its viscous and 
tangential components. These three-dimensional WSS values were then exported into text 
files (program fidapconversion2.m). These exported text files were then converted into a 
file format readable by Tecplot 9.0 (Amtec Engineering, Bellevue, WA) (program 
testmod.m). Within Tecplot, the computational grid was decomposed into circular cross-
sections every 0.1 mm. At these locations, the velocity and WSS values were exported to 
text files. These files were then processed by a MATLAB program designed to describe 
the various hemodynamic parameters along the axial length of the graft (programs 
testfinal.m and spatial1.m). The hemodynamic data were compressed into a description 
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of wall shear stress as a function of distance along the axial direction of the vascular 
graft. Along the graft’s axial length, this was accomplished by averaging the WSS 
measurements around the circumference of the vessel. This term is referred to as spatially 
averaged WSS or τs(z,t) (Equation 5.5). 
                                         Equation 5.5 
 
At each axial location along the graft, the pulse spatially averaged WSS (Pulse WSS) was 
calculated. Over a cardiac cycle, the Pulse WSS measures the difference between the 
maximum spatially averaged WSS and the minimum spatially averaged WSS. 
Furthermore, the temporal mean of the spatially averaged WSS was calculated. This 
manipulation produced the spatially averaged, temporal mean wall shear stress (τavg) 
(Equation 5.6). 
                                                                                                                         Equation 5.6     
The three-dimensional oscillatory shear index was also calculated (Equation 5.7). 
 
























These different descriptions of WSS and OSI were then correlated with the measured 
histologic data. The histologic data described intimal thickness (mm) as a function of 
axial distance along the length of the vascular graft as described in Chapter III and IV.          
 CFD Code Validation. 
 In order to validate the accuracy of the FIDAP simulations, the velocity values generated 
by the simulations were compared to the PCMRI measurements at the distal anastomosis 
of the unstretched stenosis. At this distal site, a program was generated that calculated the 
average velocity within the inner 70 % of the lumen’s cross-sectional area (program 
average.m).  The average velocities of the core flow were then statistically compared 
between the PCMRI measurement and the FIDAP simulations. 
Statistics.  
Statistical analysis was performed on a Pentium IV P.C. with the use of either MATLAB 
or Excel 2000 statistical software (Microsoft Co.). The documented values are given as 
the mean ± the standard deviation. The correlations coefficients between the various 
hemodynamic parameters and the intimal thickness were considered significant if the p 
value was less than 0.05. 
 
 192
Results:   
Computational Grids. 
 A selection of different computational grids was constructed. The various computational 
grids reflected the different investigational modalities used to model their borders. First, 
the ideal grids were created (Figure 5.9, 5.10, 5.11). These grids were based upon the 
original design parameters of the vascular grafts. Secondly, the computational grids based 
on the MRI images were generated (Figures 5.12 and 5.13). Thirdly, the computational 
grids based on the histologic contours were made. Some of the grids imposed the best-fit 
line passing through the centroids of the MRI generated grids (Figures 5.14, 5.16, 5.18). 
These computational grids assumed a natural shape for a vascular graft implanted within 
the distal abdominal aortic tree. The remaining grids imposed a common parallel z-axis 
throughout the axial length of the vessel (Figures 5.15, 5.17). These computational grids 
appeared distorted as though they were not implanted within in vivo conditions. Lastly, 
the extended grids were created for the unstretched stenosis (Figures 5.19).   
Boundary Conditions. 
The ensemble averaged volumetric flow rates were generated for both the control and the 
stenotic grafts at implantation and at sacrifice (Figures 5.20, 5.21). The velocity profiles 
were then created for the ensemble averaged flow rates and for the PCMRI (Figure 5.22). 
Node Independence. 
Node independence was demonstrated by comparing wall shear stress calculations within 
a straight control graft with varying number of nodes. These simulations were performed 
under pulsatile conditions Between the four different computational grids of 70,000, 
80000, 90000, and 100000 nodes, the wall shear stress
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Figure 5.10: Ideal Stretched Stenosis.  
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Figure 5.12: Unstretched Control Based on the MRI Image. This computational grid is 




Figure 5.13: Unstretched Stenosis based on the MRI Images. This computational grid is 
referred to as the MRI Unstretched Stenosis. 
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Figure 5.14: Control Based on Histologic Contours and MRI Center Line. The best fit 
line through the centroids of the MRI control was imposed. This computational grid is 




Figure 5.15: Control Based on Histologic Contours and Parallel  Z- Axis. This 




Figure 5.16: Stretched Stenosis Based on Histologic Contours and MRI Center Line. The 
best-fit line through the centroids of the MRI Stenosis was imposed. This computational 





Figure 5.17: Stretched Stenosis Based on Histologic Contours and a Parallel  Z-Axis. 




Figure 5.18: Unstretched Stenosis Based on the Histologic Contours and the MRI Center 
Line. The best fit line through the centroids of the MRI Stenosis was imposed. This 









































Student Version of MATLAB 




























Volumetric Flow Rate for Control Graft at Harvest
 


























































Volumetric Flow Rate for Stenotic Graft at Harvest
 
 









Figure 5.22: Velocity Profiles during Peak Systole at the Inlet for the Ensemble 
Averaged Volumetric Flow Rates and the PCMRI. (A) Ensemble Averaged Volumetric 




along the graft’s axial length revolved around 2.75 dynes/cm2 and the maximum variation 
was only 3.6 % (Figure 5.23). 
Stretched Graft Control Study. The flowfields within the control vessels were solved 
for conditions both at implantation and at sacrifice. The speed of the ideal stretched 
harvest control reached as high as 16 cm/sec during peak systole (Figure 5.24). The wall 
shear stress calculations showed variation depending upon which computational grid was 
analyzed. During peak systole, the ideal stretched harvest control showed a consistent 
wall shear stress level of 6 dynes/cm2 (Figure 5.25). At peak systole, the histologic 
stretched harvest control experienced wall shear stress levels as high as 13 dynes/cm2 
with the majority of the vessel being exposed to 6.5 dynes/cm2 (Figure 5.26), while the 
flat histologic stretched harvest control reached only a maximum of 12 dynes/cm2 with 
most of the vessel residing at 6 dynes/cm2 (Figure 5.27).   
 The τavg maintained a mean of 2.6 dynes/cm2 for the ideal stretched harvest 
control, 4.0 dynes/cm2 for the histologic stretched implant control, and 2.2 dynes/cm2 for 
the flat histologic stretched implant control (Figure 5.28). At sacrifice the τavg leveled at 
a mean of 3.0 dynes/cm2 for the ideal stretched harvest control, 4.5 dynes/cm2 for the 
histologic stretched harvest control, and 2.8 dynes/cm2 for the flat histologic stretched 
harvest control (Figure 5.29). For both implantation and harvest, τavg and intimal 
thickness were compared.    
Stretched Graft Stenotic Study. The stretched stenosis studies were analyzed. Within 
the histologic stretched harvest stenosis, the speed reached a 30 cm/sec during peak 
systole (Figure 5.30). Very little local reversal of occurred during systole (Figure 5.31); 





Figure 5.23: Node Independence Study for the Ideal Control Grafts with Varying 
Number of Nodes 

















































Figure 5.24: The Speed for an Ideal Stretched Harvest Control during Systole.  




Figure 5.25: Wall Shear Stress Magnitude for an Ideal Stretched Harvest Control during 
Systole.  
WSS Magnitude for an Ideal Stretched Harvest Control during Systole
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Figure 5.26: Wall Shear Stress Magnitude for a Histologic Stretched Harvest Control 
during Systole. This computational grid was constructed from the histologic contours and 
imposed upon a best-fit line running through the centroids of a later analyzed series of 
MRI Images.  
 
 WSS Magnitude for a Histologic Stretched Harvest Control during Systole 
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Figure 5.27: Wall Shear Stress Magnitude for a Flat Histologic Stretched Harvest 
Control during Systole. This computational grid was constructed from the histologic 
contours and imposed upon a flat z-plane running along the length of the vessel.  
  
WSS Magnitude for a Flat Histologic Stretched Harvest Control at Systole 
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Implant Control : Stretched Study








































Histologic Stretched Implant Control
 
Ideal Stretched Implant Control
 





Figure 5.28: τavg and Intimal Thickness for Stretched Implant Controls along the Axial 















Stretched Study : Control Harvest








































Histologic Stretched Harvest Control
 
Ideal Stretched Harvest Control
 






Figure 5.29: τavg and Intimal Thickness for Stretched Harvest Controls along the Axial 





Figure 5.30: Speed for a Histologic Stretched Harvest Stenosis at Systole.  








Figure 5.31: Axial Velocity Vectors near Peak Systole for the Histologic Stretched 
Stenosis. The images depict the axial velocity vectors at defined distances from the 
proximal anastomosis (A) 2.2 cm (B) 2.4 cm (C) 2.6 cm. Note the absence of transient 













Figure 5.32: Axial Velocity Vectors during Diastole for the Histologic Stretched 
Stenosis. The images depict the axial velocity vectors at defined distances from the 
proximal anastomosis (A) 2.2 cm (B) 2.4 cm (C) 2.6 cm. The velocity vectors oriented in 







 The oscillatory shear index (OSI) quantified the flow reversal. For both at implantation 
and at sacrifice, the elevated OSI numbers reflected the post-stenotic local reversal of 
flow (Figures 5.33, 5.34).  
The wall shear stress magnitude was investigated for the stretched stenotic 
vessels. During mid-diastole, the ideal stretched stenosis experienced WSS values of 2 
dynes/cm2 in the stenotic throat (Figure 5.35), while during peak systole this value 
increased to 100 dynes/cm2 (Figure 5.37). In the upstream and downstream portions of 
the graft, the WSS levels maintained near 4 dynes/cm2. During peak systole, the speed in 
the stenotic throat reached a maximum of 45 cm/sec (Figure 5.36). In the histologic 
stretched harvest stenosis, the throat evolved WSS values of 1.2 dynes/cm2 during mid-
diastole (Figure 5.38) and of 45 dynes/cm2 during peak systole (Figure 5.39). Post-
stenotically, the vessel experienced higher wall shear stress levels on it anterior surface. 
For the flat histologic stretched stenosis, WSS values of 1.5 dynes/cm2 were observed 
within the stenotic throat during diastole (Figure 5.40) and as large as 47 dynes/cm2 
during systole (Figure 5.41). Upstream and downstream of the stenosis, the WSS values 
leveled near 7-8 dynes/cm2.  
The τavg reached a peak of 63 dynes/cm2 for the ideal stretched implant stenosis, 
50 dynes/cm2 for the histologic stretched implant stenosis, and 50 dynes/cm2 for the flat 
histologic stretched implant stenosis (Figure 5.42). At sacrifice the τavg peaked within 
the stenotic throat at 24 dynes/cm2 for the ideal stretched harvest stenosis, 18 dynes/cm2 
for the histologic stretched harvest stenosis, and 18 dynes/cm2 for the flat histologic 
stretched harvest stenosis (Figure 5.44). For both implantation and harvest, τavg and 
intimal thickness were compared.  Within the stenotic throat, high levels of Pulse WSS  
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Stretched Study : Stenosis Implant
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Figure 5.33: Oscillatory Shear Index for Stretched Implant Stenotic Grafts. Observe the 
transient flow separation post-stenotically. 
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Stretched Study : Stenosis Harvest














Histologic Stretched Harvest Stenosis
 
Ideal Stretched Harvest Stenosis
 






Figure 5.34: Oscillatory Shear Index for Stretched Harvest Stenotic Grafts. Observe the 




Figure 5.35: WSS Magnitude for an Ideal Stretched Harvest Stenosis during Diastole. 
The WSS reaches as high as 2 Dynes/Cm2 within the stenotic throat. 
  WSS Magnitude for an Ideal Stretched Harvest Stenosis during Diastole 
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Figure 5.36: Speed for an Ideal Stretched Harvest Stenosis during Systole. Within the 
stenotic throat, the speed exceeds 45 cm/sec. 
                 Speed for an Ideal Stretched Harvest Stenosis during Systole        WSS Magnitude for an Ideal Stretched Harvest Stenosis during Systole 
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Figure 5.37: Wall Shear Stress Magnitude for an Ideal Stretched Harvest Stenosis during 
Systole. The WSS reaches as high as 67 Dynes/Cm2 within the stenotic throat. 
WSS Magnitude for an Ideal Stretched Harvest Stenosis during Systole 
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Figure 5.38: Wall Shear Stress Magnitude for a Histologic Stretched Harvest Stenosis 
during Diastole. The WSS reaches as high as 2 Dynes/Cm2 within the stenotic throat. 




Figure 5.39: Wall Shear Stress Magnitude for a Histologic Stretched Harvest Stenosis 









Figure 5.40: Wall Shear Stress Magnitude for a Flat Histologic Stretched Harvest 
Stenosis at Diastole. The WSS reaches as high as 2 Dynes/Cm2 within the stenotic throat. 





Figure 5.41: Wall Shear Stress Magnitude for a Flat Histologic Stretched Harvest 





WSS Magnitude for a Flat Histologic Stretched Harvest Stenosis at Systole 
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Figure 5.42: τavg and Intimal Thickness for Stretched Implant Stenotic Grafts along the 
Axial Length of the Vessels. 
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Figure 5.43: Pulse Spatially Averaged Wall Shear Stress for Stretched Implant Stenotic 

















Stretched Study : Stenosis Harvest








































Histologic Stretched Harvest Stenosis
 
Ideal Stretched Harvest Stenosis
 
Flat Histologic Stretched Harvest Stenosis
 
 
Figure 5.44: τavg and Intimal Thickness for Stretched Harvest Stenotic Grafts along the 
Axial Length of the Vessels. 
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were observed within all the different graft varieties (Figures 5.43, 5.45). At 
implantation, the Pulse WSS reached a peak of 120 dynes/cm2 for the ideal stretched 
implant stenosis, 90 dynes/cm2 for the histologic stretched implant stenosis, and 90 
dynes/cm2 for the flat histologic stretched implant stenosis. At sacrifice, the Pulse WSS 
peaked within the stenotic throat at 58 dynes/cm2 for the ideal stretched harvest stenosis, 
47 dynes/cm2 for the histologic stretched harvest stenosis, and 40 dynes/cm2 for the flat 
histologic stretched harvest stenosis. 
Unstretched Graft Control Study. 
 The hemodynamics within the unstretched control grafts were quantified. The 
PCMRI boundary conditions were applied to these computational models. Within the 
MRI implant control, the speed peaked at 24 cm/s during systole (Figure 5.46). There 
was variation in the WSS measurements for the MRI harvest control during systole 
(Figure 5.47). At some points within the vessel, the WSS reached as high as 18 
dynes/cm2; however, mostly the WSS resided near 5-7 dynes/cm2. During systole, the 
WSS within the histologic unstretched harvest control (Figure 5.48) exceeded 15 
dynes/cm2, but mostly it leveled near 3 dynes/cm2. Lastly, during peak systole for the flat 
histologic unstretched harvest control (Figure 5.49), the WSS exceeded 25 dynes/cm2 
near geometric shape changes. For both implantation and sacrifice, the τavg stayed 
between 2 to 6 dynes/cm2 for all the control computational grids (Figures 5.50, 5.52). As 
seen before, τavg and intimal thickness were compared. The simulations using the 













Stretched Study : Stenosis Harvest
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Figure 5.45: Pulse Spatially Averaged Wall Shear Stress for Stretched Harvest Stenotic 





Figure 5.46: During Systole Speed for an Unstretched Harvest Control Imaged with 
MRI. 
Speed for an Unstretched Harvest Control Imaged with MRI at Systole 
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Figure 5.47: Wall Shear Stress Magnitude for an Unstretched MRI Harvest Control 
during Systole. 
WSS Magnitude for Unstretched MRI Harvest Control during Systole 
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Figure 5.48: Wall Shear Stress Magnitude for a Histologic Unstretched Harvest Control 
during Systole.  
WSS Magnitude for a Histologic Unstretched Harvest Control during Systole 
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Figure 5.49: Wall Shear Stress Magnitude for a Flat Histologic Unstretched  Control 








   WSS Magnitude for a Flat Histologic Unstretched Control during Systole 
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Figure 5.50: τavg and Intimal Thickness for Unstretched Implant Control Grafts along 
the Axial Length of the Vessels.  
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Unstretched Study : Control PCMRI
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Unstretched Study : Control Harvest
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Figure 5.52: τavg and Intimal Thickness for Unstretched Harvest Control Grafts along 
the Axial Length of the Vessels. 
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Unstretched Stenosis.  
Within the unstretched stenosis the flow environment was analyzed. Once again, 
the PCMRI boundary conditions were applied to these computational models. The 
velocity vectors within the stenotic throat were expectedly very high during systole. 
Surprisingly, during diastole some local flow reversal was observed within the stenotic 
throat (Figure 5.53). Distal to the stenotic throat, this phenomenon became more 
apparent. During both diastole and systole, this flow reversal was observed (Figure 5.54 
and 5.55).  In diastole this transient flow separation was very pronounced. This was 
quantitatively confirmed with the oscillatory shear index (OSI) (Figures 5.56, 5.57). 
Distal to the stenosis, the OSI was consistently above 0.25.  
Descriptions of WSS magnitude were obtained for the three different model types. 
During diastole, all three model types showed low, physiologic levels of WSS less than 
10 dynes/cm2 (Figures 5.58, 5.60, 5.63). During systole, the ideal unstretched harvest 
stenosis reached a peak WSS within its stenotic throat of over 130 dynes/cm2 (Figure 
5.59), while the histologic unstretched harvest stenosis exceeded 160 dynes/cm2 at this 
location (Figure 5.62), and the MRI unstretched harvest stenosis apexed at 130 dynes/cm2 
(Figure 5.65). Consistent within all its representations, the histologic unstretched harvest 
stenosis had a very high level of WSS on the anterior wall of the stenotic throat’s distal 
end. For implantation, once the stenotic throat was entered, the τavg illustrated very high 
levels of WSS. The ideal unstretched implant stenosis peaked over 100 dynes/cm2 
(Figure 5.66), while the histologic unstretched implant stenosis exceeded 120 dynes/cm2, 




Figure 5.53: Velocity within the Stenotic Throat during Systole and Diastole. (A) 
Systole. The velocity in the axial direction was very large. (B) Diastole. Even within the 
stenotic throat, there appears some local flow reversal.  
A 
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Figure 5.54: Flow Recirculation Downstream of the Stenotic Throat during Systole. 
Axial velocity vectors illustrate flow dynamics at different locations downstream of the 
proximal anastomosis: (A) 2.2 cm (B) 2.4 cm (C) 2.6 cm. The velocity vectors oriented in 










Figure 5.55: Flow Recirculation Downstream of the Stenotic Throat during Diastole. 
Axial vectors illustrate flow dynamics at different locations downstream of the proximal 
anastomosis: (A) 2.2 cm (B) 2.3 cm (C) 2.4 cm. The velocity oriented in the retrograde 
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Figure 5.56: Oscillatory Shear Index for Unstretched Implant Stenotic Grafts. Observe 
the increase in flow recirculation downstream of the stenosis. 
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Unstretched Study : Stenosis Harvest
















Ideal Unstretched Harvest Stenosis
 
Histologic Unstretched Harvest Stenosis
 





Figure 5.57: Oscillatory Shear Index for Unstretched Harvest Stenotic Grafts. Observe 
the increase in flow recirculation downstream of the stenosis. 
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Figure 5.58: Wall Shear Stress Magnitude for an Ideal Unstretched Stenosis during 
Diastole. 
          WSS Magnitude for an Ideal Unstretched Stenosis during Diastole 
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Figure 5.60: Wall Shear Stress Magnitude for a Histologic Unstretched Harvest Stenosis 
during Diastole. 




Figure 5.61: Speed for a Histologic Unstretched Harvest Stenosis during Diastole. 
Speed for a Histologic Unstretched Harvest Stenosis during Diastole 
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Figure 5.62: Wall Shear Stress Magnitude for a Histologic Unstretched Harvest Stenosis 
during Systole. 
 




Figure 5.63: Wall Shear Stress Magnitude for an MRI Unstretched Harvest Stenosis 
during Diastole. 
WSS Magnitude for an MRI Unstretched Harvest Stenosis during Diastole 
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Figure 5.64: Speed for an MRI Unstretched Harvest Stenosis during Systole. 
              Speed for an MRI Unstretched Harvest Stenosis during Systole 
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  WSS Magnitude for an MRI Unstretched Harvest Stenosis during Systole 
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Figure 5.66: τavg and Intimal Thickness for Unstretched Implant Stenotic Grafts along 
the Axial Length of the Vessels. 
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seen with the Pulse WSS with the respective levels equally 180 dynes/cm2, 250 
dynes/cm2, and 200 dynes/cm2 (Figure 5.67). For harvest, the τavg did not increase to the 
same magnitude once the stenotic throat was entered.  The ideal unstretched implant 
stenosis reached 38 dynes/cm2 (Figure 5.68), while the histologic unstretched implant 
stenosis peaked at 53 dynes/cm2, and the MRI unstretched implant stenosis hit a 
maximum at 35 dynes/cm2. Once again, a mirrored picture was observed with the Pulse 
WSS with the respective levels equally 90 dynes/cm2, 120 dynes/cm2, and 100 dynes/cm2 
(Figure 5.69).   As seen before, τavg and intimal thickness were compared. The PCMRI 
results resembled the harvest results both for τavg and the Pulse WSS (Figures 5.70, 
5.71). 
CFD Experimental Validation. 
  At the distal anastomosis of the MRI unstretched stenosis, the core velocity over 
the cardiac cycle was compared to the PCMRI measurements. At the same respective 
distal anastomotic position and corresponding points in time, the core velocities differed 
by only 7.09 %. In comparison, the same PCMRI measurements were compared to the 
histologic unstretched stenosis. With this computational grid, the core velocity differed 
by 38% from the PCMRI measurement. A node by node comparison was made between 
the PCMRI measurements and the two before-mentioned computational grids. The error 
was as large as 58 % for the MRI grid and 64 % for the histologic grid. 
Comparison of Boundary Conditions.  
 Next, we investigated which of the volumetric flow rates, implant or harvest, 
modeled the physiology best. The τavg results for these two boundary conditions were 
compared to the τavg results using the PCMRI boundary condition. First, the MRI 
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Figure 5.67: Pulse Wall Shear Stress for Unstretched Implant Stenotic Grafts along the 
Axial Length of the Vessels. 
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Unstretched Study : Stenosis Harvest
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Figure 5.69: Pulse Wall Shear Stress for Unstretched Harvest Stenotic Grafts along the 
Axial Length of the Vessels. 
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Unstretched Study : Stenosis PCMRI
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Figure 5.71: Pulse Wall Shear Stress for Unstretched PCMRI Stenotic Grafts along the 
Axial Length of the Vessels. 
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unstretched stenosis grid was analyzed. Between the PCMRI and the harvested 
volumetric boundary conditions, a 13.84 % difference in τavg was observed, while 
between the PCMRI and the implanted volumetric boundary conditions, a 192 % 
difference in τavg was seen. Next, the ideal unstretched stenosis grid was investigated. 
Between the PCMRI and the harvested volumetric boundary conditions, a 10.73 % 
difference in τavg was calculated, while between the PCMRI and the implanted 
volumetric boundary conditions, a 138 % difference in τavg was observed. 
Comparison of Computational Grids. 
The τavg values were compared between the five different models of the unstretched 
stenosis. Table 5.6 illustrates these results for implanted volumetric boundary conditions, 
while Table 5.7 highlights these results for harvested volumetric boundary conditions.   
Correlations between WSS and Intimal Thickness.  
Since the material properties of the stretched vascular grafts changed along the course of 
the vessel, little was gained from correlating the intimal thickness measurements with the 
hemodynamics. For the unstretched vascular grafts, the WSS measurements derived from 
harvest conditions and PCMRI were correlated to intimal thickness measurements. No 
statistically significant correlations were found between intimal thickness and OSI. In the 
case of the MRI unstretched stenosis, statistically significant correlation coefficients were 
identified between intimal thickness and the hemodynamics. For a harvested volumetric 
boundary condition, statistically significant correlation coefficients emerged between 
intimal thickness and the reciprocal of τavg (R = -.77), the reciprocal of the Pulse WSS 
(R = -.79), and the reciprocal of the maximum WSS (R = -0.79). For the PCMRI 
boundary condition, statistically significant correlation coefficients were observed  
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Table 5.6: Comparison of τavg at Implantation 
Computational Grids Percent Difference in τavg 
MRI Unstretched Stenosis vs Histologic 
Unstretched Stenosis 
41 % 
MRI Unstretched Stenosis vs Ideal 
Unstretched Stenosis 
40 % 
Histologic Unstretched Stenosis vs Ideal 
Unstretched Stenosis 
49 % 
MRI Ensemble Average Unstretched 
Stenosis vs MRI Unstretched Stenosis with 
PCMRI  
63 % 
Ideal Ensemble Average Unstretched 






Table 5.7: Comparison of τavg at Harvest 
Computational Grids Percent Difference in τavg 
MRI Unstretched Stenosis vs Histologic 
Unstretched Stenosis 
38 % 
MRI Unstretched Stenosis vs Ideal 
Unstretched Stenosis 
37 % 
Histologic Unstretched Stenosis vs Ideal 
Unstretched Stenosis 
46 % 
MRI Unstretched Stenosis vs MRI 
Unstretched Stenosis with PCMRI  
11 % 
Ideal Unstretched Stenosis vs MRI 




between intimal thickness and the reciprocal of τavg (R = -.78), the reciprocal of the 
Pulse WSS (R = -.80), and the reciprocal of the maximum WSS (R = -0.80).  
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Discussion:  
The objective of this study was to investigate the differences in generating computational 
models of an in vivo vascular graft. Three different types of computational models were 
constructed: (1) ideal (2) histologic (3) MRI. Each of these models possessed certain 
strengths and weaknesses in capturing the geometry of an in vivo vascular graft. Since 
small errors in the arterial geometry resulted in large errors in the calculated wall shear 
stress, preservation of the arterial geometry was critically important. Upstream and 
downstream variations in geometry further compound this error in WSS. The actual CFD 
execution resulted in only a small amount of error. Researchers have documented that 
finite element discretization and computational techniques introduce an error in WSS 
calculations of only 6 to 8 percent [134,135]. The remaining error originates from 
techniques used to interrogate the vessel geometry and how that information is 
incorporated into a volumetric description of the vascular graft. This explanation helps to 
clarify the large variation in the τavg measurements between the different computational 
models (Tables 5.2 and 5.3). 
 
Ideal Grids.  
Ideal models were constructed based on the material dimensions of the designed vascular 
grafts. These ideal models incorporated the exact parameters of the vascular grafts before 
implantation. Unfortunately, the ideal grids failed to accurately model the dynamics of an 
in vivo vessel. When a graft was implanted into the distal abdominal aorta, numerous 
shape changes were imposed by adjacent structures. First, the lumbar lordosis curved the 
vascular graft. Second, the suture line changed the shape of both the proximal and distal 
anastomosis. Third, overlying structures altered the overall vessel configuration. The 
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ideal model did provide intuition into how the stenotic geometry altered the lumenal fluid 
mechanics; yet it provided no useful information when establishing a relationship 
between the intimal thickening and the vessel hemodynamics.  
 
Histologic Grids.  
The histologic model provided better details concerning an in vivo graft’s geometry. The 
histologic model was constructed from the circular cross-sections of an in vivo pressure-
perfused vessel. Previously, Moore [135] had created computational grids based on ex 
vivo pressure-perfused vessels. She recognized that fixing these grafts ex vivo introduced 
changes in the preserved shape of the vessel. She attempted to correct for these 
differences by introducing information gathered by x-ray computer tomography. 
Although this corrected some of the issues, problems still persisted. With any imaging 
modality, approximations have to be made as to where the borders reside. This fact holds 
true even for imaging modalities with very high degrees of resolution like X-ray CT.  By 
using the histology, the exact borders of the vessel’s wall can be outlined. These borders 
become distorted by post-mortem conditions such as ex vivo pressure perfusion. By 
fixing the vessel in vivo, these concerns were removed. The fixative preserved the exact 
shape of the vessel’s wall. No technique provides the same level of detail for the wall 
location.  
 The histologic technique did suffer from some inherent limitations. The method 
failed to preserve any three dimensional information about how the cross-sections were 
oriented in space. Once the cross-sections were cut from the vessel, this information was 
forever lost. This spatial information was critical for accurate reconstruction of the vessel 
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shape. Other possible techniques for processing the tissue involved longitudinally 
sectioning the vessel. While this technique better illustrates the spatial orientation of the 
graft, it fails to preserve the exquisite information of wall location. More importantly, the 
information from these longitudinal sections is very difficult to use in the construction of 
a computational grid. The contours from the circular cross-sections better accommodated 
the construction of a cylindrically shaped object. Other investigators have argued general 
limitations associated with the histologic approach. First and foremost, approximations 
are always involved when processing the fresh tissue. For instance, when making circular 
cross-sections, the vessels are aligned next to a ruler and then the 5 mm tissue blocks are 
sectioned. This approach can introduce an error as large as 2 mm.  Second, during the 
pressure-perfusion process, incomplete elastin fixation can result. Third, exposure of the 
retroperitoneum at sacrifice can alter the shape of the vessel even before fixation. The 
evisceration of the overlying bowel can induce a change in the vessel’s geometry [138]. 
All of these reasons compelled us to seek alternative means to model the in vivo vessel 
geometry. 
 
MRI Grids.  
Magnetic Resonance Imaging provided a very powerful tool for non-invasively imaging 
an in vivo vessel. The MRI furnished exquisite information about the vessel orientation in 
space. The ability to image the vessel every 1 to 2 mm provided this level of three-
dimensional detail. Such variations in the vessel shape as curvature were well preserved. 
By imaging the vessel using axial slices, the captured contours were then effectively 
incorporated into a computational grid. Unfortunately, the MRI faltered slightly in its 
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ability to map the vessel’s wall. This MRI segmentation error leads to difficulty in 
reconstruction of the in vivo vessels. The MRI resolution limited our ability to map the 
outlines of the wall. At the very most, estimates of the vessel wall were in error by one 
pixel. For our MRI scanning, one pixel was equivalent to 0.15 mm. If we assume that a 
one-pixel error was made consistently around the vessel’s circumference, the vessel’s 
diameter can have an introduced error as large as 0.30 mm. For a large caliber vessel, this 
error is insignificant; however, for a small 3 mm inner diameter (id) stenotic throat, this 
error equals 10 % of the vessel’s id. This error can exert a profound effect upon the 
calculations of wall shear stress. This noticeably contrasts with the 0.005 mm resolution 
of the histologic approach. The resolution of the histologic approach was determined by 
the microscope’s magnification.  
Cardiac gating eliminated some of the errors associated with outlining the vessel 
wall. This method reduced blurring of the wall that can introduce an error as large as 10 
%. Other errors were introduced by the constraints of time-of-flight imaging. Saturation 
errors became important with slow moving blood. This issue assumed importance when 
imaging the post-stenotic regions where transient flow separation occurred. As illustrated 
through the CFD simulations, this transient flow separation was very distinct during 
diastole and even sometimes during systole. This effect can further reduce estimates of 
the luminal cross-section. The use of the gadolinium contrast marker and a large volume 
3D gradient echo pulse sequence helped to mitigate this effect. Even despite these 
concerns, comparative results demonstrated that the MRI imaging reliably reconstructed 




 We evaluated the accuracy of the CFD simulations by comparing the results to the 
PCMRI velocity measurement. In this comparison we analyzed the core velocity. 
Initially, a node-by-node comparison was performed. In the case of the MRI grid, this 
produced a difference of 58 %, while for the histologic grid this generated a difference of 
64 %. This discrepancy resulted from an assortment of reasons. First, when using the 
PCMRI measurements to calculate the velocity at each of the nodes, an interpolation 
scheme was used. As a result, a node-by-node comparison evaluated as much the 
accuracy of the interpolation scheme as the simulation’s estimate of velocity. Second, the 
PCMRI velocity measurements were used as the standard of comparison. Although an 
adequate marker, PCMRI still possesses inherent limitations. The PCMRI was 
constrained by the same factors that restricted imaging of the vessel geometry. Near the 
wall, the PCMRI did not accurately evaluate the velocity of the moving blood. At this 
location, the velocity measurement was restricted by the pixel resolution. This motivated 
our decision to limit our comparison to the inner 75 % of the vessel’s lumen or the core 
velocity. The PCMRI provided a very reliable means of experimentally measuring the 
vessel’s core velocity. PCMRI can measure core velocity within 8 % of intravascular 
measurements; consequently, the PCMRI functioned as a good gold standard [139]. Upon 
comparison with the PCMRI, the small difference in core velocity helped to establish the 
MRI grid as a reliable representation of the in vivo geometry and its CFD results as 
reliable descriptors of the hemodynamic environment. The larger error of the histologic 
grid cast significant doubt upon its reliability as a computational model. 
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Boundary Conditions.  
The PCMRI helped to establish which boundary condition was a more accurate 
description of the vessel physiology, implant or harvest volumetric flow rate. In 
comparison to the simulations using the PCMRI as a boundary condition, the harvest 
volumetric flow rate produced results that differed significantly less than the results 
generated by the implant volumetric flow rate. Why did the PCMRI function as a 
standard of comparison? The PCMRI velocity measurements were obtained two weeks 
following surgery. At this point, the animal had compensated for the implanted stenotic 
graft by adjusting its volumetric flow rate through the vessel. At the time of implantation, 
the animal had not even begun this process; therefore, the implant measurement was 
temporarily inflated. In conclusion, simulations performed with the harvest boundary 
conditions were considered more representative of the true hemodynamic environment 
imposed upon the vascular graft.  
 
Correlations with Intimal Thickness.  
Correlations were not made between the intimal thickness and the hemodynamics of the 
straight control grafts. The WSS measurements demonstrated too little variation to 
elaborate any underlying mechanism. Likewise, correlations were not made between the 
intimal thickness and the hemodynamics of the stretched stenosis. As documented earlier, 
its material properties changed along the length of the vascular graft; therefore, confusion 
surrounded whether any change in intimal thickening was a result of changing 
hemodynamics or changing material properties.  
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Earlier, we established the MRI unstretched stenosis as the most accurate 
description of the graft’s in vivo geometry. Still, all of the other computational models 
still succeeded in qualitatively describing the gross features of the vessels’ 
hemodynamics. For instance, in all models transient flow separation and high shear rate 
were isolated to the same relative location. The distinction in these models emerged when 
comparing the quantitative estimates of the flow field. For example, when comparing the 
core velocities to the experimentally measured PCMRI velocity, this distinguishing 
feature was highlighted. When correlating the biology and the hemodynamics, this 
difference was significant enough to produce contrasting conclusions. Having validated 
its results with the PCMRI, we felt comfortable in limiting our correlative study to the 
MRI grids. 
In our analysis, we revealed that the most accurate estimates of WSS were made 
with boundary conditions from the PCMRI and harvested volumetric flow rate. An 
inverse relationship was established between the stenotic graft’s intimal thickness and the 
reciprocal of τavg, Pulse WSS, and Max WSS. In essence, this result communicated a 
very interesting message concerning the healing of prosthetic vascular grafts.  A positive 
relationship may exist between intimal healing and the wall shear stress. Our discussion 
within Chapter IV detailed why this may be happening. 
In summary, this work investigated several different methods of generating a 
computational model of an implanted vascular graft. The MRI grids represented the best 
choice in preserving the geometry of the vessel and in accurately modeling its 
hemodynamics. Furthermore, both the volumetric flow rate at harvest and PCMRI served 
as the most appropriate parameters for the inlet boundary condition. Future work will 
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focus attention on improving our techniques of using MRI images to construct 





Comparison of the Stretched and Unstretched Stenosis 
 
 
This chapter outlines conclusions drawn from a comparison of the stretched and 
unstretched stenosis. While there were many similarities, the two graft types 
distinguished themselves as separate models. First and foremost, there existed a 
pronounced difference in the material properties of the two stenotic grafts. As previously 
discussed, the graft ultrastructure of the unstretched stenosis remained consistent between 
the upstream or downstream regions and the stenotic throat. Material alteration only 
occurred within the 0.25 cm transition regions before and after the stenotic throat. Within 
the stretched stenosis, the material properties changed along the course of the vascular 
graft. The stenotic throat represented the only region where the material properties were 
not altered. At this location, the original inner diameter was preserved, and there was no 
observed stretching of the graft material.  
Between the two vascular grafts, two different hemodynamic environments were 
generated. A couple of different factors lead to this contrast. First, the length of the 
stenotic region varied between the two vascular graft types. The unstretched stenosis 
possessed an extended stenotic throat with a length of 1.5 cm, while the stretched stenosis 
symmetrically contracted according to a cosine function down from a 6 mm id to a 3 mm 
id.  
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Secondly, the actual reduction in cross-luminal area differed between the two 
vascular graft types. For the unstretched stenosis, the histologic analysis documented an 
upstream and downstream diameter of 5.9 ± 0.3 cm, while the MRI analysis observed an 
upstream and downstream diameter of 5.6 ± 0.13 cm. For the stenotic throat, the 
histologic analysis recorded a diameter of 3.2 ± 0.2 cm, while the MRI analysis 
documented a diameter of 2.9 cm ± 0.3 cm. In summary, the histologic analysis observed 
a 70 % reduction in its cross-luminal area, while the MRI analysis noted a 73 % reduction 
in its cross-luminal area. In the end, the average of the two methods described a 72 % 
reduction in the cross luminal area of the unstretched stenosis.  For the stretched stenosis, 
the histologic analysis revealed an upstream and downstream diameter of 5.3 ± 0.3 cm, 
while for the stenotic throat, a diameter of 3.2 ± 0.2 cm was measured. For this stretched 
stenosis, a 63 % reduction in the cross-luminal area was created. Even before addressing 
other geometric differences, this result highlighted an important change in the 
hemodynamic environment of the two graft types.  
The computational analysis further quantified this dissimilarity in the 
hemodynamic environment. Within the throat of the unstretched stenosis, the τavg 
equaled 31 dynes/cm2, whereas the Pulse WSS equaled 67 dynes/cm2. In comparison, 
within the throat of the stretched stenosis, the τavg equaled 15 dynes/cm2, whereas the 
Pulse WSS equaled 38 dynes/cm2. Not surprisingly, there emerged a difference in the 
measured intimal thickness of the two stenotic regions. In the case of the unstretched 
stenosis, the average intimal thickness equaled 0.132 ± 0.03 mm, while for the stretched 
graft study, the average intimal thickness equaled 0.34 ± 0.06 mm. A statistically 
significant difference existed between these two levels of intimal thickening. The 
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question then emerges as to why we observed this difference in the average intimal 
thickness.  
Both graft varieties were implanted into baboon subjects with no variation in the 
surgical protocol. As a result, the vascular graft types were exposed to the same rheologic 
environment and humoral variables. Between the two grafts, the material properties were 
identical within the stenotic throat; therefore, both graft types possessed the same 
potential to heal by transmural ingrowth. At the stenotic throat, the luminal surfaces of 
both grafts were healed. The hemodynamic environment distinguished itself as the only 
remaining difference. As documented earlier, the unstretched stenosis evolved a higher 
level of WSS than the stretched stenosis. Upon comparison to the stretched stenosis, the 
τavg and Pulse WSS of the unstretched stenosis were respectively 106 % and 76 % 
larger. Focusing only on the stenotic throat, correlations were separately conducted 
between the two hemodynamic parameters (τavg and Pulse WSS) and the measured 
intimal thickness. The scatter plots display an inverse trend between the two WSS 
parameters and the measured intimal thickness (Figures 6.1 and 6.2). Due to the small 
sample size at the stenotic throat, a statisitical comparison can not be generated;however, 
the story described by the figures suggests an inverse relationship between the WSS and 
the intimal thickness. With a significant rise in WSS values, a mechanism arose that 
inhibited or controlled the intimal thickening. 
 In Chapter IV a positive relationship was identified between the intimal healing of 
the unstretched stenosis and the examined hemodynamics. Along the axial length of the 
vessel, this relationship was statistically shown between the intimal thickening and the  
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Figure 6.1: Scatter Plot of Intimal Thickening versus τavg.  
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Figure 6.2: Scatter Plot of Intimal Thickening versus Pulse WSS. 
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reciprocals of τavg and Pulse WSS. A question then surfaces as to why an inhibitory 
effect was observed in the comparison of the two stenotic throats but not in this 
previously discussed analysis of the unstretched stenosis. In the Chapter IV discussion, 
the entire length of the vessel was investigated. Progressing along this axial expanse, both 
low and high WSS settings were encountered. In contrast our comparison of the stenotic 
throats was restricted to only high WSS environments. Within the throat of the 
unstretched stenosis, a significant amount of high WSS developed. This level was large 
enough to inhibit intimal thickening relative to the level observed within the stretched 
stenosis. Within its throat, the stretched stenosis generated a high WSS environment; 
however, the WSS did not achieve the magnitude necessary to inhibit intimal thickening. 
In the case of the unstretched stenosis, this needed level was attained. As a result, its 
measured intimal thickening was statistically different than the amount generated by the 
stretched stenosis.  
This apparent need for a minimum level of high WSS assumed greater importance 
given that the shear stress responsive endothelium had only recently been deposited. This 
shear stress responsive endothelium occupies a critical role in detecting changes in the 
WSS. Since the endothelium had only recently been deposited, sufficient time had not 
passed for the vessel to adequately react to the changing hemodynamics. Potentially, the 
endothelium could only react to an excessively elevated level of WSS as seen within the 
unstretched stenosis. This leads us to question whether such an elevated level of high 
WSS would be needed if the shear stress responsive endothelium had been present during 
the entire period of implantation. Essentially, if the endothelium had been present for a 
longer period of time, other changes in the level of intimal thickening of the stretched 
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stenosis may have been recorded. This observation characterizes the differences in the 
healing dynamics between sub-acute and chronic studies of graft healing. In the future, 
greater insight may be offered by studies using tissue-engineered vessels already seeded 





Future Direction and Recommendations 
 
 
 This study provided a nice framework for future investigations of vascular grafts 
and their healing response. There is an assortment of different projects that could be 
pursued. First, further work could be conducted into the healing response of allogeneic 
vessels. Our previously discussed study documented how the vessels heal under sub-
acute conditions. Naturally, the question arises as to how these vessels would heal under 
more chronic conditions and how the measurements of intimal thickening and media 
thickness would vary. The tools used in this work could be used to quantify the histology. 
Secondly, further investigations could be pursued into how graft ultrastructure affects 
healing. We would like to pursue a study where the void fraction of the graft material is 
changed but without a concordant reduction in graft thickness. Such a study would 
further reveal to what extent that transmural ingrowth is governed by such ultrastructure 
parameters as void fraction. Thirdly, we would like to further investigate the stenotic 
model of the vascular graft.  We completed a detailed study under sub-acute conditions, 
and the natural progression follows to investigate the same questions under more chronic 
conditions. Furthermore, we are interested in the differences in graft healing as you 
progress around the circumference of the vessel. There are many possible questions that 
arise from such an investigation. Is more intimal thickening deposited upon the anterior 
or posterior surface post-stenotically and how does this relate to the hemodynamics? 
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Does the lumbar lordosis affect intimal deposition on the lateral walls of the graft? Such 
an investigation may provide additional insight into the relationship between 
hemodynamics and graft healing. In our already completed work this positional 
information was not preserved. New experimental techniques using molecular beacons 
may facilitate this approach. Lastly, we are interested in further studying vessel 
reconstruction of in vivo vascular grafts using such non-invasive imaging modalities as 
MRI. More powerful magnets have become available that possess much improved 
resolution. With greater resolution, the quality of the PCMRI measurements will also be 
enhanced. Improvements in the smoothing algorithm may better preserve details of the 
geometry. One possible means of improving the vessel reconstruction is by combining 
information from both the histology and the MRI. Combining the strengths of the 
histologic approach to capture the borders of the graft’s wall with the three-dimensional 
information afforded by the MRI creates a very complete model. The construction of 
such a model will furnish future insight into how future models can be constructed using 
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